2025/04/05 更新

写真a

モリイシ コウジ
森石 恆司
Moriishi Kohji
所属
大学院 総合研究部 医学域 基礎医学系(微生物学) 教授
職名
教授
連絡先
メールアドレス

その他の所属・職名

  • 基礎医学系(総合分析実験センター)  センター長

経歴

  • 北海道大学   遺伝子病制御研究所 肝炎ウイルス分野   教授

    2022年1月 - 2028年12月

  • 大阪大学医学部、非常勤講師・招へい教授   教授

    2011年4月 - 現在

  • 山梨大学教授(微生物学講座)   教授

    2010年8月 - 現在

  • 大阪大学微生物病研究所 准教授   准教授

    2007年4月 - 2010年7月

  • 大阪大学微生物病研究所分子ウイルス分野 助教授   准教授

    2005年4月 - 2007年3月

  • 大阪大学微生物病研究所エマージング感染症研究センター助教授   准教授

    2000年8月 - 2005年3月

  • 国立感染症研究所、主任研究官   主任研究官

    2000年4月 - 2000年7月

  • 国立感染症研究所 研究員   研究員

    1999年3月 - 2000年3月

  • 日本科学技術振興財団、海外派遣研究員、The Walter and Eliza Hall Institute of Medical Research (Melbourne, Australia)   海外派遣研究員

    1997年3月 - 1999年3月

  • 国立予防衛生研究所(現国立感染症研究所)研究員   研究員

    1993年4月 - 1997年3月

  • ヒューマンサイエンス財団流動研究員(国立予防衛生研究所、現国立感染症研究所)   ポスドク

    1992年4月 - 現在

  • 日本学術振興会特別研究員   ポスドク

    1991年4月 - 現在

▼全件表示

学歴

  • 北海道大学   獣医学研究科   形態機能学専攻

    - 1992年3月

      詳細を見る

    国名: 日本国

    備考: (事項) 北海道大学大学院獣医学研究科形態機能学専攻博士課程後期修了

    課程: 博士後期

  • 北海道大学   獣医学研究科   形態機能学専攻

    - 1989年3月

      詳細を見る

    国名: 日本国

    備考: (事項) 北海道大学大学院獣医学研究科形態機能学専攻博士課程前期修了

    課程: 博士前期

  • 北海道大学   獣医学部   獣医学科

    - 1987年3月

      詳細を見る

    国名: 日本国

    備考: (事項) 北海道大学獣医学部卒業

    課程: 修士

学位

  • 博士(獣医学) ( 1992年3月   北海道大学 )

  • 修士(獣医学) ( 1989年3月   北海道大学 )

その他の経歴

  • 北海道大学遺伝子病制御研究所 肝炎ウイルス分野 教授(クロスアポイント)2022年〜

研究分野

  • ライフサイエンス / ウイルス学

  • ライフサイエンス / ウイルス学

研究キーワード

  • C型肝炎ウイルス、B型肝炎ウイルス、日本脳炎ウイルス、フラビウイルス、SARS-CoV-2

研究テーマ

  • B型肝炎ウイルスの病原性発現機構とウイルス感染機序に関する研究

  • C型肝炎ウイルスの感染機構と病原性発現に関する研究

共同研究・競争的資金等の研究

  • B型肝炎ウイルス持続感染実験モデルを用いた病態解明及び新しい治療法の開発に資する研究

    研究課題/領域番号:24fk0310511h0903  2022年4月 - 2025年3月

    AMED  AMED  B型肝炎創薬実用化等研究事業  肝炎等克服実用化研究事業 

    森石恆司

      詳細を見る

    担当区分:研究分担者  資金種別:競争的資金  資金の種類:他の外部資金

  • 変異型新型コロナウイルスに対する診断・予防・治療法研究プラットホームの開発

    2021年10月 - 2022年3月

    AMED  新興・再興感染症に対する革新的医薬品等開発推進研究事業  101 新型コロナウイルス感染症の克服及び今後新たに発生する感染症対策のための基盤整備事業(新興・再興感染症データバンク事業)等を活用した研究

    豊嶋 崇徳

      詳細を見る

    資金種別:競争的資金 

    本研究開発は、北海道と東北が連携して、変異を続ける新型コロナウイルスSARS-CoV-2感染者からの検体収集プラットフォームを構築するとともに、それら検体を用いて国際的にもトップの全国の研究者が協働し、当該ウイルスの新規診断・予防・治療法の研究開発プラットフォームを構築し、当該感染症を制圧し、将来の新たな新興感染症に対する基盤の整備を目的とする。

  • 肝炎ウイルスの感染複製増殖と病原性発現を阻止するための基盤的研究とその応用のための基盤的開発

    2021年4月 - 2022年3月

    肝炎等克服実用化研究事業  日本医療研究開発機構  肝炎等克服実用化研究事業

    村松正道

      詳細を見る

    資金種別:競争的資金 

  • ウイルス-人体相互作用ネットワークの理解と制御

    2020年12月 - 2025年11月

    国立研究開発法人科学技術振興機構  山梨大学  ムーンショット型研究開発事業  ウイルス-人体相互作用ネットワークの理解と操作

    森石 恆司

      詳細を見る

    担当区分:研究分担者 

  • ウイルス-人体相互作用ネットワークの理解と制御 (慢性肝炎原因のウイルスモデル作製とネットワーク解析)

    2020年11月 - 2021年3月

    内閣府 日本学術新興機構  ムーンショット  ムーンショット 「2050年までに、超早期に疾患の予測・予防をすることができる社会を実現」目標2

    松浦善治

      詳細を見る

    資金種別:競争的資金 

  • メカニズムに基づく抗SARS-CoV-2薬の創薬を目指した研究

    2020年11月 - 2021年3月

    AMED  新興・再興感染症に対する革新的医薬品等開発推進研究事業  新興・再興感染症に対する革新的医薬品等開発推進研究事業

    松浦善治

      詳細を見る

    資金種別:競争的資金 

  • 2020年度 / 令和2年度 「新興・再興感染症に対する革新的医薬品等開発推進研究事業(新型コロナウイルス感染症(COVID-19)に対する研究)」に係る公募(5次公募)(課題公募番号101、201、301)について

    2020年10月 - 2021年3月

    国立研究開発法人日本医療研究開発機構  山梨大学  日本医療研究開発機構研究費・新興・再興感染症に対する革新的医薬品等開発推進研究事業  メカニズムに基づくSARS-CoV-2創薬を目指した基礎および非臨床研究

    森石 恆司

      詳細を見る

    担当区分:研究分担者 

  • B型肝炎ウイルス(HBV)感染サイクル(生活環)で機能する宿主・ウイルス因子を標的とした新規抗HBV剤・HBV感染制御法の開発

    2020年4月 - 2021年3月

    国立研究開発法人日本医療研究開発機構  B型肝炎創薬実用化等研究事業  2017年度肝炎等克服実用化研究事業(B型肝炎創薬実用化等研究事業)

      詳細を見る

    資金種別:競争的資金 

  • 肝炎ウイルスの感染複製増殖と病原性発現を阻止するための基盤的研究とその応用のための基盤的開発

    2020年4月 - 2021年3月

    肝炎等克服実用化研究事業  日本医療研究開発機構  肝炎等克服実用化研究事業

    村松正道

      詳細を見る

    資金種別:競争的資金 

  • 肝炎ウイルスの感染複製増殖と病原性発現を阻止するための基盤的研究とその応用のための基盤的開発

    2019年4月 - 2022年3月

    国立研究開発法人日本医療研究開発機構  山梨大学  肝炎等克服実用化研究事業・肝炎等克服緊急対策研究事業 

    森石 恆司

      詳細を見る

    担当区分:研究分担者 

  • 肝炎ウイルスの感染複製増殖と病原性発現を阻止するための基盤的研究とその応用のための基盤的開発

    2019年4月 - 2020年3月

    肝炎等克服実用化研究事業  日本医療研究開発機構  肝炎等克服実用化研究事業

    村松正道

      詳細を見る

    資金種別:競争的資金 

  • B型肝炎ウイルス(HBV)感染サイクル(生活環)で機能する宿主・ウイルス因子を標的とした新規抗HBV剤・HBV感染制御法の開発

    2017年4月 - 2022年3月

    国立研究開発法人日本医療研究開発機構  山梨大学  肝炎等克服実用化研究事業・B型肝炎創薬実用化等研究事業 

    森石 恆司

      詳細を見る

    担当区分:研究分担者 

  • 新規メカニズムに基づくB型肝炎治療薬の探索

    2017年4月 - 2022年3月

    国立研究開発法人日本医療研究開発機構  山梨大学  肝炎等克服実用化研究事業・B型肝炎創薬実用化等研究事業 

    森石 恆司

      詳細を見る

    担当区分:研究分担者 

  • B型肝炎ウイルス(HBV)感染サイクル(生活環)で機能する宿主・ウイルス因子を標的とした新規抗HBV剤・HBV感染制御法の開発

    2017年4月 - 2018年3月

    AMED  感染症実用化研究事業  肝炎等克服実用化研究事業 B型肝炎創薬実用化等研究事業

    上田啓次

      詳細を見る

    資金種別:競争的資金 

  • B型肝炎ウイルスの完全排除等、完治を目指した新規治療法の開発に関する包括的研究

    2016年4月 - 2017年3月

    AMED 

      詳細を見る

    資金種別:競争的資金 

  • プロテオミクスに基づく新規の抗肝炎ウイルス戦略

    2016年4月 - 2017年3月

      詳細を見る

    資金種別:競争的資金 

  • B型肝炎ウイルス感染受容体の分離・同定と感染系の樹立及び感染系による病態機構の解析と新規抗HBV剤の開発

    2016年4月 - 2017年3月

    AMED 

      詳細を見る

    資金種別:競争的資金 

  • サンゴ礁生物からの新規抗ウイルス剤の探索

    研究課題/領域番号:26350973  2014年4月 - 2017年3月

    日本学術振興会  琉球大学  科学研究費助成事業  基盤研究(C)

    田中 淳一, 野田 尚弘, 関口 勇地, 谷 英典, 森石 恆司, 山下 篤哉, 常田 聡, 秋光 信佳, 津吹 政可, 藤田 喜久, 東 雅大

      詳細を見る

    沖縄沿岸で採集したサンゴ礁生物からエキスライブラリー、ならびに少数の海洋天然物ライブラリーを作成し、それらを HCV NS3 helicase、HCV replicon、HBV core promoterなどの抗ウイルススクリーニングに提供した。ヒットしたエキスからは、アッセイと並行して活性成分を単離・構造決定をするとともに、同定した化合物の類縁体の探索、誘導体の作成、活性評価を行った。これらの内容を研究協力者とともに論文と学会で報告してきた。

  • 海洋生物を創薬ソースとしたC型慢性肝炎治療薬候補化合物の探索

    研究課題/領域番号:25460985  2013年4月 - 2016年3月

    日本学術振興会  山梨大学  科学研究費助成事業  基盤研究(C)

    山下 篤哉, 榎本 信幸, 森石 恆司

      詳細を見る

    我々は、これまでに、新規C型慢性肝炎治療薬の候補化合物を見出すための創薬ソースとして海洋生物抽出物に着目し、C型肝炎ウイルス(HCV)増殖抑制活性を有するものを探索してきた。その結果、海綿Amphimedonの抽出物にHCVヘリカーゼ及びNS34Aプロテアーゼの阻害活性があり、レプリコン細胞においてもHCV増殖阻害活性があることを見出した。そこで、その活性成分の同定を試みたが見出すことは出来なかった。更に、HCV NS2/3 プロテアーゼの阻害剤スクリーニングシステムを構築し、海洋生物抽出物よりその探索を試みたが、NS2/3 プロテアーゼ阻害活性を有するものを見出すことが出来なかった。

  • 肝細胞癌で発現するp63の機能:DNA損傷応答およびウイルス発癌との関連

    研究課題/領域番号:25460475  2013年4月 - 2016年3月

    日本学術振興会  山梨大学  科学研究費助成事業  基盤研究(C)

    加藤 伊陽子, 森石 恆司, 倉田 俊一

      詳細を見る

    本研究はがん抑制遺伝子p53ファミリーの1つであるp63の肝癌細胞での発現と機能、肝癌ウイルス関連因子とp63の相互作用を解析し、p63と肝癌発症の関連を明らかにすることを目的とした。扁平上皮癌と対照的に、p63のTAアイソフォーム(TAp63)を強く発現する肝癌細胞が多かった。しかし、肝癌細胞ではTAp63のDNA損傷に対する応答性やp63とウイルス関連因子の直接的な相互作用は検出できなかった。B型およびC型肝炎ウイルスで活性化されるWnt/βカテニンシグナル伝達をΔNp63αが核内で抑制することが明らかになり、ΔNp63が発現される場合、腫瘍化・悪性化の過程を抑制する可能性が示唆された。

  • C型肝炎ウイルスに近縁なウイルスの探索と複製機構の解明

    研究課題/領域番号:24659204  2012年4月 - 2014年3月

    日本学術振興会  山梨大学  科学研究費助成事業  挑戦的萌芽研究

    森石 恆司, 山下 篤哉, 葛西 宏威

      詳細を見る

    本研究の目的はC型肝炎ウイルスと近縁な非霊長類ヘパシウイルスあるいは相同性が高いウイルスの日本における感染状況を明らかにすることを目的にしている。11頭の犬の鼻スワブからそのウイルスは検出できなかったが、ほぼ同一のウイルスが日本産外来種の馬から単離同定できた(馬ヘパシウイルス:EHcV)。血清学的な解析からも感染が確認され、およそ30%前後の日本産馬の既感染が分かった。また、今まで明らかになっていなかったゲノム全領域を決定し、HCVの非翻訳領域と同じ二次RNA構造をもつことがわかった。以上のことから、非霊長類ヘパシウイルスは日本でも高率に日本産馬に感染していることが明らかとなった。

  • プロテアソームによるウイルス感染制御の解析

    研究課題/領域番号:21590508  2009年 - 2011年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    森石 恆司

      詳細を見る

    ユビキチン非依存プロテアソーム活性は、C型肝炎ウイルス(HCV)感染を正に制御するが、その作用点は不明であった。ユビキチン非依存プロテアソーム活性の抑制に伴って、ウイルスゲノム複製以降の過程が低下し、マウス肝臓内における細胞増殖とDNA修復に影響することが示唆された。本研究の結果から、HCV感染と感染による病原性発現にユビキチン非依存プロテアソーム系が関与していることが示唆された。

  • C型肝炎ウイルスによる脂肪合成活性化と関連病態の解析

    研究課題/領域番号:19590473  2007年 - 2008年

    日本学術振興会  大阪大学  科学研究費助成事業  基盤研究(C)

    森石 恆司, 森石 恆司

      詳細を見る

    C型肝炎ウイルス(HCV)コア蛋白質は、細胞内のラフト様構造にも局在してるが、ウイルス感染環あるいは病原性における役割はわかっていない。本研究によって、膜内切断を受けたコア蛋白質はウイルス粒子形成に必要であることが示された。また、コア蛋白質とPA28γの発現によって脂質代謝が増強される現象は、インターフェロン抵抗性を示すC型肝炎患者で多く認められるコア蛋白質変異によって減弱していた。以上のことから、コア蛋白質を修飾する宿主蛋白質を標的にした薬剤が、抗HCV薬として期待出来ることが分かった

  • C型肝炎ウイルス感染による肝発癌に関与する宿主因子の同定とその作用機構

    研究課題/領域番号:16017258  2004年 - 2005年

    日本学術振興会  大阪大学  科学研究費助成事業  特定領域研究

    森石 恆司

      詳細を見る

    肝癌は我が国の癌死の第3位を占め、その約8割がC型肝炎ウイルス(HCV)感染に起因している。HCVコア蛋白質を発現するマウスがヒトと似た経過で脂肪肝・肝癌を発症することから、HCVコア蛋白質の宿主細胞内での機能が注目されている。本研究では、HCVコア蛋白質の成熟過程と病原性発現機構の詳細を明らかにし、宿主蛋白質を標的とした新規治療法開発の基盤確立を目的としている。
    1)HCVコア蛋白質による肝臓脂肪化および癌化におけるPA28γの意義
    PA28γ(-/-)マウス、PA28γ(+/+)コアTgマウス、PA28γ(-/-)コアTgマウスおよびPA28γ(+/+)マウスの肝臓の脂肪化について観察した。PA28γ(+/+)コアTgマウスのみで肝臓の脂肪化が確認され、PA28γ欠損あるいはコア蛋白質非発現のマウスでは肝臓の脂肪化は観察されなかった。脂肪滴の蓄積の原因はトリグリセリド・脂肪酸の蓄積が考えれられることから、脂肪合成関連遺伝子の発現を解析し、特定の転写因子の活性化がマウスおよび培養細胞でコア蛋白質およびPA28γに依存して認められた。その上流域の転写因子の活性化も、コア蛋白質およびPA28γに依存して認められた。肝細胞癌に関してもPA28γノックアウトによって軽減された。
    2)PA28γ遺伝子欠損・コア蛋白質発現による宿主内蛋白質発現の変化:PA28γ(+/+)コアTgマウス、PA28γ(-/-)コアTgマウスおよびPA28γ(+/+)マウス肝臓内蛋白質発現の違いを抗体アレイによって解析し、特定の蛋白質の発現に変化が認められた。

  • プロテアソームによるC型肝炎ウイルス感染機構への影響

    研究課題/領域番号:16590385  2004年 - 2005年

    日本学術振興会  大阪大学  科学研究費助成事業  基盤研究(C)

    森石 恆司

      詳細を見る

    肝癌は我が国の癌死の第3位を占める肝臓細胞癌の原因の8割がC型肝炎による。原因ウイルスであるC型肝炎ウイルス(HCV)のコア蛋白質はその脂肪肝および肝細胞癌発症に深く関わっている。本研究では、HCVコア蛋白質の成熟過程と病原性発現機構の詳細を明らかにし、宿主蛋白質を標的とした新規治療法開発の基盤確立を目的としている。
    1)PA28γによるコア蛋白質の成熟週程への影響
    RNA干渉によるPA28γ発現抑制のために、PA28γに対するsiRNA標的遺伝子配列をU6プロモーターで発現することによって決定し、培養細胞におけるPA28γの発現を大幅に抑制することに成功した。この細胞を解析したところ、翻訳後の修飾あるいは転写調節による脂肪合成および細胞増殖に関与する蛋白質の増減が観察された。膜内切断酵素SPPによる切断に必須なコア蛋白質内のアミノ酸残基および小胞体局在に必須なコア蛋白質内の領域を139-144アミノ酸と176-177アミノ酸領域と同定した。コア蛋白質とE1蛋白質はウイルス粒子を形成するために必須の構造蛋白質である。粒子形成をする際、E1の膜貫通領域を介して、コア蛋白質は結合することが予想され、その結合にはコア蛋白質多量体形成が重要であることがわかった。
    2)SPPおよびPA28γによるコア蛋白質の活性調節
    ヒト細胞内のSPPによる膜貫通領域の切断部位をMALDI-TOF/MSで同定した。また、SPPによる切断によってコア蛋白質の細胞内画分に変化が認められた。PA28γに対する標的配列を決定し、short hairpin RNAによるPA28γの発現調節を培養細胞レベルで行った。その結果、PA28γ発現およびコア蛋白質の発現に伴って、核内プロテアソーム活性が上昇していることが分かった。

  • C型肝炎ウイルスの感染成熟機構と宿主応答

    研究課題/領域番号:15209017  2003年 - 2005年

    日本学術振興会  大阪大学  科学研究費助成事業  基盤研究(A)

    松浦 善治, 森石 恆司

      詳細を見る

    HCVに感染すると肝硬変を経て高率に肝細胞癌を発症する。我が国には2百万人ものHCV感染者が存在すると推定され、既感染者に対する有効な肝癌進展阻止法の開発が急務である。しかしながら、HCVを効率よく複製できる細胞培養系を欠くため、HCVの感染様式や発癌機構は依然として謎に包まれたままである。本研究ではHCVの宿主細胞への侵入および自然免疫の誘導を担うリセプター分子の同定を試みるとともに、ウイルス粒子の成熟過程の解析を解析し、各ステップをターゲットとした新しいC型肝炎治療法の開発の可能性を探ることを目的とした。C型肝炎患者の体内にはhCD81-tropicとhFGFR5-tropicなHCVが産生されている可能性が示唆された。この性状の違いは、感染細胞の種類(肝細胞、リンパ球など)に起因するのか、あるいは同一細胞における感染経過の違いによるものなのかは今のととろ不明である。hCD81-tropicなHCVは大量に産生されて、hCD81との相互作用を介して、主に免疫機構の撹乱やクリオグロブリン血症などの肝外病変の発症に関与し、hFGFR5-tropicなHCVは少量産生され、抗体に中和されずに持続感染に関与しているのかも知れない。

  • C型肝炎ウイルスの感染機構の解折

    研究課題/領域番号:12470072  2000年 - 2002年

    日本学術振興会  大阪大学  科学研究費助成事業  基盤研究(B)

    松浦 善治, 宮沢 孝幸, 森石 恆司

      詳細を見る

    C型肝炎ウイルス(HCV)の肝細胞における感染機構の知見は極めて乏しい。本研究ではHCVの感染の初期過程を解析するため、HCVのエンベロープ蛋白質を粒子表面に被ったシュードタイプウイルス及び細胞融合検出系を構築した。これまでの成績から、ヒト肝癌由来のHepG2細胞にHCVの細胞融合ならびに感染を許容するヒトCD81以外の蛋白因子が存在することが推測される。そこで、HepG2細胞からHCVのレセプター分子の同定を進め以下の成績を得た。
    1)HepG2細胞からmRNAを分離し、そのcDNA発現ライブラリーを作製した。これをシュードタイプウイルスに全く感受性を示さなかったCHO細胞に導入した。
    2)この細胞にシュードタイプウイルスが感染するとGFPを発現する。そこでGFP発現細胞をセルソーターで回収し、そこから発現プラスミドを回収して再度、細胞に導入する操作を繰り返すことによってリセプター遺伝子の同定を進めている。
    3)HepG2細胞の細胞膜画分を抗原としてマウスを免疫して、細胞融合やシュードタイプウイルスの感染を中和できるモノクローナル抗体を作製した。上記の中和抗体が認識する分子を精製した結果、いくつかの侯補分子がクローニングされた。

  • ボツリヌスC1型神経毒素のアクセプターの一次構造と分子機構

    研究課題/領域番号:06760270  1994年

    日本学術振興会  国立予防衛生研究所  科学研究費助成事業  奨励研究(A)

    森石 恆司

      詳細を見る

    パニングによるボツリヌス神経毒素の標的細胞上のアクセプター分子の単離するために、1.毒素分子上の結合領域の大腸菌による発現、2.パニングによるアクセプター分子の単離の二段階で行うことにした。
    1.毒素分子上の結合領域の大腸菌による発現
    C1型毒素とD型毒素は結合する標的細胞上のアクセプター分子は異なると考えられ、その毒素分子結合領域は毒素分子上のC末端側に存在すると考えられている。毒素分子上の結合領域の位置を正確に把握すると共にその部分をクリアカットに単離するために、C1型およびD型毒素遺伝子を単離し、大腸菌で発現する試みを行った。C1型毒素遺伝子をC型6813株からPCRによって、八つの断片として単離し、全核酸配列を決定した。コードされるC1型毒素は1280個のアミノ酸で構成され、分子量147,814であった。また、D型毒素遺伝子をD型サウスアフリカ株の毒素伝達ファージのゲノムDNAから、プラスミドベクターを用いてクローニングした。そこにコードされるD型毒素は既に発表されているC型ストックホルム株とD型1873株の毒素とから構成されるキメラ毒素であることがわかった。結合領域はC末端に存在し、しかもC1型毒素とD型毒素と構造が異なることが予想される。したがって、それら毒素分子の比較分析からC末端380個以内にアクセプター結合領域が存在すると推定した。そのC末端380個と、その中でもさらに相同性低いC末端100個の領域をPCRによって増幅し、PLプロモーターによって発現するpTrxFusベクターに組み込み可溶化画分にチオレドキシン融合蛋白質として得た。その発現蛋白質の結合活性を各種神経芽細胞で検査中である。
    2.パニングによるアクセプター分子の単離
    NG108細胞からmRNAを単離し、それらcDNAを合成しベクターに組み込みCOS細胞で発現ライブラリーを作成した。抗チオレドキシン抗体をプレートに結合させ、発現融合蛋白質をその抗体に結合させ、結合細胞をクローニングしているところである。

▼全件表示

論文

  • NEDD4-binding protein 1 suppresses hepatitis B virus replication by regulating viral RNAs 査読

    Kobayashi N, Suzuki S, Sakamoto Y, Suzuki R, Mori K, Kosugi Y, Saito T, Ma Y, Liang L, Izumi T, Noda K, Okuzaki D, Kanegae Y, Hayashi S, Tanaka Y, Yamashita A, Moriishi K, Matsuura Y, Takeuchi O, Tamura T, Taketomi A, Fukuhara T.

    Journal of General Virology   106 ( 3 )   2025年3月( ISSN:0022-1317 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Microbiology Society  

    DOI: 10.1099/jgv.0.002082.

    DOI: 10.1099/jgv.0.002082.

  • Berberine promotes K48-linked polyubiquitination of HNF4α, leading to the inhibition of HBV replication. 査読 重要な業績

    Atsuya Yamashita, Hirotake Kasai, Shinya Maekawa, Tomohisa Tanaka, Yasunori Akaike, Akihide Ryo, Nobuyuki Enomoto, Kohji Moriishi

    Antiviral research   232   106027 - 106027   2024年11月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.antiviral.2024.106027

    PubMed

  • HCV infection activates the proteasome via PA28γ acetylation and heptamerization to facilitate the degradation of RNF2, a catalytic component of polycomb repressive complex 1. 査読 重要な業績

    Hirotake Kasai, Atsuya Yamashita, Yasunori Akaike, Tomohisa Tanaka, Yoshiharu Matsuura, Kohji Moriishi

    mBio   e0169124   2024年9月( ISSN:2150-7511 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We previously reported that hepatitis C virus (HCV) infection or HCV core protein expression induces HOX gene expression by impairing histone H2A monoubiquitination via a proteasome-dependent reduction in the level of RNF2, a key catalytic component of polycomb repressive complex 1 (H. Kasai, K. Mochizuki, T. Tanaka, A. Yamashita, et al., J Virol 95:e01784-20, 2021, https://doi.org/10.1128/jvi.01784-20). In this study, we aimed to investigate the mechanism by which HCV infection accelerates RNF2 degradation. Yeast two-hybrid screening and an immunoprecipitation assay revealed that RNF2 is a PA28γ-binding protein. The proteasome activator PA28γ destabilized the RNF2 protein in a proteasome-dependent manner, since RNF2 degradation was impaired by PA28γ knockout or MG132 treatment. HCV infection or core protein expression reduced the levels of RNF2 and histone H2A K119 monoubiquitination and induced the expression of HOX genes in the presence of PA28γ, while PA28γ knockout reversed these changes. Treatment with a lysine acetyltransferase inhibitor inhibited the acetylation of PA28γ at K195 and the degradation of the RNF2 protein, while treatment with a lysine deacetylase inhibitor accelerated these events in a PA28γ-dependent manner. RNF2 protein degradation was increased by expression of the acetylation mimetic PA28γ mutant but not by expression of the acetylation-defective mutant or the proteasome activation-defective mutant. Furthermore, HCV infection or core protein expression facilitated the interaction between PA28γ and the lysine acetyltransferase CBP/p300 and then accelerated PA28γ acetylation and heptazmerization to promote RNF2 degradation. These data suggest that HCV infection accelerates the acetylation-dependent heptamerization of PA28γ to increase the proteasomal targeting of RNF2.IMPORTANCEHCV is a causative agent of HCV-related liver diseases, including hepatic steatosis, cirrhosis, and hepatocellular carcinoma. PA28γ, which, in heptameric form, activates the 20S core proteasome for the degradation of PA28γ-binding proteins, is responsible for HCV-related liver diseases. HCV core protein expression or HCV infection accelerates RNF2 degradation, leading to the induction of HOX gene expression via a decrease in the level of H2Aub on HOX gene promoters. However, the mechanism of RNF2 degradation in HCV-infected cells has not been clarified. The data presented in this study suggest that PA28γ acetylation and heptamerization are promoted by HCV infection or by core protein expression to activate the proteasome for the degradation of RNF2 and are responsible for HCV propagation. This study provides novel insights valuable for the development of therapies targeting both HCV propagation and HCV-related diseases.

    DOI: 10.1128/mbio.01691-24

    PubMed

  • SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity. 国際共著

    Aulia Fitri Rhamadianti, Takayuki Abe, Tomohisa Tanaka, Chikako Ono, Hisashi Katayama, Yoshiteru Makino, Lin Deng, Chieko Matsui, Kohji Moriishi, Fumi Shima, Yoshiharu Matsuura, Ikuo Shoji

    Journal of Virology   98 ( 9 )   e0085524   2024年9月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1128/jvi.00855-24

    PubMed

  • Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus 査読

    Yato, K. Matsuda, M. Fukano, K. Tanaka, T. Moriishi, K. Nishitsuji, H. Shimotohno, K. Tamura, K. Wakita, T. Muramatsu, M. Kato, T. Suzuki, R.

    Virus Research   323   2023年1月( ISSN:0168-1702 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

  • Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus. 査読

    Keigo Yato, Mami Matsuda, Kento Fukano, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, Kunitada Shimotohno, Koji Tamura, Takaji Wakita, Masamichi Muramatsu, Takanobu Kato, Ryosuke Suzuki

    Virus research   323   199014 - 199014   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Hepatitis B virus (HBV) infection is a major public health problem. The sodium taurocholate cotransporting polypeptide (NTCP) has been identified as an essential HBV receptor. Human hepatocytes are infected with HBV via binding between the preS1 region of the HBV large envelope protein and the NTCP. However, the role of preS2 in HBV entry is not well understood. In this study, we induced anti-preS2 serum in mice by DNA immunization, and showed that the resulting antiserum neutralized HBV infectivity. Competition assays using overlapping peptides suggested that the neutralizing epitope is located in the N-terminal region of preS2. In addition, monoclonal antibodies targeting the N-terminal region of preS2 neutralized HBV infectivity, indicating that these domains are critical epitopes for viral neutralization. These findings provide new insights into the HBV entry machinery while suggesting a novel modality for the prevention and treatment of HBV infection.

    DOI: 10.1016/j.virusres.2022.199014

    PubMed

  • Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen 査読

    Washizaki, A. Murayama, A. Murata, M. Kiyohara, T. Yato, K. Yamada, N. Aly, H. H. Tanaka, T. Moriishi, K. Nishitsuji, H. Shimotohno, K. Goh, Y. Ishii, K. J. Yotsuyanagi, H. Muramatsu, M. Ishii, K. Takahashi, Y. Suzuki, R. Akari, H. Kato, T.

    Nature Communications   13 ( 1 )   5207   2022年9月( ISSN:2041-1723 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Springer  

  • Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen 査読

    Ayaka Washizaki, Asako Murayama, Megumi Murata, Tomoko Kiyohara, Keigo Yato, Norie Yamada, Hussein Hassan Aly, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, Kunitada Shimotohno, Yasumasa Goh, Ken J. Ishii, Hiroshi Yotsuyanagi, Masamichi Muramatsu, Koji Ishii, Yoshimasa Takahashi, Ryosuke Suzuki, Hirofumi Akari, Takanobu Kato

    Nature Communications   13 ( 1 )   2022年9月(  eISSN:2041-1723 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    Although the current hepatitis B (HB) vaccine comprising small-HBs antigen (Ag) is potent and safe, attenuated prophylaxis against hepatitis B virus (HBV) with vaccine-escape mutations (VEMs) has been reported. We investigate an HB vaccine consisting of large-HBsAg that overcomes the shortcomings of the current HB vaccine. Yeast-derived large-HBsAg is immunized into rhesus macaques, and the neutralizing activities of the induced antibodies are compared with those of the current HB vaccine. Although the antibodies induced by the current HB vaccine cannot prevent HBV infection with VEMs, the large-HBsAg vaccine-induced antibodies neutralize those infections. The HBV genotypes that exhibited attenuated neutralization via these vaccines are different. Here, we show that the HB vaccine consisting of large-HBsAg is useful to compensate for the shortcomings of the current HB vaccine. The combined use of these HB vaccines may induce antibodies that can neutralize HBV strains with VEMs or multiple HBV genotypes.

    DOI: 10.1038/s41467-022-32910-z

    その他リンク: https://www.nature.com/articles/s41467-022-32910-z

  • Hydrophobic Alpha-Helical Short Peptides in Overlapping Reading Frames of the Coronavirus Genome 査読

    Okura, T. Shirato, K. Kakizaki, M. Sugimoto, S. Matsuyama, S. Tanaka, T. Kume, Y. Chishiki, M. Ono, T. Moriishi, K. Sonoyama, M. Hosoya, M. Hashimoto, K. Maenaka, K. Takeda, M.

    Pathogens   11 ( 8 )   877   2022年8月( ISSN:2076-0817 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI  

  • Hydrophobic Alpha-Helical Short Peptides in Overlapping Reading Frames of the Coronavirus Genome 査読

    Takashi Okura, Kazuya Shirato, Masatoshi Kakizaki, Satoko Sugimoto, Shutoku Matsuyama, Tomohisa Tanaka, Yohei Kume, Mina Chishiki, Takashi Ono, Kohji Moriishi, Masashi Sonoyama, Mitsuaki Hosoya, Koichi Hashimoto, Katsumi Maenaka, Makoto Takeda

    Pathogens   11 ( 8 )   877 - 877   2022年8月(  eISSN:2076-0817 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    In this study, we show that the coronavirus (CoV) genome may encode many functional hydrophobic alpha-helical peptides (HAHPs) in overlapping reading frames of major coronaviral proteins throughout the entire viral genome. These HAHPs can theoretically be expressed from non-canonical sub-genomic (sg)RNAs that are synthesized in substantial amounts in infected cells. We selected and analyzed five and six HAHPs encoded in the S gene regions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively. Two and three HAHPs derived from SARS-CoV-2 and MERS-CoV, respectively, specifically interacted with both the SARS-CoV-2 and MERS-CoV S proteins and inhibited their membrane fusion activity. Furthermore, one of the SARS-CoV-2 HAHPs specifically inhibited viral RNA synthesis by accumulating at the site of viral RNA synthesis. Our data show that a group of HAHPs in the coronaviral genome potentially has a regulatory role in viral propagation.

    DOI: 10.3390/pathogens11080877

  • Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action 査読

    Toyama, M. Watashi, K. Ikeda, M. Yamashita, A. Okamoto, M. Moriishi, K. Muramatsu, M. Wakita, T. Sharon, A. Baba, M.

    Antimicrobial Agents and Chemotherapy   66 ( 6 )   e0207321   2022年6月( ISSN:0066-4804 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ASM  

  • Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action 査読

    Masaaki Toyama, Koichi Watashi, Masanori Ikeda, Atsuya Yamashita, Mika Okamoto, Kohji Moriishi, Masamichi Muramatsu, Takaji Wakita, Ashoke Sharon, Masanori Baba

    Antimicrobial Agents and Chemotherapy   2022年5月( ISSN:0066-4804  eISSN:1098-6596 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:American Society for Microbiology  

    Novel neplanocin A derivatives have been identified as potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro . These include (1S,2R,5R)-5-(5-bromo-4-methyl-7H-pyrrolo[2,3-d]-pyrimidin-7-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol (AR-II-04-26) and (1S,2R,5R)-5-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3-(hydroxylmethyl)cyclopent-3-ene-1,2-diol (MK-III-02-03).

    DOI: 10.1128/aac.02073-21

  • SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication 査読

    Miyamoto, Y. Itoh, Y. Suzuki, T. Tanaka, T. Sakai, Y. Koido, M. Hata, C. Wang, C. X. Otani, M. Moriishi, K. Tachibana, T. Kamatani, Y. Yoneda, Y. Okamoto, T. Oka, M.

    Commun Biol   5 ( 1 )   483   2022年5月( ISSN:2399-3642 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Springer  

  • SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.

    Yoichi Miyamoto, Yumi Itoh, Tatsuya Suzuki, Tomohisa Tanaka, Yusuke Sakai, Masaru Koido, Chiaki Hata, Cai-Xia Wang, Mayumi Otani, Kohji Moriishi, Taro Tachibana, Yoichiro Kamatani, Yoshihiro Yoneda, Toru Okamoto, Masahiro Oka

    Communications biology   5 ( 1 )   483 - 483   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORF6 is an antagonist of interferon (IFN)-mediated antiviral signaling, achieved through the prevention of STAT1 nuclear localization. However, the exact mechanism through which ORF6 prevents STAT1 nuclear trafficking remains unclear. Herein, we demonstrate that ORF6 directly binds to STAT1 with or without IFN stimulation, resulting in the nuclear exclusion of STAT1. ORF6 also recognizes importin α subtypes with different modes, in particular, high affinity to importin α1 but a low affinity to importin α5. Although ORF6 potentially disrupts the importin α/importin β1-mediated nuclear transport, thereby suppressing the nuclear translocation of the other classical nuclear localization signal-containing cargo proteins, the inhibitory effect of ORF6 is modest when compared with that of STAT1. The results indicate that the drastic nuclear exclusion of STAT1 is attributed to the specific binding with ORF6, which is a distinct strategy for the importin α1-mediated pathway. Combined with the results from a newly-produced replicon system and a hamster model, we conclude that SARS-CoV-2 ORF6 acts as a virulence factor via regulation of nucleocytoplasmic trafficking to accelerate viral replication, resulting in disease progression.

    DOI: 10.1038/s42003-022-03427-4

    PubMed

  • Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus 査読

    Zhang H, Itoh Y, Suzuki T, Ihara KI, Tanaka T, Haga S, Enatsu H, Yumiya M, Kimura M, Takada A, Itoh D, Shibazaki Y, Nakao S, Yoshio S, Miyakawa K, Miyamoto Y, Sasaki H, Kajita T, Sugiyama M, Mizokami M, Tachibana T, Ryo A, Moriishi K, Miyoshi E, Kanto T, Okamoto T, Matsuura Y.

    Microbiol Immunol   66 ( 4 )   179 - 192   2022年4月( ISSN:0385-5600 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1111/1348-0421.12964

    PubMed

  • Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.   査読 重要な業績

    Tanaka, T. Saito, A. Suzuki, T. Miyamoto, Y. Takayama, K. Okamoto, T. Moriishi , K.

    Antiviral Research   189   105268 - 105268   2022年3月( ISSN:0166-3542 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

    DOI: 10.1016/j.antiviral.2022.105268

  • Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry 査読 重要な業績

    Tanaka, T. Okuyama-Dobashi, K. Motohashi, R. Yokoe, H. Takahashi, K. Wiriyasermkul, P. Kasai, H. Yamashita, A. Maekawa, S. Enomoto, N. Ryo, A. Nagamori, S. Tsubuki, M. Moriishi, K.

    Antiviral Research   194   105165 - 105165   2021年8月( ISSN:0166-3542 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

    DOI: 10.1016/j.antiviral.2021.105165

    PubMed

  • Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure 査読

    Honda, T. Yamada, N. Murayama, A. Shiina, M. Aly, H. H. Kato, A. Ito, T. Ishizu, Y. Kuzuya, T. Ishigami, M. Murakami, Y. Tanaka, T. Moriishi, K. Nishitsuji, H. Shimotohno, K. Ishikawa, T. Fujishiro, M. Muramatsu, M. Wakita, T. Kato, T.

    Cellular and Molecular Gastroenterology and Hepatology   12 ( 5 )   1583 - 1598   2021年8月( ISSN:2352-345X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.jcmgh.2021.07.013

    PubMed

  • DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples 査読

    Izumi, T. Morioka, Y. Urayama, S. I. Motooka, D. Tamura, T. Kawagishi, T. Kanai, Y. Kobayashi, T. Ono, C. Morinaga, A. Tomiyama, T. Iseda, N. Kosai, Y. Inokuchi, S. Nakamura, S. Tanaka, T. Moriishi, K. Kariwa, H. Yoshizumi, T. Mori, M. Matsuura, Y. Fukuhara, T.

    PLoS One   13 ( 7 )   1310   2021年7月( ISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3390/v13071310

    PubMed

  • Hepatitis C virus modulates signal peptide peptidase to alter host protein processing 査読

    Hirano J, Yoshio S, Sakai Y, Songling L, Suzuki T, Itoh Y, Zhang H, Chen DV, Haga S, Oomori H, Kodama T, Maeda Y, Ono Y, Takahashi Y, Standley DM, Yamamoto M, Moriishi K, Moriya K, Kanto T, Takehara T, Koike K, Matsuura Y, Okamoto T

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   118 ( 22 )   e2026184118   2021年6月( ISSN:0027-8424 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1073/pnas.2026184118.

  • Hepatitis C virus modulates signal peptide peptidase to alter host protein processing 査読 国際共著

    Junki Hirano, Sachiyo Yoshio, Yusuke Sakai, Li Songling, Tatsuya Suzuki, Yumi Itoh, He Zhang, David Virya Chen, Saori Haga, Hiroko Oomori, Takahiro Kodama, Yusuke Maeda, Yoshihiro Ono, Yu Takahashi, Daron M. Standley, Masahiro Yamamoto, Kohji Moriishi, Kyoji Moriya, Tatsuya Kanto, Tetsuo Takehara, Kazuhiko Koike, Yoshiharu Matsuura, Toru Okamoto

    Proceedings of the National Academy of Sciences   118 ( 22 )   e2026184118 - e2026184118   2021年6月( ISSN:0027-8424  eISSN:1091-6490 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Proceedings of the National Academy of Sciences  

    Immunoevasins are viral proteins that prevent antigen presentation on major histocompatibility complex (MHC) class I, thus evading host immune recognition. Hepatitis C virus (HCV) evades immune surveillance to induce chronic infection; however, how HCV-infected hepatocytes affect immune cells and evade immune recognition remains unclear. Herein, we demonstrate that HCV core protein functions as an immunoevasin. Its expression interfered with the maturation of MHC class I molecules catalyzed by the signal peptide peptidase (SPP) and induced their degradation via HMG-CoA reductase degradation 1 homolog, thereby impairing antigen presentation to CD8+ T cells. The expression of MHC class I in the livers of HCV core transgenic mice and chronic hepatitis C patients was impaired but was restored in patients achieving sustained virological response. Finally, we show that the human cytomegalovirus US2 protein, possessing a transmembrane region structurally similar to the HCV core protein, targets SPP to impair MHC class I molecule expression. Thus, SPP represents a potential target for the impairment of MHC class I molecules by DNA and RNA viruses.

    DOI: 10.1073/pnas.2026184118

    PubMed

    その他リンク: https://syndication.highwire.org/content/doi/10.1073/pnas.2026184118

  • Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses. 査読 重要な業績

    Otoguro T, Tanaka T, Kasai H, Kobayashi N, Yamashita A, Fukuhara T, Ryo A, Fukai M, Taketomi A, Matsuura Y, Moriishi K

    Hepatology Communications   5 ( 4 )   634 - 649   2021年4月( ISSN:2471-254X  eISSN:2471-254X )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Weily  

    DOI: 10.1002/hep4.1653

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep4.1653

  • Induction of HOX genes by HCV infection via impairment of histone H2A monoubiquitination. 査読 重要な業績

    Kasai H, Mochizuki K, Tanaka T, Yamashita A, Matsuura Y, Moriishi K

    Journal of Virology   95 ( 6 )   e01784-20 - e01784-20   2021年2月( ISSN:0022-538X )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:American Society for Microbiology  

    DOI: 10.1128/JVI.01784-20

    PubMed

  • N-Terminal PreS1 Sequence Regulates Efficient Infection of Cell-Culture-Generated Hepatitis B Virus 査読 重要な業績

    Asako Murayama , Norie Yamada , Yoshiki Osaki , Masaaki Shiina , Hussein Hassan Aly , Masashi Iwamoto, Senko Tsukuda, Koichi Watashi , Mami Matsuda , Ryosuke Suzuki , Tomohisa Tanaka , Kohji Moriishi, Tetsuro Suzuki, Hironori Nishitsuji, Masaya Sugiyama , Masashi Mizokami , Kunitada Shimotohno , Takaji Wakita , Masamichi Muramatsu , T Jake Liang , Takanobu Kato

    Hepatology   73 ( 2 )   520 - 532   2021年2月( ISSN:0270-9139 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1002/hep.31308

    PubMed

  • Deep Sequencing Analysis of Serum Hepatitis B Virus-RNA During Nucleot (side Analogue Therapy 査読

    Matsuda, S. Maekawa, S. Komiyama, Y. Nakakuki, N. Muraoka, M. Suzuki, Y. Sato, M. Tatsumi, A. Miura, M. Amemiya, F. Shindo, H. Takano, S. Fukasawa, M. Yamaguchi, T. Nakayama, Y. Inoue, T. Sato, T. Yamashita, A. Moriishi, K. Enomoto, N.

    Hepatology Research   51 ( 1 )   39 - 50   2021年1月( ISSN:1386-6346  eISSN:1872-034X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1111/hepr.13574

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/hepr.13574

  • B型肝炎ウイルスpreS2領域に対する抗体はウイルス感染を抑制する

    矢藤慶悟, 矢藤慶悟, 深野顕人, 松田麻未, 田中智久, 森石恆司, 西辻裕紀, 下遠野邦忠, 田村浩二, 加藤孝宣, 村松正道, 鈴木亮介, 鈴木亮介

    日本ウイルス学会学術集会プログラム・予稿集(Web)   68th   2021年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)  

    J-GLOBAL

  • SARS-CoV-2構成因子ORF6による核輸送制御機構

    宮本洋一, 伊東祐美, 鈴木達也, 田中智久, 坂井祐介, 小井土大, 波田千彰, WANG Cai-Xia, 大谷真弓, 森石恆司, 立花太郎, 立花太郎, 鎌谷洋一郎, 米田悦啓, 岡本徹, 岡正啓

    日本細胞生物学会大会(Web)   73rd   2021年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)  

    J-GLOBAL

  • Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes. 査読

    Yuichi Akahori, Hiroki Kato, Takashi Fujita, Kohji Moriishi, Yasuhito Tanaka, Koichi Watashi, Michio Imamura, Kazuaki Chayama, Takaji Wakita, Makoto Hijikata

    Scientific reports   10 ( 1 )   21718 - 21718   2020年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent development of hepatitis B virus (HBV) culture systems has made it possible to analyze the almost all steps of the viral life cycle. However, the reproducibility of interaction between HBV and host cells seemed inaccurate in those systems because of utilization of cancer cell lines with a difference from hepatocytes in the majority of cases. In this study, in order to resolve this point, a novel HBV culture system using non-cancer-derived immortalized human hepatocytes derived cell lines, producing exogenous human sodium taurocholate cotransporting polypeptide, was developed. One of the cell clones, E/NtG8 cells, was permissive to both blood-borne HBV (HBVbb) and culture-derived recombinant HBV when cultured in the three-dimensional condition. Furthermore, the production of infectious HBV particles, which showed the similar physicochemical properties to HBVbb, was observed for about a month after HBVbb infection in this system, suggesting that it may reproduce whole steps of the HBV lifecycle under the condition analogous to human liver cells infected with HBV. This system seemed to contribute not only to find novel interactions between HBV and host cells but also to understand mechanism of HBV pathogenesis.

    DOI: 10.1038/s41598-020-78655-x

    PubMed

  • Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1 査読

    Yato, K. Onodera, T. Matsuda, M. Moriyama, S. Fujimoto, A. Watashi, K. Aizaki, H. Tanaka, T. Moriishi, K. Nishitsuji, H. Shimotohno, K. Tamura, K. Takahashi, Y. Wakita, T. Muramatsu, M. Kato, T. Suzuki, R.

    Journal of Virology   95 ( 5 )   e01680-20   2020年12月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:American Society of Microbiology  

    DOI: 10.1128/JVI.01680-20

    PubMed

  • Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings 査読

    Muraoka, M. Maekawa, S. Suzuki, Y. Sato, M. Tatsumi, A. Matsuda, S. Miura, M. Nakakuki, N. Shindo, H. Amemiya, F. Takano, S. Fukasawa, M. Nakayama, Y. Yamaguchi, T. Inoue, T. Sato, T. Yamashita, A. Moriishi, K. Matsuda, M. Enomoto, N.

    Hepatology Research   50 ( 9 )   1071 - 1081   2020年9月( ISSN:1386-6346  eISSN:1872-034X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1111/hepr.13529

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/hepr.13529

  • Anti-Viral Effects of Interferon-λ3 on Hepatitis B Virus Infection in Cell Culture 査読

    N. Yamada, A. Murayama, M. Shiina, H. H. Aly, M. Iwamoto, S. Tsukuda, K. Watashi, T. Tanaka, K. Moriishi, H. Nishitsuji, M. Sugiyama, M. Mizukami, K. Shimotohno, M. Muramatsu, K. Murata, T. Kato

    Hepatology Research   50 ( 3 )   283 - 291   2020年3月( ISSN:1386-6346  eISSN:1872-034X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/hepr.13449

    PubMed

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/hepr.13449

  • C-terminal alpha Domain of p63 Binds to p300 to Coactivate beta-Catenin 査読

    Katoh I, Maehata Y, Moriishi K, Hata RI, Kurata SI:

    Neoplasia   21 ( 5 )   494 - 503   2019年3月( ISSN:1476-5586 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.neo.2019.03.010

    PubMed

  • HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers 査読

    Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N.

    PLOS one   14   e0212559   2019年2月( ISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Potential Risk of Virus Carryover by Fabrics of Personal Protective Gowns. 査読

    Katoh I, Tanabe F, Kasai H, Moriishi K, Shimasaki N, Shinohara K, Uchida Y, Koshiba T, Arakawa S, Morimoto M

    Front Public Health   7   121   2019年1月( ISSN:2296-2565 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3389/fpubh.2019.00121

    PubMed

  • USP15 participates in HCV propagation through the regulation of viral RNA translation and lipid droplet formation. 査読

    Kusakabe S, Suzuki T, Sugiyama Y, Haga S, Horike K, Tokunaga M, Hirano J, He Z, Chen DV, Ishiga H, Komoda Y, Ono C, Fukuhara T, Yamamoto M, Ikawa M, Satoh T, Akira S, Tanaka T, Moriishi K, Fukai M, Taketomi A, Yoshio S, Kanto T, Suzuki T, Okamoto T, Matsuura Y.

    Journal of Virology   93 ( 6 )   e01708-18   2019年1月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1128/JVI.01708-18

    PubMed

  • HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers. 査読

    Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N

    PloS one   14 ( 2 )   e0212559 - e0212559   2019年(  eISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1371/journal.pone.0212559

    PubMed

  • HBV patients with low HBsAg and high HBcrAg titers have a high risk of HBV-related HCC. 査読

    Suzuki, Y. Maekawa, S. Komatsu, N. Sato, M. Tatsumi, A. Miura, M. Matsuda, S. Muraoka, M. Nakakuki, N. Shindo, H. Amemiya, F. Takano, S. Fukasawa, M. Nakayama, Y. Yamaguchi, T. Inoue, T. Sato, T. Sakamoto, M. Yamashita, A. Moriishi, K. Enomoto, N.

    Hepatol Res   49 ( 1 )   51 - 63   2018年10月( ISSN:1386-6346 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • HBV patients with low HBsAg and high HBcrAg titers have a high risk of HBV-related HCC. 査読

    Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N

    Hepatology research : the official journal of the Japan Society of Hepatology   49 ( 1 )   51 - 63   2018年10月( ISSN:1386-6346 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/hepr.13277

    PubMed

  • Generation of monoclonal antibodies against hepatitis B virus preS1 region from antigen‐specific memory B cells

    YATO Keigo, YATO Keigo, ONODERA Taishi, MATSUDA Mami, FUJIMOTO Akira, WATASHI Koichi, AIZAKI Hideki, KATO Takanobu, MORIISHI Kohji, TAMURA Koji, TAKAHASHI Yoshimasa, WAKITA Takaji, MURAMATSU Masamichi, SUZUKI Ryosuke

    日本ウイルス学会学術集会プログラム・抄録集   66th   177   2018年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(その他学術会議資料等)  

    J-GLOBAL

  • Roles of the 5' untranslated region of non-primate hepacivirus in translation initiation and viral replication. 査読 重要な業績

    Tanaka T, Otoguro T, Yamashita A, Kasai H, Fukuhara T, Matsuura Y, Moriishi K

    Journal of Virology   92 ( 7 )   e01997-17   2018年4月( ISSN:0022-538X  eISSN:1098-5514 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:American Society for Microbiology  

    DOI: 10.1128/JVI.01997-17

    Scopus

    PubMed

  • Catechol Group of Cinnamic Acid Derivative Is Essential for Its Anti-Hepatitis C Virus Activity. 査読

    Amano R, Yamashita A, Kasai H, Hori T, Miyasato S, Saito S, Tsubuki M, Moriishi K

    Yamanashi Medical Journal   32 ( 2 )   95 - 103   2018年1月( ISSN:1348-5091 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Seroepidemiology of non-primate hepacivirus (NPHV) in Japanese native horses 査読

    Shizuka HAYASHI, Tomohisa TANAKA, Kohji MORIISHI, Kazuhiro HIRAYAMA, Akio YAMADA, Kozue HOTTA

    Journal of Veterinary Medical Science   80 ( 1 )   186 - 189   2018年( ISSN:0916-7250  eISSN:1347-7439 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Japanese Society of Veterinary Science  

    DOI: 10.1292/jvms.17-0527

    Scopus

    PubMed

  • Characterization of SPP inhibitors suppressing propagation of HCV and protozoa 査読

    Hirano, J., Okamoto, T., Sugiyama, Y., Suzuki, T., Kusakabe, S., Tokunaga, M., Fukuhara, T., Sasai, M., Tougan, T., Matsunaga, Y., Yamashita, K., Sakai, Y., Yamamoto, M., Horii, T., Standley, D. M., Moriishi, K., Moriya, K., Koike, K., Matsuura, Y.

    Proceedings of the National Academy of Sciences of the United States of America   114 ( 50 )   E10782 - E10791   2017年12月( ISSN:0027-8424 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1073/pnas.1712484114

    Web of Science

    PubMed

  • Insights into the mechanism of isoenzyme-specific signal peptide peptidase-mediated translocation of heme oxygenase 査読

    Schaefer, B. Moriishi, K. Behrends, S.

    PLoS one   12 ( 11 )   e0188344   2017年11月( ISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PLOS  

    DOI: 10.1371/journal.pone.0188344

    Web of Science

    PubMed

  • The potential of signal peptide peptidase as a therapeutic target for hepatitis C 招待 査読 重要な業績

    Moriishi, K.

    Expert Opinion on Therapeutic Targets   21 ( 9 )   827 - 836   2017年8月( ISSN:1472-8222  eISSN:1744-7631 )

     詳細を見る

    担当区分:筆頭著者, 最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Tayer & Francis  

    DOI: 10.1080/14728222.2017.1369959

    Web of Science

    PubMed

  • Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity 査読 重要な業績

    Yamashita, A. Tamaki, M. Kasai, H. Tanaka, T. Otoguro, T. Ryo, A. Maekawa, S. Enomoto, N. de Voogd, N. J. Tanaka, J. Moriishi, K.

    Antiviral Research   145   136 - 145   2017年8月( ISSN:0166-3542  eISSN:1872-9096 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

    DOI: 10.1016/j.antiviral.2017.08.001

    Web of Science

    PubMed

  • Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress 査読 重要な業績

    Amano, R. Yamashita, A. Kasai, H. Hori, T. Miyasato, S. Saito, S. Yokoe, H. Takahashi, K. Tanaka, T. Otoguro, T. Maekawa, S. Enomoto, N. Tsubuki, M. Moriishi, K.

    Antiviral Research   145   123 - 130   2017年8月( ISSN:0166-3542  eISSN:1872-9096 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

    DOI: 10.1016/j.antiviral.2017.07.018

    Web of Science

    PubMed

  • Hepatitis B virus prevents excessive viral production via reduction of cell-death inducing DFF45-like effectors 査読 重要な業績

    Jun Yasumoto, Hirotake Kasai, Kentaro Yoshimura, Teruhime Otoguro, Koichi Watashi, Takaji Wakita, Atsuya Yamashita, Tomohisa Tanaka, Sen Takeda and Kohji Moriishi

    Journal of General Virology   98 ( 7 )   1762 - 1773   2017年8月( ISSN:0022-1317  eISSN:1465-2099 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1099/jgv.0.000813

    Web of Science

    PubMed

  • Immunological function of Langerhans cells in HIV infection. 査読

    Matsuzawa T, Ogawa Y, Moriishi K, Shimada S, Kawamura T.

    J Dermatol Sci   87 ( 2 )   159 - 167   2017年8月( ISSN:0923-1811 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

    DOI: 10.1016/j.jdermsci.2017.03.015.

  • Immunological function of Langerhans cells in HIV infection 査読

    Takamitsu Matsuzawa, Youichi Ogawa, Kohji Moriishi, Shinji Shimada, Tatsuyoshi Kawamura

    JOURNAL OF DERMATOLOGICAL SCIENCE   87 ( 2 )   159 - 167   2017年8月( ISSN:0923-1811  eISSN:1873-569X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    Background: Langerhans cells (LCs) are one of the initial target cells for HIV following sexual exposure and they are productively infected by HIV. HIV-infected LCs migrate to the draining lymph nodes (dLNs) and transmit the virus to CD4+ T cells, leading to the dissemination of HIV. In contrast with the role of LCs in initial HIV acquisition, little is known about the modulation of immune responses by HIV-infected LCs.
    Objective: We aimed to elucidate the induction of HIV-specific CD8+ T cells and regulatory T cells (Tregs), both of which play important roles in regulating the progression of HIV infection.
    Methods: We examined the inducibility of HLA-A*0201 restricted HIV-specific CD8+ T cells and Tregs by HIV -primed LCs or HIV -primed dendritic cells (DCs) as a control.
    Results: The number of HIV-specific CD8+ T cells induced by HIV -primed monocyte-derived LCs (mLCs) was significantly higher than that by HIV -primed monocyte-derived DCs (mDCs). Additionally, HIV-specific CD8+ T cells induced by HIV -primed mLCs produced more IFN-gamma than HIV-nonspecific CD8+ T cells. HIV -primed human epidermal LCs also induced IFN-gamma-producing HIV-specific CD8+ T cells. As for the induction of Tregs, HIV -primed mLCs and human epidermal LCs significantly impaired the induction of FoxP3(hi)CD45RA(-) effector Tregs than HIV-unprimed mLCs and human epidermal LCs.
    Conclusions: HIV -primed LCs trigger beneficial immune responses against HIV infection through the increased induction of HIV-specific CD8+ T cells and the decreased induction of effector Tregs in the initial phase of HIV infection, thereby contributing to the prolonged onset of AIDS. (C) 2017 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.jdermsci.2017.03.015

    Web of Science

    PubMed

  • Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expression of host proteins involved in pathogenicity 査読

    Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    MICROBIOLOGY AND IMMUNOLOGY   60 ( 11 )   740 - 753   2016年11月( ISSN:0385-5600  eISSN:1348-0421 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Hepatitis C virus (HCV) core protein is responsible for the formation of infectious viral particles and induction of pathogenicity. The C-terminal transmembrane region of the immature core protein is cleaved by signal peptide peptidase (SPP) for maturation of the core protein. SPP belongs to the family of presenilin-like aspartic proteases. Some presenilin inhibitors are expected to suppress HCV infection and production; however, this anti-HCV effect has not been investigated in detail. In this study, presenilin inhibitors were screened to identify anti-HCV compounds. Of the 13 presenilin inhibitors tested, LY411575 was the most potent inhibitor of SPP-dependent cleavage of HCV core protein. Production of intracellular core protein and supernatant infectious viral particles from HCV-infected cells was significantly impaired by LY411575 in a dose-dependent manner (half maximum inhibitory concentration =0.27 mu M, cytotoxic concentration of the extracts to cause death to 50% of viable cells > 10 mu M). No effect of LY411575 on intracellular HCV RNA in the subgenomic replicon cells was detected. LY411575 synergistically promoted daclatasvir-dependent inhibition of viral production, but not that of viral replication. Furthermore, LY411575 inhibited HCV-related production of reactive oxygen species and expression of NADPH oxidases and vascular endothelial growth factor. Taken together, our data suggest that LY411575 suppresses HCV propagation through SPP inhibition and impairs host gene expressions related to HCV pathogenicity.

    DOI: 10.1111/1348-0421.12448

    Web of Science

    PubMed

  • Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expressions of host proteins involved in pathogenicity 査読 重要な業績

    Otoguro, T.,Tanaka, T.,Kasai, H.,Yamashita, A.,Moriishi, K.

    Microbiology and Immunology   60 ( 11 )   740 - 753   2016年10月( ISSN:0385-5600 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/1348-0421.12448.

  • Single peptide peptidase a target for anti-HCV drug 査読

    Toru Okamoto, Junki Hirano, Tatsuya Suzuki, Shinji Kusakabe, Takasuke Fukuhara, Kohji Moriishi, Kazuhiko Koike, Yoshiharu Matsuura

    2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(研究会,シンポジウム資料等)  

  • Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation 査読 重要な業績

    Tanaka, T.,Okuyama-Dobashi, K.,Murakami, S.,Chen, W.,Okamoto, T.,Ueda, K.,Hosoya, T.,Matsuura, Y.,Ryo, A.,Tanaka, Y.,Hagiwara, M.,Moriishi, K.

    Antiviral Research   133   156 - 164   2016年9月( ISSN:0166-3542  eISSN:1872-9096 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.antiviral.2016.08.008

    Web of Science

    PubMed

  • The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate Immunity 査読 重要な業績

    Aoki, R.,Kawamura, T.,Goshima, F.,Ogawa, Y.,Nakae, S.,Moriishi, K.,Nakao, A.,Shimada, S.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY   136 ( 6 )   1290 - 1292   2016年6月( ISSN:0022-202X  eISSN:1523-1747 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.jid.2016.01.030

    Web of Science

    PubMed

  • TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis. 査読 重要な業績

    Aizawa S, ,Okamoto T, ,Sugiyama Y, ,Kouwaki T, ,Ito A, ,Suzuki T, ,Ono C, ,Fukuhara T, Yamamoto M, ,Okochi M, ,Hiraga N, ,Imamura M, ,Chayama K, ,Suzuki R, ,Shoji I, ,Moriishi K, ,Moriya K, ,Koike K, ,Matsuura Y.

    Nature Communications   4 ( 7 )   11379   2016年5月( ISSN:2041-1723 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 11.329

    DOI: 10.1038/ncomms11379

    Web of Science

    PubMed

  • Repression of Wnt/β-catenin response elements by p63 (TP63) 査読

    Katoh I, ,Fukunishi N, ,Fujimuro M, ,Kasai H, ,Moriishi K, ,Hata R, ,Kurata S

    Cell Cycle   15 ( 5 )   699 - 710   2016年3月( ISSN:1538-4101 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Repression of Wnt/β-catenin response elements by p63 (TP63). 査読

    Katoh I, Fukunishi N, Fujimuro M, Kasai H, Moriishi K, Hata R, Kurata S

    Cell cycle (Georgetown, Tex.)   15 ( 5 )   699 - 710   2016年3月( ISSN:1538-4101  eISSN:1551-4005 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1080/15384101.2016.1148837

    Web of Science

    PubMed

  • Hepatocyte factor JMJD5 regulates HBV replication through interaction with HBx 査読 重要な業績

    Kouwaki T, ,Okamoto T, ,Ito A, ,Sugiyama Y, ,Yamashita K, ,Suzuki T, Kusakabe S, ,Hirano J, ,Fukuhara T, ,Yamashita A, ,Saito K, ,Okuzaki D, ,Watashi K, ,Sugiyama M, ,Yoshio S, ,Standley DM, ,Kanto T, ,Mizokami M, ,Moriishi K, ,Matsuura Y

    Journal of Virology   90 ( 7 )   3530 - 3542   2016年1月( ISSN:0022-538X  eISSN:1098-5514 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1128/JVI.02776-15

    Web of Science

    PubMed

  • Structural proteins of HCV and biological functions 査読

    Kohji Moriishi, Yoshiharu Matsuura

    Hepatitis C Virus I: Cellular and Molecular Virology   105 - 127   2016年1月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:論文集(書籍)内論文   出版者・発行元:Springer Japan  

    Hepatitis C virus (HCV) is a major causative agent of liver disorders and a major risk factor for hepatocellular carcinoma. The induction of hepatocellular carcinoma by HCV is thought to involve not only chronic inflammation, but also the biological activity of HCV components. Structural proteins of HCV are composed of the core protein and two envelope proteins, E1 and E2. The HCV core protein has been reported to exhibit multiple biological functions involved in lipid synthesis, iron metabolism, insulin response, oxidative stress and cell growth, and to thereby contribute to the development of carcinogenesis and metabolic disorders. Moreover, several reports suggest that envelope proteins also play an important role in viral entry as well as HCV-related pathogenic events. However, the mechanism by which the structural proteins induce hepatitis C-related disorders has not been fully understood. This review focuses on the current status of biological responses mediated by HCV structural proteins.

    DOI: 10.1007/978-4-431-56098-2_6

    Scopus

  • Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. 査読 重要な業績

    Okuyama-Dobashi K, ,Kasai H, ,Tanaka T, Yamashita A, Yasumoto J, ,Chen W, Okamoto T, Maekawa S, ,Watashi K, ,Wakita T, ,Ryo A, ,Suzuki T, ,Matsuura Y, ,Enomoto N, ,Moriishi K.

    Scientific reports   5   17047   2015年11月( ISSN:2045-2322 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 5.228

    DOI: 10.1038/srep17047

    Web of Science

    PubMed

  • Involvement of FKBP6 in hepatitis C virus replication 査読 重要な業績

    Kasai H, ,Kawakami K, ,Yokoe H, ,Yoshimura K, ,Matsuda M, ,Yasumoto J, ,Maekawa S, ,Yamashita A, ,Tanaka T, ,Ikeda M, ,Kato N, ,Okamoto T, ,Matsuura Y, ,Sakamoto N, ,Enomoto N, ,Takeda S, ,Fujii H, ,Tsubuki M, ,Kusunoki M, ,Moriishi K.

    Scientific reports   5   16699   2015年11月( ISSN:2045-2322 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 5.228

    DOI: 10.1038/srep16699

    Web of Science

    PubMed

  • Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay 査読 国際共著 重要な業績

    Atsuya Yamashita, Yuusuke Fujimoto, Mayumi Tamaki, Andi Setiawan, Tomohisa Tanaka, Kaori Okuyama-Dobashi, Hirotake Kasai, Koichi Watashi, Takaji Wakita, Masaaki Toyama, Masanori Baba, Nicole J. de Voogd, Shinya Maekawa, Nobuyuki Enomoto, Junichi Tanaka, Kohji Moriishi

    MARINE DRUGS   13 ( 11 )   6759 - 6773   2015年11月( ISSN:1660-3397 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    The current treatments of chronic hepatitis B (CHB) face a limited choice of vaccine, antibody and antiviral agents. The development of additional antiviral agents is still needed for improvement of CHB therapy. In this study, we established a screening system in order to identify compounds inhibiting the core promoter activity of hepatitis B virus (HBV). We prepared 80 extracts of marine organisms from the coral reefs of Indonesia and screened them by using this system. Eventually, two extracts showed high inhibitory activity (>95%) and low cytotoxicity (66% to 77%). Solvent fractionation, column chromatography and NMR analysis revealed that 3,5-dibromo-2-(2,4-dibromophenoxy)-phenol (compound 1) and 3,4,5-tribromo-2-(2,4-dibromophenoxy)-phenol (compound 2), which are classified as polybrominated diphenyl ethers (PBDEs), were identified as anti-HBV agents in the extracts. Compounds 1 and 2 inhibited HBV core promoter activity as well as HBV production from HepG2.2.15.7 cells in a dose-dependent manner. The EC50 values of compounds 1 and 2 were 0.23 and 0.80 mu M, respectively, while selectivity indexes of compound 1 and 2 were 18.2 and 12.8, respectively. These results suggest that our cell-based HBV core promoter assay system is useful to determine anti-HBV compounds, and that two PBDE compounds are expected to be candidates of lead compounds for the development of anti-HBV drugs.

    DOI: 10.3390/md13116759

    Web of Science

    PubMed

  • Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay 査読 重要な業績

    Yamashita A, ,Fujimoto Y, ,Tamaki M, ,Setiawan A, ,Tanaka T, ,Okuyama-Dobashi K, ,Kasai H, ,Watashi K, ,Wakita T, ,Toyama M, ,Baba M, ,de Voogd NJ, ,Maekawa S, ,Enomoto N, ,Tanaka J, ,Moriishi K

    Marine Drugs   13   6759 - 6773   2015年10月( ISSN:1660-3397 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.345

  • TRC8-dependent proteasome degradation of immature core protein participates in pathogenesis of HCV 査読

    Toru Okamoto, Yukari Sugiyama, Takahisa Kouwaki, Ayano Ito, Takasuke Fukuhara, Kohji Moriishi, Kazuhiko Koike, Yoshiharu Matusuura

    2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)  

  • Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase 査読

    Atsushi Furuta, Masayoshi Tsubuki, Miduki Endoh, Tatsuki Miyamoto, Junichi Tanaka, Kazi Abdus Salam, Nobuyoshi Akimitsu, Hidenori Tani, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Yuji Sekiguchi, Satoshi Tsuneda, Naohiro Noda

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES   16 ( 8 )   18439 - 18453   2015年8月( ISSN:1422-0067 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    Hepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replication. Some anthracyclines are known to be NS3 helicase inhibitors and have a hydroxyanthraquinone moiety in their structures; mitoxantrone, a hydroxyanthraquinone analogue, is also known to inhibit NS3 helicase. Therefore, we hypothesized that the hydroxyanthraquinone moiety alone could also inhibit NS3 helicase. Here, we performed a structure-activity relationship study on a series of hydroxyanthraquinones by using a fluorescence-based helicase assay. Hydroxyanthraquinones inhibited NS3 helicase with IC50 values in the micromolar range. The inhibitory activity varied depending on the number and position of the phenolic hydroxyl groups, and among different hydroxyanthraquinones examined, 1,4,5,8-tetrahydroxyanthraquinone strongly inhibited NS3 helicase with an IC50 value of 6 mu M. Furthermore, hypericin and sennidin A, which both have two hydroxyanthraquinone-like moieties, were found to exert even stronger inhibition with IC50 values of 3 and 0.8 mu M, respectively. These results indicate that the hydroxyanthraquinone moiety can inhibit NS3 helicase and suggest that several key chemical structures are important for the inhibition.

    DOI: 10.3390/ijms160818439

    Web of Science

    PubMed

  • Novel sex-dependent differentially methylated regions are demethylated in adult male mouse livers. 査読 重要な業績

    Ito, S., Hirabayashi, K., Moriishi, K., Matsui, Y., Moriya, K., Koike, K., Matsuura, Y., Shiota, K., Yagi, S.

    Biochem Biophys Res Commun   462 ( 4 )   332 - 338   2015年7月( ISSN:0006-291X  eISSN:1090-2104 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 2.371

    DOI: 10.1016/j.bbrc.2015.04.137

    Web of Science

    PubMed

  • 基礎研究医養成の試み 文部科学省GPプログラムの検証 リエゾンアカデミー研究医養成プログラム

    小泉 修一, 中尾 篤人, 竹田 扇, 杉田 完爾, 大塚 稔久, 宮澤 恵二, 範 江林, 森石 恆司, 久保田 たけお, 武田 正之

    医学教育   46 ( Suppl. )   34 - 34   2015年7月( ISSN:0386-9644 )

     詳細を見る

    記述言語:日本語   掲載種別:(MISC)総説・解説(商業誌)   出版者・発行元:(一社)日本医学教育学会  

  • Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus. 査読 重要な業績

    Sato M, ,Maekawa S, ,Komatsu N, ,Tatsumi A, 他15名

    Journal of Virology   89 ( 11 )   6105 - 6016   2015年6月( ISSN:0022-538X  eISSN:1098-5514 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.606

    DOI: 10.1128/Jvi.03127-14

    Web of Science

    PubMed

  • Maternal restraint stress during pregnancy in mice induces 11β-HSD1-associated metabolic changes in the livers of the offspring. 査読 重要な業績

    Maeyama H, ,Hirasawa T, ,Tahara Y, ,Obata C, ,Kasai H, ,Moriishi K, ,Mochizuki K, ,Kubota T.

    J Dev Orig Health Dis   6 ( 2 )   105 - 114   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 1.733

  • Long-term imipramine treatment increases N-methyl-D-aspartate receptor activity and expression via epigenetic mechanisms 査読

    Nguyen An Nghia, Takae Hirasawa, Hirotake Kasai, Chie Obata, Kohji Moriishi, Kazuki Mochizuki, Schuichi Koizumi, Takeo Kubota

    EUROPEAN JOURNAL OF PHARMACOLOGY   752   69 - 77   2015年4月( ISSN:0014-2999  eISSN:1879-0712 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Imipramine, a major antidepressant, is known to inhibit reuptake of serotonin and norepinephrine, which contributes to recovery from major depressive disorder. It has recently been reported that acute imipramine treatment inhibits N-methyl-D-aspartate (NMDA) receptor activity. However, the mechanisms underlying lung term effects of imipramine have nor been identified. We rested these distinct effects in mouse cortical neurons and found that acute (30 s) imipramine treatment decreased Ca2+ influx through NMDA receptors, whereas long term treatment (48 h) increased Ca2+ influx via the same receptors. Furthermore, long term treatment increased NMDA receptor 2B (NR2B) subunit expression via epigenetic changes, including increased acetylation of histones H3K9 and H3K27 in the NR2B promoter and decreased activity of histone deacetylase 3 (HDAC3) and HDAC4. These results suggest that the long term effects of imipramine on NMDA receptors are quire different from its acute effects. Furthermore, increased NR2B expression via epigenetic alterations might be a part of the mechanism responsible for this long-term effect. (C) 2015 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.ejphar.2015.02.010

    Web of Science

    PubMed

  • Maternal restraint stress during pregnancy in mice induces 11β-HSD1-associated metabolic changes in the livers of the offspring. 査読

    Maeyama H, Hirasawa T, Tahara Y, Obata C, Kasai H, Moriishi K, Mochizuki K, Kubota T

    Journal of developmental origins of health and disease   6 ( 2 )   105 - 114   2015年4月( ISSN:2040-1744  eISSN:2040-1752 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1017/S2040174415000100

    Web of Science

    PubMed

  • Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase 査読 重要な業績

    Furuta A, ,Tsubuki M, ,Endoh M, ,Miyamoto T, ,Tanaka J, ,Salam KA, ,Akimitsu N,Tani H, ,Yamashita A, ,Moriishi K,他4名

    Int J Mol Sci   16   18439 - 18453   2015年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.257

  • Long-term imipramine treatment increases N-methyl-d-aspartate receptor activity and expression via epigenetic mechanisms. 査読 重要な業績

    Nghia NA,Takae HIRASAWA,Hirotake KASAI,Obata C,Kohji MORIISHI,Mochizuki K,Schuichi KOIZUMI,Takeo KUBOTA

    Eur J Pharmacol   in press   2015年2月( ISSN:0014-2999 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 2.730

  • Development of a cell culture and infection system for hepatitis B virus using 3D cultured immortalized human hepatocytes.

    AKAHORI Yuichi, KATO Hiroki, FUJITA Takashi, MORIISHI Kohji, WATASHI Koichi, WAKITA Takaji, HIJIKATA Makoto

    2015 International meeting on the molecular biology of hepatitis B viruses, Bad Nauheim, Germany, Oct. 3-8, 2015   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)  

  • Development of a cell culture and infection system for hepatitis B virus using 3D cultured non-neoplastic HuS-E/2 cells. 査読

    AKAHORI Yuichi, KATO Hiroki, FUJITA Takashi, MORIISHI Kohji, WATASHI Koichi, WAKITA Takajoi, HIJIKATA Makoto

    第63回日本ウイルス学会学術集会.福岡 2015年11月22-24日   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(その他学術会議資料等)  

  • Hallmarks of hepatitis C virus in equine hepacivirus. 査読 重要な業績

    Tanaka T, ,Kasai H, ,Yamashita A, ,Okuyama-Dobashi K, ,Yasumoto J, ,Maekawa S, ,Enomoto N, ,Okamoto T, ,Matsuura Y, ,Morimatsu M, ,Manabe N, ,Ochiai K, ,Yamashita K, ,Moriishi K.

    Journal of Virology   88 ( 22 )   13352 - 13366   2014年11月( ISSN:0022-538X  eISSN:1098-5514 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.606

    DOI: 10.1128/Jvi.02280-14

    Web of Science

    PubMed

  • Processing of Core Protein by Signal Peptide Peptidase Participates in Propagation and Pathogenesis of Hepatitis C Virus 査読

    Toru Okamoto, Sayaka Aizawa, Takahisa Kouwaki, Tatsuya Suzuki, Francesc Puig-Basagoiti, Shinya Watanabe, Takasuke Fukuhara, Kohji Moriishi, Kazuhiko Koike, Yoshiharu Matsuura

    2014年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)  

  • EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium. 査読 重要な業績

    Matsuzawa T, ,Kawamura T, ,Ogawa Y, ,Maeda K, ,Nakata H, ,Moriishi K, ,Koyanagi Y, ,Gatanaga H, ,Shimada S, ,Mitsuya H.

    J Invest Dermatol   134 ( 4 )   1158   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 6.915

  • PBDE: structure-activity studies for the inhibition of hepatitis C virus NS3 helicase. 査読

    Salam KA, ,Furuta A, ,Noda N, , Sekiguchi Y, ,Yamashita A, ,Moriishi K, ,Nakakoshi M, 他

    Molecules   19 ( 4 )   4006   2014年4月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    IF = 2.465

  • Cholesterol sulfate as a potential inhibitor of hepatitis C virus NS3 helicase 査読

    Atsushi Furuta, Kazi Abdus Salam, Nobuyoshi Akimitsu, Junichi Tanaka, Hidenori Tani, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Masayoshi Tsubuki, Yuji Sekiguchi, Satoshi Tsuneda, Naohiro Noda

    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY   29 ( 2 )   223 - 229   2014年4月( ISSN:1475-6366  eISSN:1475-6374 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:INFORMA HEALTHCARE  

    Hepatitis C virus nonstructural protein 3 (NS3) helicase is a promising target for developing new therapeutics. In this study, we identified cholesterol sulfate (CS) as a novel NS3 helicase inhibitor (IC50 = 1.7 +/- 0.2 mu M with a Hill coefficient of 3.9) by screening the extracts from marine organisms. The lack of the sulfate group, sterol structure or alkyl side chain of CS diminished the inhibition, suggesting that an anion binding and hydrophobic region in NS3 may be a target site of CS. It was further found that CS partly inhibits NS3-RNA binding activity, but exerted no or less inhibition against ATPase and serine protease activities. Moreover, we demonstrated that CS probably does not bind to RNA. Our findings suggest that CS may inhibit NS3 helicase not by abolishing the other NS3 activities but by inducing conformational changes via interaction with possible allosteric sites of NS3.

    DOI: 10.3109/14756366.2013.766607

    Web of Science

    PubMed

  • PBDE: Structure-Activity Studies for the Inhibition of Hepatitis C Virus NS3 Helicase 査読

    Kazi Abdus Salam, Atsushi Furuta, Naohiro Noda, Satoshi Tsuneda, Yuji Sekiguchi, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Hidenori Tani, Sona Rani Roy, Junichi Tanaka, Masayoshi Tsubuki, Nobuyoshi Akimitsu

    MOLECULES   19 ( 4 )   4006 - 4020   2014年4月( ISSN:1420-3049 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    The helicase portion of the hepatitis C virus nonstructural protein 3 (NS3) is considered one of the most validated targets for developing direct acting antiviral agents. We isolated polybrominated diphenyl ether (PBDE) 1 from a marine sponge as an NS3 helicase inhibitor. In this study, we evaluated the inhibitory effects of PBDE (1) on the essential activities of NS3 protein such as RNA helicase, ATPase, and RNA binding activities. The structure-activity relationship analysis of PBDE (1) against the HCV ATPase revealed that the biphenyl ring, bromine, and phenolic hydroxyl group on the benzene backbone might be a basic scaffold for the inhibitory potency.

    DOI: 10.3390/molecules19044006

    Web of Science

    PubMed

  • EFdA, a Reverse Transcriptase Inhibitor, Potently Blocks HIV-1 Ex Vivo Infection of Langerhans Cells within Epithelium 査読

    Takamitsu Matsuzawa, Tatsuyoshi Kawamura, Youichi Ogawa, Kenji Maeda, Hirotomo Nakata, Kohji Moriishi, Yoshio Koyanagi, Hiroyuki Gatanaga, Shinji Shimada, Hiroaki Mitsuya

    JOURNAL OF INVESTIGATIVE DERMATOLOGY   134 ( 4 )   1158 - 1161   2014年4月( ISSN:0022-202X  eISSN:1523-1747 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    DOI: 10.1038/jid.2013.467

    Web of Science

    PubMed

  • Identification and biochemical characterization of halisulfate 3 and suvanine as novel inhibitors of hepatitis C virus NS3 helicase from a marine sponge. 査読

    Furuta A, ,Salam KA, ,Hermawan I, ,Akimitsu N, ,Tanaka J, ,Tani H, ,Yamashita A, ,Moriishi K, ,Nakakoshi M, ,Tsubuki M, 他

    Mar Drugs   12 ( 1 )   462 - 476   2014年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.345

  • Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity 査読 重要な業績

    Allen, S. J.,Mott, K. R.,Matsuura, Y.,Moriishi, K.,Kousoulas, K. G.,Ghiasi, H.

    PLOS one   9 ( 1 )   e8536 - e8536   2014年1月( ISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.057

  • Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity 査読 国際共著

    Sariah J. Allen, Kevin R. Mott, Yoshiharu Matsuura, Kohji Moriishi, Konstantin G. Kousoulas, Homayon Ghiasi

    PLOS ONE   9 ( 1 )   e85360   2014年1月( ISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Glycoprotein K (gK) is a virion envelope protein of herpes simplex virus types 1 (HSV-1) and 2 (HSV-2), which plays important roles in virion entry, morphogenesis and egress. Two-hybrid and pull-down assays were utilized to demonstrate that gK and no other HSV-1 genes specifically binds to signal peptide peptidase (SPP), also known as minor histocompatibility antigen H13. SPP dominant negative mutants, shRNA against SPP significantly reduced HSV-1 replication in vitro. SPP also affected lysosomes and ER responses to HSV-1 infection. Thus, in this study we have shown for the first time that gK, despite its role in fusion and egress, is also involved in binding the cytoplasmic protein SPP. These results also suggest that SPP plays an important role in viral replication and possibly virus pathogenesis. This makes SPP unique in that its function appears to be required by the virus as no other protein can compensate its loss in terms of viral replication.

    DOI: 10.1371/journal.pone.0085360

    Web of Science

    PubMed

  • Identification and Biochemical Characterization of Halisulfate 3 and Suvanine as Novel Inhibitors of Hepatitis C Virus NS3 Helicase from a Marine Sponge 査読

    Atsushi Furuta, Kazi Abdus Salam, Idam Hermawan, Nobuyoshi Akimitsu, Junichi Tanaka, Hidenori Tani, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Masayoshi Tsubuki, Poh Wee Peng, Youichi Suzuki, Naoki Yamamoto, Yuji Sekiguchi, Satoshi Tsuneda, Naohiro Noda

    MARINE DRUGS   12 ( 1 )   462 - 476   2014年1月( ISSN:1660-3397 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    Hepatitis C virus (HCV) is an important etiological agent that is responsible for the development of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV nonstructural protein 3 (NS3) helicase is a possible target for novel drug development due to its essential role in viral replication. In this study, we identified halisulfate 3 (hal3) and suvanine as novel NS3 helicase inhibitors, with IC50 values of 4 and 3 mu M, respectively, from a marine sponge by screening extracts of marine organisms. Both hal3 and suvanine inhibited the ATPase, RNA binding, and serine protease activities of NS3 helicase with IC50 values of 8, 8, and 14 mu M, and 7, 3, and 34 mu M, respectively. However, the dengue virus (DENV) NS3 helicase, which shares a catalytic core (consisting mainly of ATPase and RNA binding sites) with HCV NS3 helicase, was not inhibited by hal3 and suvanine, even at concentrations of 100 mu M. Therefore, we conclude that hal3 and suvanine specifically inhibit HCV NS3 helicase via an interaction with an allosteric site in NS3 rather than binding to the catalytic core. This led to the inhibition of all NS3 activities, presumably by inducing conformational changes.

    DOI: 10.3390/md12010462

    Web of Science

    PubMed

  • Deep-Sequencing Analysis of the Association between the Quasispecies Nature of the Hepatitis C Virus Core Region and Disease Progression 査読 重要な業績

    Miura, M.,Maekawa, S.,Takano, S.,Komatsu, N.,Tatsumi, A.,Asakawa, Y.,Shindo, K.,Amemiya, F.,Nakayama, Y.,Inoue, T.,Sakamoto, M.,Yamashita, A.,Moriishi, K.,Enomoto, N.

    J Virol   87 ( 23 )   12541 - 12551   2013年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.606

  • Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus 査読 重要な業績

    Shen, H.,Yamashita, A.,Nakakoshi, M.,Yokoe, H.,Sudo, M.,Kasai, H.,Tanaka, T.,Fujimoto, Y.,Ikeda, M.,Kato, N.,Sakamoto, N.,Shindo, H.,Maekawa, S.,Enomoto, N.,Tsubuki, M.,Moriishi, K.

    PLOS ONE   8 ( 12 )   e8229   2013年12月( ISSN:1932-6203 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.057

  • Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression 査読

    Mika Miura, Shinya Maekawa, Shinichi Takano, Nobutoshi Komatsu, Akihisa Tatsumi, Yukiko Asakawa, Kuniaki Shindo, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto

    Journal of Virology   87 ( 23 )   12541 - 12551   2013年12月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Variation of core amino acid (aa) 70 of hepatitis C virus (HCV) has been shown recently to be closely correlated with liver disease progression, suggesting that the core region might be present as a quasispecies during persistent infection and that this quasispecies nature might have an influence on the progression of disease. In our investigation, the subjects were 79 patients infected with HCV genotype 1b (25 with chronic hepatitis [CH], 29 with liver cirrhosis [LC], and 25 with hepatocellular carcinoma [HCC]). Deep sequencing of the HCV core region was carried out on their sera by using a Roche 454 GS Junior pyrosequencer. Based on a plasmid containing a cloned HCV sequence (pCV-J4L6S), the background error rate associated with pyrosequencing, including the PCR procedure, was calculated as 0.092 ± 0.005/base. Deep sequencing of the core region in the clinical samples showed a mixture of "mutant-type" Q/H and "wild-type" R at the core aa 70 position in most cases (71/79 [89.9%]), and the ratio of mutant residues to R in the mixture increased as liver disease advanced to LC and HCC. Meanwhile, phylogenetic analysis of the almost-complete core region revealed that the HCV isolates differed genetically depending on the mutation status at core aa 70. We conclude that the core aa 70 mixture ratio, determined by deep sequencing, reflected the status of liver disease, demonstrating a significant association between core aa 70 and disease progression in CH patients infected with HCV genotype 1b. © 2013, American Society for Microbiology.

    DOI: 10.1128/JVI.00826-13

    Scopus

    PubMed

  • Oral Administration of the CCR5 Inhibitor, Maraviroc, Blocks HIV Ex Vivo Infection of Langerhans Cells within the Epithelium 査読

    Takamitsu Matsuzawa, Tatsuyoshi Kawamura, Youichi Ogawa, Masaaki Takahashi, Rui Aoki, Kohji Moriishi, Yoshio Koyanagi, Hiroyuki Gatanaga, Andrew Blauvelt, Shinji Shimada

    JOURNAL OF INVESTIGATIVE DERMATOLOGY   133 ( 12 )   2803 - 2805   2013年12月( ISSN:0022-202X  eISSN:1523-1747 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    DOI: 10.1038/jid.2013.215

    Web of Science

    PubMed

  • Inhibitory Effects of Caffeic Acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus 査読

    Hui Shen, Atsuya Yamashita, Masamichi Nakakoshi, Hiromasa Yokoe, Masashi Sudo, Hirotake Kasai, Tomohisa Tanaka, Yuusuke Fujimoto, Masanori Ikeda, Nobuyuki Kato, Naoya Sakamoto, Hiroko Shindo, Shinya Maekawa, Nobuyuki Enomoto, Masayoshi Tsubuki, Kohji Moriishi

    PLOS ONE   8 ( 12 )   e82299   2013年12月( ISSN:1932-6203 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Caffeic acid phenethyl ester (CAPE) has been reported as a multifunctional compound. In this report, we tested the effect of CAPE and its derivatives on hepatitis C virus (HCV) replication in order to develop an effective anti-HCV compound. CAPE and CAPE derivatives exhibited anti-HCV activity against an HCV replicon cell line of genotype 1b with EC50 values in a range from 1.0 to 109.6 mu M. Analyses of chemical structure and antiviral activity suggested that the length of the n-alkyl side chain and catechol moiety are responsible for the anti-HCV activity of these compounds. Caffeic acid n-octyl ester exhibited the highest anti-HCV activity among the tested derivatives with an EC50 value of 1.0 mu M and an SI value of 63.1 by using the replicon cell line derived from genotype 1b strain Con1. Treatment with caffeic acid n-octyl ester inhibited HCV replication of genotype 2a at a similar level to that of genotype 1b irrespectively of interferon signaling. Caffeic acid n-octyl ester could synergistically enhance the anti-HCV activities of interferon-alpha 2b, daclatasvir, and VX-222, but neither telaprevir nor danoprevir. These results suggest that caffeic acid n-octyl ester is a potential candidate for novel anti-HCV chemotherapy drugs.

    DOI: 10.1371/journal.pone.0082299

    Web of Science

    PubMed

  • Psammaplin A inhibits hepatitis C virus NS3 helicase. 査読 国際共著

    Kazi Abdus Salam, Atsushi Furuta, Naohiro Noda, Satoshi Tsuneda, Yuji Sekiguchi, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Masayoshi Tsubuki, Hidenori Tani, Junichi Tanaka, Nobuyoshi Akimitsu

    Journal of natural medicines   67 ( 4 )   765 - 72   2013年10月( ISSN:1340-3443 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Hepatitis C virus (HCV) is the causative agent of hepatitis C, a chronic infectious disease that can lead to development of hepatocellular carcinoma. The NS3 nucleoside triphosphatase (NTPase)/helicase has an essential role in HCV replication, and is therefore an attractive target for direct-acting antiviral strategies. In this study, we employed high-throughput screening using a photo-induced electron transfer (PET) system to identify an inhibitor of NS3 helicase from marine organism extracts. We successfully identified psammaplin A as a novel NS3 inhibitor. The dose-response relationship clearly demonstrates the inhibition of NS3 RNA helicase and ATPase activities by psammaplin A, with IC₅₀ values of 17 and 32 μM, respectively. Psammaplin A has no influence on the apparent Km value (0.4 mM) of NS3 ATPase activity, and acts as a non-competitive inhibitor. Additionally, it inhibits the binding of NS3 to single-stranded RNA in a dose-dependent manner. Furthermore, psammaplin A shows an inhibitory effect on viral replication, with EC₅₀ values of 6.1 and 6.3 μM in subgenomic replicon cells derived from genotypes 1b and 2a, respectively. We postulate that psammaplin A is a potential anti-viral agent through the inhibition of ATPase, RNA binding and helicase activities of NS3.

    DOI: 10.1007/s11418-013-0742-7

    PubMed

  • Mast Cells Play a Key Role in Host Defence against Herpes Simplex Virus Infection through TNF-α and IL-6 Production 査読 重要な業績

    Rui Aoki,Tatsuyoshi Kawamura,Fumi Goshima,Youichi Ogawa,Susumu Nakae,Atsuhito NAKAO,Kohji MORIISHI,Yukihiro Nishiyama,Shinji Shimada

    Journal of Investigative Dermatology   133 ( 9 )   2170 - 2179   2013年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 6.915

  • Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. 査読

    Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, Moriishi K, Nishiyama Y, Shimada S

    The Journal of investigative dermatology   133 ( 9 )   2170 - 2179   2013年9月( ISSN:0022-202X  eISSN:1523-1747 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/jid.2013.150

    Web of Science

    PubMed

  • Microglia Release ATP by Exocytosis 査読 重要な業績

    Yoshio Imura,Yousuke Morizawa,Ryouhei Komatsu,Keisuke Shibata,Youichi SHINOZAKI,Hirotake KASAI,Kohji MORIISHI,Yoshinori Moriyama,Schuichi KOIZUMI

    Glia   61   1320 - 1330   2013年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 5.997

  • Ca2+/S100 proteins regulate HCV virus NS5A-FKBP8/FKBP38 interaction and HCV virus RNA replication 査読

    Joji Tani, Seiko Shimamoto, Kyoko Mori, Nobuyuki Kato, Kohji Moriishi, Yoshiharu Matsuura, Hiroshi Tokumitsu, Mitsumasa Tsuchiya, Tomohito Fujimoto, Kiyohito Kato, Hisaaki Miyoshi, Tsutomu Masaki, Ryoji Kobayashi

    LIVER INTERNATIONAL   33 ( 7 )   1008 - 1018   2013年8月( ISSN:1478-3223 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Background & Aim: FKBP8/FKBP38 is a unique FK506-binding protein with a C-terminal membrane anchor and localizes at the outer membranes of mitochondria and the endoplasmic reticulum. Similar to some immunophilins, such as FKBP51, FKBP52 and Cyclophilin 40, FKBP8/FKBP38 contain a putative Calmodulin-binding domain and a tetratricopeptide-repeat (TPR) domain for the binding of Hsp90. Both Hsp90 and the non-structural protein 5A (NS5A) of the hepatitis C virus (HCV) interact specifically with FKBP8/FKBP38 through its TPR domain, and the ternary complex formation plays a critical role in HCV RNA replication. The goal of this study is to evaluate that the host factor inhibits the ternary complex formation and the replication of HCV in vitro and in vivo. Methods: S100 proteins, FKBP38, FKBP8, HCV NS5A, Hsp90, and calmodulin were expressed in E.coli and purified. In vitro binding studies were performed by GST pull-down, S-tag pull-down and surface plasmon resonance analyses. The effect of S100 proteins on HCV replication was analysed by Western blotting using an HCV NS3 antibody following transfection of S100 proteins into the HCV replicon harbouring cell line (sO cells). Results: In vitro binding studies showed that S100A1, S100A2, S100A6, S100B and S100P directly interacted with FKBP8/FKBP38 in a Ca2+-dependent manner and inhibited the FKBP8/FKBP38-Hsp90 and FKBP8/FKBP38-NS5A interactions. Furthermore, overexpression of S100A1, S100A2 and S100A6 in sO cells resulted in the efficient inhibition of HCV replication. Conclusion: The association of the S100 proteins with FKBP8/FKBP38 provides a novel Ca2+-dependent regulatory role in HCV replication through the NS5A-host protein interaction.

    DOI: 10.1111/liv.12151

    Web of Science

    PubMed

  • Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis C 査読

    Kazuki Komase, Shinya Maekawa, Mika Miura, Ryota Sueki, Makoto Kadokura, Hiroko Shindo, Kuniaki Shindo, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto

    HEPATOLOGY RESEARCH   43 ( 8 )   865 - 875   2013年8月( ISSN:1386-6346 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aim Prediction of treatment responses to pegylated interferon (PEG IFN) plus ribavirin (RBV) therapy is uncertain for genotype 1b chronic hepatitis C.
    Methods In this study, 96 patients were investigated for the correlation between 36 pretreatment serum chemokine/cytokine levels and PEG IFN/RBV treatment efficacy by a sandwich enzyme-linked immunoassay (ELISA) and a bead array.
    Results First, chemokines/cytokines were measured semiquantitatively by sandwich ELISA in 31 randomly-selected patients and the serum regulated on activation normal T-cell expressed and secreted (RANTES) level was found to be significantly higher in the sustained virological response (SVR) group than the non-SVR group (P=0.048). Precise RANTES measurement in all 96 patients using a bead array confirmed this correlation (P=0.002). However, the genetic RANTES haplotype was not significantly related to the serum level. The serum RANTES level was extracted by multivariate analysis (odds ratio=4.09, 95% confidence interval=1.02-16.5, P=0.048) as an independent variable contributing to SVR.
    Conclusion The serum RANTES level is an important determinant influencing the virological response to PEG IFN/RBV therapy in chronic hepatitis C.

    DOI: 10.1111/hepr.12032

    Web of Science

    PubMed

  • Microglia release ATP by exocytosis 査読

    Yoshio Imura, Yosuke Morizawa, Ryohei Komatsu, Keisuke Shibata, Youichi Shinozaki, Hirotake Kasai, Kohji Moriishi, Yoshinori Moriyama, Schuichi Koizumi

    GLIA   61 ( 8 )   1320 - 1330   2013年8月( ISSN:0894-1491 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Microglia survey the brain environment by sensing several types of diffusible molecules, among which extracellular nucleotides released/leaked from damaged cells have central roles. Microglia sense ATP or other nucleotides by multiple P2 receptors, after which they change into several different phenotypes. However, so far, it is largely unknown whether microglia themselves release ATP and, if so, by what mechanism. Here we show that exocytosis is the mechanism by which microglia release ATP. When we stimulated microglia with ionomycin, they released ATP and the release was dependent on Ca2+, vesicular H+-ATPase, or SNAREs but independent of connexin/pannexin hemichannels. VNUT was found to be expressed in microglia and exhibited no colocalization with lysosome. We also visualized the exocytosis of ATP by a quinacrine-based fluorescent time-lapse imaging. Moreover, we found that lipopolysaccharide increased the ionomycin-induced release of ATP, which was dependent on the increase in VNUT. Taken together, our data suggested that exocytosis is the mechanism of ATP release from microglia. When activated, they would release ATP by increasing VNUT-dependent exocytotic mechanisms. GLIA 2013;61:1320-1330

    DOI: 10.1002/glia.22517

    Web of Science

    PubMed

  • 長波長蛍光標識RNAプローブを用いたC型肝炎ウイルスNS3 helicaseの新規な活性測定手法

    古田 篤史, Salam Kazi Abdus, 秋光 信佳, 田中 淳一, 山下 篤哉, 森石 恆司, 中越 雅道, 津吹 政可, 谷 英典, 常田 聡, 野田 尚宏

    日本生物工学会大会講演要旨集   平成25年度   162 - 162   2013年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)   出版者・発行元:(公社)日本生物工学会  

  • Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta 査読 重要な業績

    Hashimoto, K.,Yamada, S.,Katano, H.,Fukuchi, S.,Sato, Y.,Kato, M.,Yamaguchi, T.,Moriishi, K.,Inoue, N.

    Vaccine   31 ( 31 )   3199 - 3205   2013年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.413

  • Understanding the Biological Context of NS5A-Host Interactions in HCV Infection: A Network-Based Approach 査読 重要な業績

    Tripathi, L. P.,Kambara, H.,Chen, Y. A.,Nishimura, Y.,Moriishi, K.,Okamoto, T.,Morita, E.,Abe, T.,Mori, Y.,Matsuura, Y.,Mizuguchi, K.

    J. Proteome Res.   12 ( 6 )   2537 - 2551   2013年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.173

  • Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta 査読

    Kaede Hashimoto, Souichi Yamada, Harutaka Katano, Saki Fukuchi, Yuko Sato, Minami Kato, Toyofumi Yamaguchi, Kohji Moriishi, Naoki Inoue

    VACCINE   31 ( 31 )   3199 - 3205   2013年6月( ISSN:0264-410X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    Background: Cytomegalovirus (CMV) is the most common cause of congenital virus infection. Infection of guinea pigs with guinea pig CMV (GPCMV) can provide a useful model for the analysis of its pathogenesis as well as for the evaluation of vaccines. Although glycoprotein B (gB) vaccines have been reported to reduce the incidence and mortality of congenital infection in human clinical trials and guinea pig animal models, the mechanisms of protection remain unclear.
    Methods: To understand the gB vaccine protection mechanisms, we analyzed the spread of challenged viruses in the placentas and fetuses of guinea pig dams immunized with recombinant adenoviruses expressing GPCMV gB and beta-galactosidase, rAd-gB and rAd-LacZ, respectively.
    Results: Mean body weight of the fetuses in the dams immunized with rAd-LacZ followed by GPCMV challenge 3 weeks after immunization was 78% of that observed for dams immunized with rAd-gB. Under conditions in which congenital infection occurred in 75% of fetuses in rAd-LacZ-immunized dams, only 13% of fetuses in rAd-gB-immunized dams were congenitally infected. The placentas were infected less frequently in the gB-immunized animals. In the placentas of the rAd-LacZ- and rAd-gB-immunized animals, CMV early antigens were detected mainly in the spongiotrophoblast layer. Focal localization of viral antigens in the spongiotrophoblast layer suggests cell-to-cell viral spread in the placenta. In spite of a similar level of antibodies against gB and avidity indices among fetuses in each gB-immunized dam, congenital infection was sometimes observed in a littermate fetus. In such infected fetuses, CMV spread to most organs.
    Conclusions: Our results suggest that antibodies against gB protected against infection mainly at the interface of the placenta rather than from the placenta to the fetus. The development of strategies to block cell-to-cell viral spread in the placenta is, therefore, required for effective protection against congenital CMV infection. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.vaccine.2013.04.078

    Web of Science

    PubMed

  • Understanding the Biological Context of NS5A-Host Interactions in HCV Infection: A Network-Based Approach 査読 国際共著

    Lokesh P. Tripathi, Hiroto Kambara, Yi-An Chen, Yorihiro Nishimura, Kohji Moriishi, Toru Okamoto, Eiji Morita, Takayuki Abe, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi

    JOURNAL OF PROTEOME RESEARCH   12 ( 6 )   2537 - 2551   2013年6月( ISSN:1535-3893  eISSN:1535-3907 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    Hepatitis C virus (HCV) is a major cause of chronic liver disease. HCV NSSA protein plays an important role in HCV infection through its interactions with other HCV proteins and host factors. In an attempt to further our understanding of the biological context of protein interactions between NSSA and host factors in HCV pathogenesis, we generated an extensive physical interaction map between NSSA and cellular factors. By combining a yeast two-hybrid assay with comprehensive literature mining, we built the NSSA interactome composed of 132 human proteins that interact with NSSA These interactions were integrated into a high-confidence human protein interactome (HPI) with the help of the TargetMine data warehouse system to infer an overall protein interaction map linking NSSA with the components of the host cellular networks. The NSSA-host interactions that were integrated with the HPI were shown to participate in compact and well-connected cellular networks. Functional analysis of the NSSA "infection" network using TargetMine highlighted cellular pathways associated with immune system, cellular signaling, cell adhesion, cellular growth and death among others, which were significantly targeted by NSSA host interactions. In addition, cellular assays with in vitro HCV cell culture systems identified two ER-localized host proteins RTN1 and RTN3 as novel regulators of HCV propagation. Our analysis builds upon the present understanding of the role of NSSA protein in HCV pathogenesis and provides potential targets for more effective anti-HCV therapeutic intervention.

    DOI: 10.1021/pr3011217

    Web of Science

    PubMed

  • IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication. 査読

    Shindo H, Maekawa S, Komase K, Miura M, Kadokura M, Sueki R, Komatsu N, Shindo K, Amemiya F, Nakayama Y, Inoue T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N

    Journal of viral hepatitis   20 ( 4 )   281 - 289   2013年4月( ISSN:1352-0504 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/j.1365-2893.2012.01649.x

    Scopus

    PubMed

  • IL-28B and IFN-alpha synergistically inhibit HCV replication 査読 重要な業績

    ShindoH.,MaekawaS.,Kamatsu N.,Kamase K.,Miura M.,Kadokura M.,Sueki R.,Shindo K.,Amemiya F.,Nakayama Y.,Inoe T.,Sakamoto N.,Yamashita A.,Moriishi K.,Enomoto N.

    J Viral Hepatitis   2013年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.179

  • Ca(2+) /S100 proteins regulate HCV virus NS5A-FKBP8/FKBP38 interaction and HCV virus RNA replication. 査読 重要な業績

    Tani, J.,Shimamoto, S.,Mori, K.,Kato, N.,Moriishi, K.,Matsuura, Y.,Tokumitsu, H.,Tsuchiya, M.,Fujimoto, T.,Kato, K.,Miyoshi, H.,Masaki, T.,Kobayashi, R.

    Liver int.   33 ( 7 )   1008 - 1018   2013年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.470

  • Antimicrobial Peptide LL-37 Produced by HSV-2-Infected Keratinocytes Enhances HIV Infection of Langerhans Cells 査読 重要な業績

    Youichi Ogawa,Tatsuyoshi Kawamura,Takamitsu Matsuzawa,Rui Aoki,Peter Gee,Atsuya YAMASHITA,Kohji MORIISHI,Kenshi Yamasaki,Yoshio Koyanagi,Andrew Blauvelt,Shinji Shimada

    Cell Host & Microbe   13 ( 1 )   77 - 86   2013年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 12.552

  • Antimicrobial Peptide LL-37 Produced by HSV-2-Infected Keratinocytes Enhances HIV Infection of Langerhans Cells 査読 国際共著

    Youichi Ogawa, Tatsuyoshi Kawamura, Takamitsu Matsuzawa, Rui Aoki, Peter Gee, Atsuya Yamashita, Kohji Moriishi, Kenshi Yamasaki, Yoshio Koyanagi, Andrew Blauvelt, Shinji Shimada

    CELL HOST & MICROBE   13 ( 1 )   77 - 86   2013年1月( ISSN:1931-3128 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Herpes simplex virus (HSV)-2 shedding is associated with increased risk for sexually acquiring HIV. Because Langerhans cells (LCs), the mucosal epithelium resident dendritic cells, are suspected to be one of the initial target cell types infected by HIV following sexual exposure, we examined whether and how HSV-2 affects HIV infection of LCs. Although relatively few HSV-2/HIV-coinfected LCs were detected, HSV-2 dramatically enhanced the HIV susceptibility of LCs within skin explants. HSV-2 stimulated epithelial cell production of antimicrobial peptides (AMPs), including human beta defensins and LL-37. LL-37 strongly upregulated the expression of HIV receptors in monocyte-derived LCs (mLCs), thereby enhancing their HIV susceptibility. Culture supernatants of epithelial cells infected with HSV-2 enhanced HIV susceptibility in mLCs, and this effect was abrogated by blocking LL-37 production. These data suggest that HSV-2 enhances sexual transmission of HIV by increasing HIV susceptibility of LCs via epithelial cell production of LL-37.

    DOI: 10.1016/j.chom.2012.12.002

    Web of Science

    PubMed

  • Probe Electrospray Ionization質量分析法(PESI-MS)を用いたHCV感染細胞内脂質組成の解析 査読

    葛西宏威, 吉村健太郎, 安本順, 山下篤哉, 田中智久, 竹田扇, 森石恆司

    日本ウイルス学会学術集会プログラム・抄録集   61st   2013年

     詳細を見る

    担当区分:責任著者   記述言語:日本語   掲載種別:研究論文(研究会,シンポジウム資料等)  

    J-GLOBAL

  • Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp 査読 重要な業績

    Fujimoto Y.,Salam K. A.,Furuta A.,Matsuda Y.,Fujita O.,Tani H.,Ikeda M.,Kato N.,Sakamoto N.,Maekawa S.,Enomoto N.,de Voogd N. J.,Nakakoshi M.,Tsubuki M.,Sekiguchi Y.,Tsuneda S.,Akimitsu N.,Noda N.,Yamashita A.,Tanaka J.,Moriishi K.

    PLOS One   7 ( 11 )   48635   2012年11月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.057

  • Inhibition of Both Protease and Helicase Activities of Hepatitis C Virus NS3 by an Ethyl Acetate Extract of Marine Sponge Amphimedon sp. 査読

    Yuusuke Fujimoto, Kazi Abdus Salam, Atsushi Furuta, Yasuyoshi Matsuda, Osamu Fujita, Hidenori Tani, Masanori Ikeda, Nobuyuki Kato, Naoya Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Nicole J. de Voogd, Masamichi Nakakoshi, Masayoshi Tsubuki, Yuji Sekiguchi, Satoshi Tsuneda, Nobuyoshi Akimitsu, Naohiro Noda, Atsuya Yamashita, Junichi Tanaka, Kohji Moriishi

    PLOS ONE   7 ( 11 )   e48685   2012年11月( ISSN:1932-6203 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Combination therapy with ribavirin, interferon, and viral protease inhibitors could be expected to elicit a high level of sustained virologic response in patients infected with hepatitis C virus (HCV). However, several severe side effects of this combination therapy have been encountered in clinical trials. In order to develop more effective and safer anti-HCV compounds, we employed the replicon systems derived from several strains of HCV to screen 84 extracts from 54 organisms that were gathered from the sea surrounding Okinawa Prefecture, Japan. The ethyl acetate-soluble extract that was prepared from marine sponge Amphimedon sp. showed the highest inhibitory effect on viral replication, with EC50 values of 1.5 and 24.9 mu g/ml in sub-genomic replicon cell lines derived from genotypes 1b and 2a, respectively. But the extract had no effect on interferon-inducing signaling or cytotoxicity. Treatment with the extract inhibited virus production by 30% relative to the control in the JFH1-Huh7 cell culture system. The in vitro enzymological assays revealed that treatment with the extract suppressed both helicase and protease activities of NS3 with IC50 values of 18.9 and 10.9 mu g/ml, respectively. Treatment with the extract of Amphimedon sp. inhibited RNA-binding ability but not ATPase activity. These results suggest that the novel compound(s) included in Amphimedon sp. can target the protease and helicase activities of HCV NS3.

    DOI: 10.1371/journal.pone.0048685

    Web of Science

    PubMed

  • Upregulation of nuclear PA28γ expression in cirrhosis and hepatocellular carcinoma 査読 重要な業績

    Motoi KONDO,Kohji MORIISHI,Hiroshi WADA,Takehiro NODA,Shigeru MARUBASHI,Kenichi WAKASA,Yoshiharu MATSUURA,Yuichiro DOKI

    Experimental and Therapeutic Medicine   3 ( 3 )   379 - 385   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 1.280

  • 海洋生物抽出物より取得した複数種の硫酸化合物によるC型肝炎ウイルスNS3 helicase阻害作用 査読

    古田 篤史, Kazi Abdus Salam, 秋光 信佳, 田中 淳一, 山下 篤哉, 森石 恆司, 中越 雅道, 津吹 政可, 谷 英典, 関口 勇地, 常田 聡, 野田 尚宏

    日本生物工学会大会講演要旨集   平成24年度   145 - 145   2012年9月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)   出版者・発行元:(公社)日本生物工学会  

  • Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study. 査読 国際共著

    Tripathi LP, Kambara H, Moriishi K, Morita E, Abe T, Mori Y, Chen YA, Matsuura Y, Mizuguchi K

    Journal of proteome research   11 ( 7 )   3664 - 3679   2012年7月( ISSN:1535-3893  eISSN:1535-3907 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1021/pr300121a

    Web of Science

    PubMed

  • Proteomic Analysis of Hepatitis C Virus (HCV) Core Protein Transfection and Host Regulator PA28gamma Knockout in HCV Pathogenesis: A Network-Based Study 査読 重要な業績

    Tripathi L. P.,Kambara H.,Moriishi K.,Morita E.,Abe T.,Mori Y.,Chen Y. A.,Matsuura Y.,Mizuguchi K.

    J. Proteome Res.   11 ( 7 )   3664 - 3679   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.173

  • CD44 Participates in IP-10 Induction in Cells in Which Hepatitis C Virus RNA Is Replicating, through an Interaction with Toll-Like Receptor 2 and Hyaluronan 査読 国際共著

    Takayuki Abe, Takasuke Fukuhara, Xiauyu Wen, Akinori Ninomiya, Kohji Moriishi, Yoshihiko Maehara, Osamu Takeuchi, Taro Kawai, Shizuo Akira, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   86 ( 11 )   6159 - 6170   2012年6月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The mechanisms of induction of liver injury during chronic infection with hepatitis C virus (HCV) are not well understood. Gamma interferon (IFN-gamma)-inducible protein 10 (IP-10), a member of the CXC chemokine family, is expressed in the liver of chronic hepatitis C (CHC) patients and selectively recruits activated T cells to the sites of inflammation. Recently, it was shown that a low plasma concentration of IP-10 in CHC patients was closely associated with the outcome of antiviral therapy. In this study, we examined the role of the Toll-like receptor (TLR) pathway on IP-10 production in cells replicating HCV. Among the CXC chemokines, the expression of IP-10 was specifically increased in cells replicating HCV upon stimulation with conventional TLR2 ligands. The enhancement of IP-10 production upon stimulation with TLR2 ligands in cells replicating HCV induced CD44 expression. CD44 is a broadly distributed type I transmembrane glycoprotein and a receptor for the glycosaminoglycan hyaluronan (HA). In CHC patients, the expression of HA in serum has been shown to increase in accord with the progression of liver fibrosis, and HA also works as a ligand for TLR2. In the present study, IP-10 production upon HA stimulation was dependent on the expression of TLR2 and CD44, and a direct association between TLR2 and CD44 was observed. These results suggest that endogenous expression of HA in hepatocytes in CHC patients participates in IP-10 production through an engagement of TLR2 and CD44.

    DOI: 10.1128/JVI.06872-11

    Web of Science

    PubMed

  • Inhibition of hepatitis C virus NS3 helicase by manoalide. 査読 重要な業績

    Salam KA,Furuta A,Noda N,Tsuneda S,Sekiguchi Y,Yamashita A,Moriishi K,Nakakoshi M,Tsubuki M,Tani H,Tanaka J,Akimitsu N.

    J Nat Prod   75 ( 4 )   650 - 654   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.662

  • Inhibition of Hepatitis C Virus NS3 Helicase by Manoalide 査読

    Kazi Abdus Salam, Atsushi Furuta, Naohiro Noda, Satoshi Tsuneda, Yuji Sekiguchi, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Masayoshi Tsubuki, Hidenori Tani, Junichi Tanaka, Nobuyoshi Akimitsu

    JOURNAL OF NATURAL PRODUCTS   75 ( 4 )   650 - 654   2012年4月( ISSN:0163-3864 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    The hepatitis C virus (HCV) causes one of the most prevalent chronic infectious diseases in the world hepatitis C, which ultimately develops into liver cancer through cirrhosis. The NS3 protein of HCV possesses nucleoside triphosphatase (NTPase) and RNA helicase activities. As both activities are essential for viral replication, NS3 is proposed as an ideal target for antiviral drug development. In this study, we identified manoalide (1) from marine sponge extracts as an RNA helicase inhibitor using a high-throughput screening photoinduced electron transfer (PET) system that we previously developed. Compound 1 inhibits the RNA helicase and ATPase activities of NS3 in a dose dependent manner, with IC50 values of 15 and 70 mu M, respectively. Biochemical kinetic analysis demonstrated that 1 does not affect the apparent K-m stranded RNA was inhibited by 1. Monoalide (1) also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase. Taken together, we conclude that 1 inhibits the ATPase, RNA binding, and helicase activities of NS3 by targeting the helicase core domain conserved in both HCV NS3 and DHX36/RHAU.

    DOI: 10.1021/np200883s

    Web of Science

    PubMed

  • Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia 査読

    Atsuya Yamashita, Kazi Abdus Salam, Atsushi Furuta, Yasuyoshi Matsuda, Osamu Fujita, Hidenori Tani, Yoshihisa Fujita, Yuusuke Fujimoto, Masanori Ikeda, Nobuyuki Kato, Naoya Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Masamichi Nakakoshi, Masayoshi Tsubuki, Yuji Sekiguchi, Satoshi Tsuneda, Nobuyoshi Akimitsu, Naohiro Noda, Junichi Tanaka, Kohji Moriishi

    MARINE DRUGS   10 ( 4 )   744 - 761   2012年4月( ISSN:1660-3397 )

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC50 of 11.7 mu g/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC50 value of 23 to 44 mu g/mL, which is similar to the IC50 value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.

    DOI: 10.3390/md10040744

    Web of Science

    PubMed

  • Baculovirus GP64-mediated entry into mammalian cells 査読 重要な業績

    Chikako KATAOKA,Yuuki KANAME,Shuhei TAGUWA,Takayuki ABE,Takasuke FUKUHARA,Hideki TANI,Kohji MORIISHI,Yoshiharu MATSUURA

    Journal of Virology   86 ( 5 )   2610 - 2620   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.606

  • Inhibition of hepatitis C virus replication and NS3 helicase by the extract of the feather star Alloeocomatella polycladia 査読 重要な業績

    Yamashita A,その他19名,Moriishi K

    Marine Drugs   10 ( 4 )   744 - 761   2012年3月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.345

  • Baculovirus GP64-Mediated Entry into Mammalian Cells 査読

    Chikako Kataoka, Yuuki Kaname, Shuhei Taguwa, Takayuki Abe, Takasuke Fukuhara, Hideki Tani, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   86 ( 5 )   2610 - 2620   2012年3月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) serves as an efficient viral vector, not only for abundant gene expression in insect cells, but also for gene delivery into mammalian cells. Lentivirus vectors pseudotyped with the baculovirus envelope glycoprotein GP64 have been shown to acquire more potent gene transduction than those with vesicular stomatitis virus (VSV) envelope glycoprotein G. However, there are conflicting hypotheses about the molecular mechanisms of the entry of AcMNPV. Moreover, the mechanisms of the entry of pseudotyped viruses bearing GP64 into mammalian cells are not well characterized. Determination of the entry mechanisms of AcMNPV and the pseudotyped viruses bearing GP64 is important for future development of viral vectors that can deliver genes into mammalian cells with greater efficiency and specificity. In this study, we generated three pseudotyped VSVs, NPVpv, VSVpv, and MLVpv, bearing envelope proteins of AcMNPV, VSV, and murine leukemia virus, respectively. Depletion of membrane cholesterol by treatment with methyl-beta-cyclodextrin, which removes cholesterol from cellular membranes, inhibited GP64-mediated internalization in a dose-dependent manner but did not inhibit attachment to the cell surface. Treatment of cells with inhibitors or the expression of dominant-negative mutants for dynamin- and clathrin-mediated endocytosis abrogated the internalization of AcMNPV and NPVpv into mammalian cells, whereas inhibition of caveolin-mediated endocytosis did not. Furthermore, inhibition of macropinocytosis reduced GP64-mediated internalization. These results suggest that cholesterol in the plasma membrane, dynamin- and clathrin-dependent endocytosis, and macropinocytosis play crucial roles in the entry of viruses bearing baculovirus GP64 into mammalian cells.

    DOI: 10.1128/JVI.06704-11

    Web of Science

    PubMed

  • Upregulation of nuclear PA28γ expression in cirrhosis and hepatocellular carcinoma. 査読

    Kondo M, Moriishi K, Wada H, Noda T, Marubashi S, Wakasa K, Matsuura Y, Doki Y, Mori M, Nagano H

    Experimental and therapeutic medicine   3 ( 3 )   379 - 385   2012年3月( ISSN:1792-0981 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/etm.2011.415

    Web of Science

    PubMed

  • Exploitation of lipid components by viral and host proteins for hepatitis C virus infection 査読 重要な業績

    Kohji MORIISHI,Yoshiharu MATSUURA

    Frontiers in Microbiology   3   1 - 14   2012年2月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.165

  • Exploitation of lipid components by viral and host proteins for hepatitis C virus infection 査読

    Kohji Moriishi, Yashiharu Matsuura

    FRONTIERS IN MICROBIOLOGY   3   54   2012年( ISSN:1664-302X )

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:FRONTIERS RESEARCH FOUNDATION  

    Hepatitis C virus (HCV), which is a major causative agent of blood-borne hepatitis, has chronically infected about 170 million individuals worldwide and leads to chronic infection, resulting in development of steatosis, cirrhosis, and eventually hepatocellular carcinoma. Hepatocellular carcinoma associated with HCV infection is not only caused by chronic inflammation, but also by the biological activity of HCV proteins. HCV core protein is known as a main component of the viral nucleocapsid. It cooperates with host factors and possesses biological activity causing lipid alteration, oxidative stress, and progression of cell growth, while other viral proteins also interact with host proteins including molecular chaperones, membrane-anchoring proteins, and enzymes associated with lipid metabolism to maintain the efficiency of viral replication and production. HCV core protein is localized on the surface of lipid droplets in infected cells. However, the role of lipid droplets in HCV infection has not yet been elucidated. Several groups recently reported that other viral proteins also support viral infection by regulation of lipid droplets and core localization in infected cells. Furthermore, lipid components are required for modification of host factors and the intracellular membrane to maintain or up-regulate viral replication. In this review, we summarize the current status of knowledge regarding the exploitation of lipid components by viral and host proteins in HCV infection.

    DOI: 10.3389/fmicb.2012.00054

    Web of Science

    PubMed

  • Dysfunction of Autophagy Participates in Vacuole Formation and Cell Death in Cells Replicating Hepatitis C Virus 査読

    Shuhei Taguwa, Hiroto Kambara, Naonobu Fujita, Takeshi Noda, Tamotsu Yoshimori, Kazuhiko Koike, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   85 ( 24 )   13185 - 13194   2011年12月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) is a major cause of chronic liver diseases. A high risk of chronicity is the major concern of HCV infection, since chronic HCV infection often leads to liver cirrhosis and hepatocellular carcinoma. Infection with the HCV genotype 1 in particular is considered a clinical risk factor for the development of hepatocellular carcinoma, although the molecular mechanisms of the pathogenesis are largely unknown. Autophagy is involved in the degradation of cellular organelles and the elimination of invasive microorganisms. In addition, disruption of autophagy often leads to several protein deposition diseases. Although recent reports suggest that HCV exploits the autophagy pathway for viral propagation, the biological significance of the autophagy to the life cycle of HCV is still uncertain. Here, we show that replication of HCV RNA induces autophagy to inhibit cell death. Cells harboring an HCV replicon RNA of genotype 1b strain Con1 but not of genotype 2a strain JFH1 exhibited an incomplete acidification of the autolysosome due to a lysosomal defect, leading to the enhanced secretion of immature cathepsin B. The suppression of autophagy in the Con1 HCV replicon cells induced severe cytoplasmic vacuolation and cell death. These results suggest that HCV harnesses autophagy to circumvent the harmful vacuole formation and to maintain a persistent infection. These findings reveal a unique survival strategy of HCV and provide new insights into the genotype-specific pathogenicity of HCV.

    DOI: 10.1128/JVI.06099-11

    Web of Science

    PubMed

  • Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M1,2 査読

    Iyoko KATOH,Anna MIROVA,Shun-ichi KURATA,Yasushi MURAKAMI,Kenji HORIKAWA,Natsuko NAKAKUKI,Takunobu SAKAI,Kunihiko HASHIMOTO,Ayako MARUYAMA,Takaaki YONAGA,Nahoko FUKUNISHI,Hirohisa HIRAI

    Neoplasia   13 ( 11 )   1081 - 1092   2011年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.509

  • Activation of the Long Terminal Repeat of Human Endogenous Retrovirus K by Melanoma-Specific Transcription Factor MITF-M 査読

    Iyoko Katoh, Anna Mirova, Shun-ichi Kurata, Yasushi Murakami, Kenji Horikawa, Natsuko Nakakuki, Takunobu Sakai, Kunihiko Hashimoto, Ayako Maruyama, Takaaki Yonaga, Nahoko Fukunishi, Kohji Moriishi, Hirohisa Hirai

    NEOPLASIA   13 ( 11 )   1081 - U133   2011年11月( ISSN:1522-8002 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NEOPLASIA PRESS  

    The human and Old World primate genomes possess conserved endogenous retrovirus sequences that have been implicated in evolution, reproduction, and carcinogenesis. Human endogenous retrovirus (HERV)-K with 5'LTR-gag-pro-pol-env-rec/np9-3'LTR sequences represents the newest retrovirus family that integrated into the human genome 1 to 5 million years ago. Although a high-level expression of HERV-K in melanomas, breast cancers, and teratocarcinomas has been demonstrated, the mechanism of the lineage-specific activation of the long terminal repeat (LTR) remains obscure. We studied chromosomal HERV-K expression in MeWo melanoma cells in comparison with the basal expression in human embryonic kidney 293 (HEK293) cells. Cloned LTR of HERV-K (HML-2.HOM) was also characterized by mutation and transactivation experiments. We detected multiple transcriptional initiator (Inr) sites in the LTR by rapid amplification of complementary DNA ends (5'RACE). HEK293 and MeWo showed different Inr usage. The most potent Inr was associated with a TATA box and three binding motifs of microphthalmia-associated transcription factor (MITF). Both chromosomal HERV-K expression and the cloned LTR function were strongly activated in HEK293 by transfection with MITF-M, a melanocyte/melanoma-specific isoform of MITF. Coexpression of MITF and the HERV-K core antigen was detected in retinal pigmented epithelium by an immunofluorescence analysis. Although malignant melanoma lines MeWo, G361, and SK-MEL-28 showed enhanced HERV-K transcription compared with normal melanocytes, the level of MITF-M messenger RNA persisted from normal to transformed melanocytes. Thus, MITF-M may be a prerequisite for the pigmented cell lineage-specific function of HERV-K LTR, leading to the high-level expression in malignant melanomas.

    DOI: 10.1593/neo.11794

    Web of Science

    PubMed

  • Heterogeneous Nuclear Ribonucleoprotein A2 Participates in the Replication of Japanese Encephalitis Virus through an Interaction with Viral Proteins and RNA 査読

    Hiroshi Katoh, Yoshio Mori, Hiroto Kambara, Takayuki Abe, Takasuke Fukuhara, Eiji Morita, Kohji Moriishi, Wataru Kamitani, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   85 ( 21 )   10976 - 10988   2011年11月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that is kept in a zoonotic transmission cycle between pigs and mosquitoes. JEV causes infection of the central nervous system with a high mortality rate in dead-end hosts, including humans. Many studies have suggested that the flavivirus core protein is not only a component of nucleocapsids but also an important pathogenic determinant. In this study, we identified heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) as a binding partner of the JEV core protein by pulldown purification and mass spectrometry. Reciprocal coimmunoprecipitation analyses in transfected and infected cells confirmed a specific interaction between the JEV core protein and hnRNP A2. Expression of the JEV core protein induced cytoplasmic retention of hnRNP A2 in JEV subgenomic replicon cells. Small interfering RNA (siRNA)-mediated knockdown of hnRNP A2 resulted in a 90% reduction of viral RNA replication in cells infected with JEV, and the reduction was cancelled by the expression of an siRNA-resistant hnRNP A2 mutant. In addition to the core protein, hnRNP A2 also associated with JEV nonstructural protein 5, which has both methyltransferase and RNA-dependent RNA polymerase activities, and with the 5'-untranslated region of the negative-sense JEV RNA. During one-step growth, synthesis of both positive-and negative-strand JEV RNAs was delayed by the knockdown of hnRNP A2. These results suggest that hnRNP A2 plays an important role in the replication of JEV RNA through the interaction with viral proteins and RNA.

    DOI: 10.1128/JVI.00846-11

    Web of Science

    PubMed

  • Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus 査読 重要な業績

    Shuhei TAGUWA,Hiroto KAMBARA,Naonobu FUJITA,Takeshi NODA,Tamotsu YOSHIMORI,Kazuhiko KOIKE,Kohji MORIISHI,Yoshiharu MATSUURA

    Journal of Virology   85 ( 24 )   13185 - 13194   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.606

  • Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA 査読 重要な業績

    Hiroshi kATOH,Yoshio MORI,Hiroto KAMBARA,Takayuki ABE,Takasuke FUKUHARA,Eiji MORITA,Kohji MORIISHI,Wataru KAMITANI,Yoshiharu MATSUURA

    Journal of Virology   85 ( 21 )   10976 - 10988   2011年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 4.606

  • 海洋生物抽出物より取得したcholesterol sulfateによるC型肝炎ウイルスNS3 helicase阻害作用

    古田 篤史, Salam Kazi Abdus, 長浜 夏樹, 秋光 信佳, 田中 淳一, 谷 英典, 山下 篤哉, 森石 恆司, 常田 聡, 関口 勇地, 野田 尚宏

    日本生物工学会大会講演要旨集   平成23年度   124 - 124   2011年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)   出版者・発行元:(公社)日本生物工学会  

  • Will There Be an HCV Meeting in 2020? Summary of the 17th International Meeting on Hepatitis C Virus and Related Viruses 査読 国際共著

    Takaji Wakita, Tetsuro Suzuki, Matthew J. Evans, Kunitada Shimotohno, Kazuaki Chayama, Yoshiharu Matsuura, Makoto Hijikata, Kohji Moriishi, Tsukasa Seya, Nobuyuki Enomoto, Kazuhiko Koike, Nobuyuki Kato, Tatsuya Kanto, Hak Hotta

    GASTROENTEROLOGY   141 ( 1 )   E1 - E5   2011年7月( ISSN:0016-5085 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    DOI: 10.1053/j.gastro.2011.05.027

    Web of Science

    PubMed

  • Will there be an HCV meeting in 2020? summary of the 17th international meeting on hapatitis C virus and related viruses 査読 重要な業績

    Takaji WAKITA,Tetsuro SUZUKI,Matthew J. EVANS,Kunitada SHIMOTOHNO,Kazuaki CHAYAMA,Yoshiharu MATSUURA,Makoto HIJIKATA,Kohji MORIISHI,Tsukasa SEYA,Nobuyuki ENOMOTO,Kazuaki KOIKE,Nobuyuki KATO,Tatsuya KANTO,Hak HOTTA

    Gestroenterology   141   e1 - e5   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 18.187

  • HCVの病原性発現に関与する宿主因子とその機構 -Functions of host factors regarding HCV pathogenicity- 重要な業績

    森石 恆司

    日本臨床   69 ( 4 )   103 - 108   2011年5月

     詳細を見る

    記述言語:日本語  

  • [Functions of host factors regarding HCV pathogenicity]. 招待 査読

    Moriishi K

    Nihon rinsho. Japanese journal of clinical medicine   69 Suppl 4   103 - 108   2011年5月( ISSN:0047-1852 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    PubMed

  • Involvement of cyclophilin B in the replication of Japanese encephalitis virus 査読

    Hiroto Kambara, Hideki Tani, Yoshio Mori, Takayuki Abe, Hiroshi Katoh, Takasuke Fukuhara, Shuhei Taguwa, Kohji Moriishi, Yoshiharu Matsuura

    VIROLOGY   412 ( 1 )   211 - 219   2011年3月( ISSN:0042-6822 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Japanese encephalitis virus (JEV) is a mosquito-borne RNA virus that belongs to the Flaviviridae family. In this study, we have examined the effect of cyclosporin A (CsA) on the propagation of JEV. CsA exhibited potent anti-JEV activity in various mammalian cell lines through the inhibition of CypB. The propagation of JEV was impaired in the CypB-knockdown cells and this reduction was cancelled by the expression of wild-type but not of peptidylprolyl cis-trans isomerase (PPlase)-deficient CypB, indicating that PPlase activity of CypB is critical for JEV propagation. Infection of pseudotype viruses bearing JEV envelope proteins was not impaired by the knockdown of CypB, suggesting that CypB participates in the replication but not in the entry of JEV. CypB was colocalized and immunoprecipitated with JEV NS4A in infected cells. These results suggest that CypB plays a crucial role in the replication of JEV through an interaction with NS4A. (c) 2011 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.virol.2011.01.011

    Web of Science

    PubMed

  • Involvement of cyclophilin B in the replication of Japanese encephalitis virus 査読 重要な業績

    Hiroto KAMBARA,Hideki TANI,Yoshio MORI,Takayuki ABE,Hiroshi KATOH,Takasuke FUKUHARA,Shuhei TAGUWA,Kohji MORIISHI,Yoshiharu MATSUURA

    Virology   412   211 - 219   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Elimination of hepatitis C virus from hepatogytes by a selective activation oftherapeutic molecules 査読 重要な業績

    Xiaoyu WEN,Takayuki ABE,Hiroshi KUKIHARA,Shuhei TAGUWA,Yoshio MORI,Hideki TANI,Nobuyuki KATO,Tetsuro SUZUKI,Masashi TATSUMI,Kohji MORIISHI,Yoshiharu MATSUURA

    PLos ONE   6 ( 1 )   15967   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IF = 3.057

  • Elimination of Hepatitis C Virus from Hepatocytes by a Selective Activation of Therapeutic Molecules 査読 国際共著

    Xiaoyu Wen, Takayuki Abe, Hiroshi Kukihara, Shuhei Taguwa, Yoshio Mori, Hideki Tani, Nobuyuki Kato, Tetsuro Suzuki, Masashi Tatsumi, Kohji Moriishi, Yoshiharu Matsuura

    PLOS ONE   6 ( 1 )   e15967   2011年1月( ISSN:1932-6203 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    To eliminate hepatitis C virus (HCV) from infected hepatocytes, we generated two therapeutic molecules specifically activated in cells infected with HCV. A dominant active mutant of interferon (IFN) regulatory factor 7 (IRF7) and a negative regulator of HCV replication, VAP-C (Vesicle-associated membrane protein-associated protein subtype C), were fused with the C-terminal region of IPS-1 (IFN beta promoter stimulator-1), which includes an HCV protease cleavage site that was modified to be localized on the ER membrane, and designated cIRF7 and cVAP-C, respectively. In cells expressing the HCV protease, cIRF7 was cleaved and the processed fragment was migrated into the nucleus, where it activated various IFN promoters, including promoters of IFN alpha 6, IFN beta, and IFN stimulated response element. Activation of the IFN promoters and suppression of viral RNA replication were observed in the HCV replicon cells and in cells infected with the JFH1 strain of HCV (HCVcc) by expression of cIRF7. Suppression of viral RNA replication was observed even in the IFN-resistant replicon cells by the expression of cIRF7. Expression of the cVAP-C also resulted in suppression of HCV replication in both the replicon and HCVcc infected cells. These results suggest that delivery of the therapeutic molecules into the liver of hepatitis C patients, followed by selective activation of the molecules in HCV-infected hepatocytes, is a feasible method for eliminating HCV.

    DOI: 10.1371/journal.pone.0015967

    Web of Science

    PubMed

  • Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor βsignaling pathway with smad2 and IkB kinase α in squamous cell carcinoma1,2 査読

    Nahoko FUKUNISHI,Iyoko KATOH,Yoshiya TOMIMORI,Keiichi TSUKINOKI,Ryu-Ichiro HATA,Atsuhito NAKAO,Yoji IKAWA,Shun-ichi KURATA

    Neoplasia   12 ( 12 )   969 - 979   2010年12月( ISSN:1522-8002 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor βsignaling pathway with smad2 and IkB kinase α in squamous cell carcinoma1,2 査読

    Nahoko FUKUNISHI, Iyoko KATOH, Yoshiya TOMIMORI, Keiichi TSUKINOKI, Ryu-Ichiro HATA, Atsuhito NAKAO, Yoji IKAWA, Shun-ichi KURATA

    Neoplasia   12 ( 12 )   969 - 979   2010年12月( ISSN:1522-8002 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1593/neo.101054

    Scopus

  • Network based analysis of hepatitis C virus core and NS4B protein interactions 査読 重要な業績

    Lokesh P. TRIPATHI,Chikako KATAOKA,Shuhei TAGUWA,Kohji MORIISHI,Yoshio MORI,yoshiharu MATSUURA,Kenji MIZUGUCHI

    Molecular BioSystems   6   2539 - 2553   2010年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection 査読 重要な業績

    Masahiko ITO,Atsuko MASUMI,Keiko MOCHIDA,Hiroshi KUKIHARA,Kohji MORIISHI,Yoshiharu MATSUURA,Kazunari YAMAGUCHI,Toshiaki MIZUOCHI

    Journal of Innate immunity   2   607 - 617   2010年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection. 査読 重要な業績

    Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, その他3名

    J Innate Immun.   2 ( 6 )   607 - 6017   2010年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Involvement of PA28gamma in the propagation of hepatitis C virus. 査読 重要な業績

    Moriishi K, Shoji I, Mori Y, Suzuki R, Suzuki T,そのほか2名

    Hepatology   52 ( 2 )   411 - 420   2010年8月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Involvement of PA28 gamma in the Propagation of Hepatitis C Virus 査読

    Kohji Moriishi, Ikuo Shoji, Yoshio Mori, Ryosuke Suzuki, Tetsuro Suzuki, Chikako Kataoka, Yoshiharu Matsuura

    HEPATOLOGY   52 ( 2 )   411 - 420   2010年8月( ISSN:0270-9139 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JOHN WILEY & SONS INC  

    We have reported previously that the proteasome activator PA28 gamma participates not only in degradation of hepatitis C virus (HCV) core protein in the nucleus but also in the pathogenesis in transgenic mice expressing HCV core protein. However, the biological significance of PA28 gamma in the propagation of HCV has not been clarified. PA28 gamma is an activator of proteasome responsible for ubiquitin-independent degradation of substrates in the nucleus. In the present study, knockdown of PA28 gamma in cells preinfection or postinfection with the JFH-1 strain of HCV impaired viral particle production but exhibited no effect on viral RNA replication. The particle production of HCV in PA28 gamma knockdown cells was restored by the expression of an small interfering RNA (siRNA)-resistant PA28 gamma. Although viral proteins were detected in the cytoplasm of cells infected with HCV, suppression of PA28 gamma expression induced accumulation of HCV core protein in the nucleus. HCV core protein was also degraded in the cytoplasm after ubiquitination by an E3 ubiquitin ligase, E6AP. Knockdown of PA28 gamma enhanced ubiquitination of core protein and impaired virus production, whereas that of E6AP reduced ubiquitination of core protein and enhanced virus production. Furthermore, virus production in the PA28 gamma knockdown cells was restored through knockdown of E6AP or expression of the siRNA-resistant wild-type but not mutant PA28 gamma incapable of activating proteasome activity. Conclusion: Our results suggest that PA28 gamma participates not only in the pathogenesis but also in the propagation of HCV by regulating the degradation of the core protein in both a ubiquitin-dependent and ubiquitin-independent manner. (HEPATOLOGY 2010;52:411-420)

    DOI: 10.1002/hep.23680

    Web of Science

    PubMed

  • Acquisition of complement resistance through incorporation of CD44/Decay-accelerating factor into viral particles bearing baculovirus GP64 査読 重要な業績

    Yuuki KANAME,Hideki TANI,Chikako KATAOKA,Mai SHIOKAWA,Shuhei TAGUWA,Takayuki ABE,Kohji MORIISHI,Taroh KINOSHITA,Yoshiharu MATSUURA

    Journal of Virology   84 ( 7 )   3210 - 3219   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Establishment of an indicator cell system for hepatitis C virus. 査読 重要な業績

    Tanaka Y, Mori Y, Tani H, Abe T, Moriishi K, Kojima H他5名

    Microbiol Immunol   54 ( 4 )   206 - 220   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Acquisition of Complement Resistance through Incorporation of CD55/Decay-Accelerating Factor into Viral Particles Bearing Baculovirus GP64 査読

    Yuuki Kaname, Hideki Tani, Chikako Kataoka, Mai Shiokawa, Shuhei Taguwa, Takayuki Abe, Kohji Moriishi, Taroh Kinoshita, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   84 ( 7 )   3210 - 3219   2010年4月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    A major obstacle to gene transduction by viral vectors is inactivation by human complement in vivo. One way to overcome this is to incorporate complement regulatory proteins, such as CD55/decay accelerating factor (DAF), into viral particles. Lentivirus vectors pseudotyped with the baculovirus envelope protein GP64 have been shown to acquire more potent resistance to serum inactivation and longer transgene expression than those pseudotyped with the vesicular stomatitis virus (VSV) envelope protein G. However, the molecular mechanisms underlying resistance to serum inactivation in pseudotype particles bearing the GP64 have not been precisely elucidated. In this study, we generated pseudotype and recombinant VSVs bearing the GP64. Recombinant VSVs generated in human cell lines exhibited the incorporation of human DAF in viral particles and were resistant to serum inactivation, whereas those generated in insect cells exhibited no incorporation of human DAF and were sensitive to complement inactivation. The GP64 and human DAF were detected on the detergent-resistant membrane and were coprecipitated by immunoprecipitation analysis. A pseudotype VSV bearing GP64 produced in human DAF knockdown cells reduced resistance to serum inactivation. In contrast, recombinant baculoviruses generated in insect cells expressing human DAF or carrying the human DAF gene exhibited resistance to complement inactivation. These results suggest that the incorporation of human DAF into viral particles by interacting with baculovirus GP64 is involved in the acquisition of resistance to serum inactivation.

    DOI: 10.1128/JVI.02519-09

    Web of Science

    PubMed

  • Establishment of an indicator cell system for hepatitis C virus 査読

    Yoshinori Tanaka, Yoshio Mori, Hideki Tani, Takayuki Abe, Kohji Moriishi, Hirotatsu Kojima, Tetsuo Nagano, Takayoshi Okabe, Tetsuro Suzuki, Masashi Tatsumi, Yoshiharu Matsuura

    MICROBIOLOGY AND IMMUNOLOGY   54 ( 4 )   206 - 220   2010年4月( ISSN:0385-5600  eISSN:1348-0421 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Although a cell culture system for HCV JFH-1 strain has been developed, no robust cell culture system for serum-derived HCV is available. In this study, we have established systems capable of monitoring infection with JFH-1 virus based on specific reporter gene expression through proteolysis of chimeric transcription factors by HCV NS3/4A protease. We utilized a transcriptional factor Gal4-TBP that synergistically enhances transcription of the GAL4UAS and HIV-1 LTR tandem promoter with the Tat protein. We constructed chimeric Tat and Gal4-TBP transcription factors containing the HCV NS3/4A cleavage sequence of a mitochondria-resident IPS-1, but not those of the HCV polyprotein, and manipulated them to localize in the ER. Upon infection with JFH-1 virus, the transcription factors were efficiently cleaved by HCV protease, migrated into the nucleus and activated the reporter gene under the tandem promoter. Upon infection with JFH-1 virus, the Huh7OK1/TG-Luc cell line carrying the transcription factors and a luciferase gene under the promoter expressed luciferase in a dose-dependent manner in close correlation with HCV RNA replication. Huh7OK1/TG-LNGFR cells carrying the transcription factors and a cDNA of human low affinity nerve growth factor receptor under the promoter were selectively concentrated by immunomagnetic cell sorting upon infection with JFH-1 virus. These results indicate that the chimeric constructs bearing the ER-resident IPS-1 sequence are specifically recognized and efficiently cleaved by HCV protease and are harnessed for detection of HCV replication and for recovery of HCV-infected cells. This strategy may be applicable for the establishment of cell culture systems for the isolation of serum-derived HCV.

    DOI: 10.1111/j.1348-0421.2010.00209.x

    Web of Science

    PubMed

  • Involvement of PA28γ in the propagation of hepatitis C virus 査読 重要な業績

    Kohji MORIISHI,Ikuo SHOJI,Yoshio MORI,Ryosuke SUZUKI,Tetsuro SUZUKI,Chikako KATAOKA,Yoshiharu MATSUURA

    Hepatology   52 ( 2 )   411 - 420   2010年3月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus 査読

    Hideki Tani, Mai Shiokawa, Yuuki Kaname, Hiroto Kambara, Yoshio Mori, Takayuki Abe, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   84 ( 6 )   2798 - 2807   2010年3月( ISSN:0022-538X  eISSN:1098-5514 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Japanese encephalitis virus (JEV) is a mosquito-borne RNA virus and one of the most important flaviviruses in the medical and veterinary fields. Although cholesterol has been shown to participate in both the entry and replication steps of JEV, the mechanisms of infection, including the cellular receptors of JEV, remain largely unknown. To clarify the infection mechanisms of JEV, we generated pseudotype (JEVpv) and recombinant (JEVrv) vesicular stomatitis viruses bearing the JEV envelope protein. Both JEVpv and JEVrv exhibited high infectivity for the target cells, and JEVrv was able to propagate and form foci as did authentic JEV. Anti-JEV envelope antibodies neutralized infection of the viruses. Treatment of cells with inhibitors for vacuolar ATPase and clathrin-mediated endocytosis reduced the infectivity of JEVpv, suggesting that JEVpv enters cells via pH-and clathrin-dependent endocytic pathways. Although treatment of the particles of JEVpv, JEVrv, and JEV with cholesterol drastically reduced the infectivity as previously reported, depletion of cholesterol from the particles by treatment with methyl beta-cyclodextrin enhanced infectivity. Furthermore, treatment of cells with sphingomyelinase (SMase), which hydrolyzes membrane-bound sphingomyelin to ceramide, drastically enhanced infection with JEVpv and propagation of JEVrv, and these enhancements were inhibited by treatment with an SMase inhibitor or C-6-ceramide. These results suggest that ceramide plays crucial roles in not only entry but also egress processes of JEV, and they should assist in the clarification of JEV propagation and the development of novel therapeutics against diseases caused by infection with flaviviruses.

    DOI: 10.1128/JVI.02499-09

    Web of Science

    PubMed

  • Establishment of an indicator cell system for hepatitis C virus 査読 重要な業績

    Yoshinori TANAKA,Yoshio MORI,Hideki TANI,Takayuki ABE,Kohji MORIISHI,Hirotatsu KOJIMA,Tetsuo NAGANO,Takayoshi OKABE,Tetsuro SUZUKI,Masashi TATSUMI,Yoshiharu MATSUURA

    Microbiology and Immunology   54   206 - 220   2010年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Involvement of ceramide in the propagation of Japanese encephalitis virus 査読 重要な業績

    Hideki TANI,Mai SHIOKAWA,Yuuki KANAME,Hiroto KAMBARA,Yoshio MORI,Takayuki ABE,Kohji MORIISHI,Yoshiharu MATSUURA

    Journal of Virology   84 ( 6 )   2798 - 2807   2010年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Network based analysis of hepatitis C virus Core and NS4B protein interactions 査読 国際共著

    Lokesh P. Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi

    MOLECULAR BIOSYSTEMS   6 ( 12 )   2539 - 2553   2010年( ISSN:1742-206X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide. Here we attempt to further our understanding of the biological context of protein interactions in HCV pathogenesis, by investigating interactions between HCV proteins Core and NS4B and human host proteins. Using the yeast two-hybrid (Y2H) membrane protein system, eleven human host proteins interacting with Core and 45 interacting with NS4B were identified, most of which are novel. These interactions were used to infer overall protein interaction maps linking the viral proteins with components of the host cellular networks. Core and NS4B proteins contribute to highly compact interaction networks that may enable the virus to respond rapidly to host physiological responses to HCV infection. Analysis of the interaction networks highlighted enriched biological pathways likely influenced in HCV infection. Inspection of individual interactions offered further insights into the possible mechanisms that permit HCV to evade the host immune response and appropriate host metabolic machinery. Follow-up cellular assays with cell lines infected with HCV genotype 1b and 2a strains validated Core interacting proteins ENO1 and SLC25A5 and host protein PXN as novel regulators of HCV replication and viral production. ENO1 siRNA knockdown was found to inhibit HCV replication in both the HCV genotypes and viral RNA release in genotype 2a. PXN siRNA inhibition was observed to inhibit replication specifically in genotype 1b but not in genotype 2a, while SLC25A5 siRNA facilitated a minor increase in the viral RNA release in genotype 2a. Thus, our analysis can provide potential targets for more effective anti-HCV therapeutic intervention.

    DOI: 10.1039/c0mb00103a

    Web of Science

    PubMed

  • Peripheral B Cells May Serve as a Reservoir for Persistent Hepatitis C Virus Infection 査読

    Masahiko Ito, Atsuko Masumi, Keiko Mochida, Hiroshi Kukihara, Kohji Moriishi, Yoshiharu Matsuura, Kazunari Yamaguchi, Toshiaki Mizuochi

    JOURNAL OF INNATE IMMUNITY   2 ( 6 )   607 - 617   2010年( ISSN:1662-811X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    A recent study by our group indicated that peripheral B cells in chronic hepatitis C (CHC) patients are infected with hepatitis C virus (HCV). This raised the logical question of how HCV circumvents the antiviral immune responses of B cells. Because type I interferon (IFN) plays a critical role in the innate antiviral immune response, IFN beta expression levels in peripheral B cells from CHC patients were analyzed, and these levels were found to be comparable to those in normal B cells, which suggested that HCV infection failed to trigger antiviral immune responses in B cells. Sensing mechanisms for invading viruses in host immune cells involve Toll-like receptor-mediated and retinoic acid-inducible gene-I (RIG-I)-mediated pathways. Both pathways culminate in IFN regulatory factor-3 (IRF-3) translocation into the nucleus for IFN beta gene transcription. Although the expression levels of RIG-I and its adaptor molecule, IFN promoter-stimulator-1, were substantially enhanced in CHC B cells, dimerization and subsequent nuclear translocation of IRF-3 were not detectable. TANK-binding kinase-1 (TBK1) and I kappa B kinase epsilon (IKK epsilon) are essential for IRF-3 phosphorylation. Constitutive expression of both kinases was markedly enhanced in CHC B cells. However, reduced expression of heat shock protein of 90 kDa, a TBK1 stabilizer, and enhanced expression of SIKE, an IKK epsilon suppressor, were observed in CHC B cells, which might suppress the kinase activity of TBK1/IKK epsilon for IRF-3 phosphorylation. In addition, the expression of vesicle-associated membrane protein-associated protein-C, a putative inhibitor of HCV replication, was negligible in B cells. These results strongly suggest that HCV utilizes B cells as a reservoir for persistent infection. Copyright (C) 2010 S. Karger AG, Basel

    DOI: 10.1159/000317690

    Web of Science

    PubMed

  • ELIMINATION OF HCV FROM HUMAN HEPATOCYTES BY INDUCTION OF TYPE I IFN VIA EXPRESSION OF IRF7 国際共著

    Xiaoyu Wen, Takayuki Abe, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF GENE MEDICINE   11 ( 12 )   1165 - 1166   2009年12月( ISSN:1099-498X )

     詳細を見る

    記述言語:英語   掲載種別:(MISC)研究発表要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS LTD  

    Web of Science

  • Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells. 査読 重要な業績

    Moriya K, Miyoshi H, Tsutsumi T, Shinzawa S, Fujie H, その他7名

    Am J Pathol.   175   1515   2009年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Cochaperone Activity of Human Butyrate-Induced Transcript 1 Facilitates Hepatitis C Virus Replication through an Hsp90-Dependent Pathway 査読

    Shuhei Taguwa, Hiroto Kambara, Hiroko Omori, Hideki Tani, Takayuki Abe, Yoshio Mori, Tetsuro Suzuki, Tamotsu Yoshimori, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   83 ( 20 )   10427 - 10436   2009年10月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a component of the replication complex consisting of several host and viral proteins. We have previously reported that human butyrate-induced transcript 1 (hB-ind1) recruits heat shock protein 90 (Hsp90) and FK506-binding protein 8 (FKBP8) to the replication complex through interaction with NS5A. To gain more insights into the biological functions of hB-ind1 in HCV replication, we assessed the potential cochaperone-like activity of hB-ind1, because it has significant homology with cochaperone p23, which regulates Hsp90 chaperone activity. The chimeric p23 in which the cochaperone domain was replaced with the p23-like domain of hB-ind1 exhibited cochaperone activity comparable to that of the authentic p23, inhibiting the glucocorticoid receptor signaling in an Hsp90-dependent manner. Conversely, the chimeric hB-ind1 in which the p23-like domain was replaced with the cochaperone domain of p23 resulted in the same level of recovery of HCV propagation as seen in the authentic hB-ind1 in cells with knockdown of the endogenous hB-ind1. Immunofluorescence analyses revealed that hB-ind1 was colocalized with NS5A, FKBP8, and double-stranded RNA in the HCV replicon cells. HCV replicon cells exhibited a more potent unfolded-protein response (UPR) than the parental and the cured cells upon treatment with an inhibitor for Hsp90. These results suggest that an Hsp90-dependent chaperone pathway incorporating hB-ind1 is involved in protein folding in the membranous web for the circumvention of the UPR and that it facilitates HCV replication.

    DOI: 10.1128/JVI.01035-09

    Web of Science

    PubMed

  • Tacrolimus Ameliorates Metabolic Disturbance and Oxidative Stress Caused by Hepatitis C Virus Core Protein Analysis Using Mouse Model and Cultured Cells 査読

    Kyoji Moriya, Hideyuki Miyoshi, Takeya Tsutsumi, Seiko Shinzawa, Hajime Fujie, Yoshizumi Shintani, Hiroshi Yotsuyanagi, Kohji Moriishi, Yoshiharu Matsuura, Tetsuro Suzuki, Tatsuo Miyamura, Kazuhiko Koike

    AMERICAN JOURNAL OF PATHOLOGY   175 ( 4 )   1515 - 1524   2009年10月( ISSN:0002-9440 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Hepatic steatosis and insulin resistance are factors that aggravate the progression of liver disease caused by hepatitis C virus (HCV) infection. In the pathogenesis of liver disease and metabolic disorders in HCV infection, oxidative stress due to mitochondrial respiratory chain dysfunction plays a pivotal role. Tacrolimus (FK506) is supposed to protect mitochondrial respiratory function. We studied whether tacrolimus affects the development of HCV-associated liver disease using HCV core gene transgenic mice, which develop hepatic steatosis, insulin resistance, and hepatocellular carcinoma. Administration of tacrolimus; to HCV core gene transgenic mice three times per week for 3 months led to a significant reduction in the amounts of lipid in the liver as well as in serum insulin. Tacrolimus treatment also ameliorated oxidative stress and DNA damage in the liver of the core gene transgenic mice. Tacrolimus administration reproduced these effects in a dose-dependent manner in HepG2 cells expressing the core protein. The intrahepatic level of tumor necrosis factor-alpha, which may be a key molecule for the pathogenesis in HCV infection, was significantly decreased in tacrolimus-treated core gene transgenic mice. Tacrolimus thus reversed the effect of the core protein in the patho genesis of HCV-associated liver disease. These results may provide new therapeutic tools for chronic hepatitis C, in which oxidative stress and abnormalities in lipid and glucose metabolism contribute to liver pathogenesis. (Am J Pathol 2009, 175:1515-1524; DOI: 10.2353/ajpath.2009.090102)

    DOI: 10.2353/ajpath.2009.090102

    Web of Science

    PubMed

  • Baculovirus Induces Type I Interferon Production through Toll-Like Receptor-Dependent and -Independent Pathways in a Cell-Type-Specific Manner 査読 重要な業績

    Abe, T.,Kaname, Y.,Wen, X. Y.,Tani, H.,Moriishi, K.,Uematsu, S.,Takeuchi, O.,Ishii, K. J.,Kawai, T.,Akira, S.,Matsuura, Y.

    Journal of Virology   83 ( 16 )   7640   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway. 査読 重要な業績

    Taguwa S, Kambara H, Omori H, Tani H, Abe T, その他5名

    Journal of Virology   83   10427   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Baculovirus Induces Type I Interferon Production through Toll-Like Receptor-Dependent and -Independent Pathways in a Cell-Type-Specific Manner 査読

    Takayuki Abe, Yuuki Kaname, Xiaoyu Wen, Hideki Tani, Kohji Moriishi, Satoshi Uematsu, Osamu Takeuchi, Ken J. Ishii, Taro Kawai, Shizuo Akira, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   83 ( 15 )   7629 - 7640   2009年8月( ISSN:0022-538X  eISSN:1098-5514 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Autographa californica nuclear polyhedrosis virus (AcNPV) is a double-stranded-DNA virus that is pathogenic to insects. AcNPV was shown to induce an innate immune response in mammalian immune cells and to confer protection of mice from lethal viral infection. In this study, we have shown that production of type I interferon (IFN) by AcNPV in murine plasmacytoid dendritic cells (pDCs) and non-pDCs, such as peritoneal macrophages and splenic CD11c(+) DCs, was mediated by Toll-like receptor (TLR)-dependent and -independent pathways, respectively. IFN regulatory factor 7 (IRF7) was shown to play a crucial role in the production of type I IFN by AcNPV not only in immune cells in vitro but also in vivo. In mouse embryonic fibroblasts (MEFs), AcNPV produced IFN-beta and IFN-inducible chemokines through TLR-independent and IRF3-dependent pathways, in contrast to the TLR-dependent and IRF3/IRF7-independent production of proinflammatory cytokines. Although production of IFN-beta and IFN-inducible chemokines was severely impaired in IFN promoter-stimulator 1 (IPS-1)-deficient MEFs upon infection with vesicular stomatitis virus, AcNPV produced substantial amounts of the cytokines in IPS-1-deficient MEFs. These results suggest that a novel signaling pathway(s) other than TLR- and IPS-1-dependent pathways participates in the production of type I IFN in response to AcNPV infection.

    DOI: 10.1128/JVI.00679-09

    Web of Science

    PubMed

  • Human VAP-C Negatively Regulates Hepatitis C Virus Propagation 査読

    Hiroshi Kukihara, Kohji Moriishi, Shuhei Taguwa, Hideki Tani, Takayuki Abe, Yoshio Mori, Tetsuro Suzuki, Takasuke Fukuhara, Akinobu Taketomi, Yoshihiko Maehara, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   83 ( 16 )   7959 - 7969   2009年8月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Human vesicle-associated membrane protein-associated protein (VAP) subtype A (VAP-A) and subtype B (VAP-B) are involved in the regulation of membrane trafficking, lipid transport and metabolism, and the unfolded protein response. VAP-A and VAP-B consist of the major sperm protein (MSP) domain, the coiled-coil motif, and the C-terminal transmembrane anchor and form homo- and heterodimers through the transmembrane domain. VAP-A and VAP-B interact with NS5B and NS5A of hepatitis C virus (HCV) through the MSP domain and the coiled-coil motif, respectively, and participate in the replication of HCV. VAP-C is a splicing variant of VAP-B consisting of the N-terminal half of the MSP domain of VAP-B followed by the subtype-specific frameshift sequences, and its biological function has not been well characterized. In this study, we have examined the biological functions of VAP-C in the propagation of HCV. VAP-C interacted with NS5B but not with VAP-A, VAP-B, or NS5A in immunoprecipitation analyses, and the expression of VAP-C inhibited the interaction of NS5B with VAP-A or VAP-B. Overexpression of VAP-C impaired the RNA replication of the HCV replicon and the propagation of the HCV JFH1 strain, whereas overexpression of VAP-A and VAP-B enhanced the replication. Furthermore, the expression of VAP-C was observed in various tissues, whereas it was barely detected in the liver. These results suggest that VAP-C acts as a negative regulator of HCV propagation and that the expression of VAP-C may participate in the determination of tissue tropism of HCV propagation.

    DOI: 10.1128/JVI.00889-09

    Web of Science

    PubMed

  • Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure 査読 国際共著

    Tetsuo Yamashita, Yoshio Mori, Naoyuki Miyazaki, R. Holland Cheng, Masato Yoshimura, Hideaki Unno, Ryoichi Shima, Kohji Moriishi, Tomitake Tsukihara, Tian Cheng Li, Naokazu Takeda, Tatsuo Miyamura, Yoshiharu Matsuura

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   106 ( 31 )   12986 - 12991   2009年8月( ISSN:0027-8424 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    Hepatitis E virus (HEV) is a causative agent of acute hepatitis. The crystal structure of HEV-like particles (HEV-LP) consisting of capsid protein was determined at 3.5-angstrom resolution. The capsid protein exhibited a quite different folding at the protruding and middle domains from the members of the families of Caliciviridae and Tombusviridae, while the shell domain shared the common folding. Tyr-288 at the 5-fold axis plays key roles in the assembly of HEV-LP, and aromatic amino acid residues are well conserved among the structurally related viruses. Mutational analyses indicated that the protruding domain is involved in the binding to the cells susceptive to HEV infection and has some neutralization epitopes. These structural and biological findings are important for understanding the molecular mechanisms of assembly and entry of HEV and also provide clues in the development of preventive and prophylactic measures for hepatitis E.

    DOI: 10.1073/pnas.0903699106

    Web of Science

    PubMed

  • Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28 gamma-Dependent Mechanism 査読

    Ryosuke Suzuki, Kohji Moriishi, Kouichirou Fukuda, Masayuki Shirakura, Koji Ishii, Ikuo Shoji, Takaji Wakita, Tatsuo Miyamura, Yoshiharu Matsuura, Tetsuro Suzuki

    JOURNAL OF VIROLOGY   83 ( 5 )   2389 - 2392   2009年3月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    We have previously reported on the ubiquitylation and degradation of hepatitis C virus core protein. Here we demonstrate that proteasomal degradation of the core protein is mediated by two distinct mechanisms. One leads to polyubiquitylation, in which lysine residues in the N-terminal region are preferential ubiquitylation sites. The other is independent of the presence of ubiquitin. Gain- and loss-of-function analyses using lysineless mutants substantiate the hypothesis that the proteasome activator PA28 gamma, a binding partner of the core, is involved in the ubiquitin-independent degradation of the core protein. Our results suggest that turnover of this multifunctional viral protein can be tightly controlled via dual ubiquitin-dependent and -independent proteasomal pathways.

    DOI: 10.1128/JVI.01690-08

    Web of Science

    PubMed

  • Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure 査読

    Yamashita, T.,Mori, Y.,Miyazaki, N.,Cheng, R. H.,Yoshimura, M.,Unno, H.,Shima, R.,Moriishi, K.,Tsukihara, T.,Li, T. C.,Takeda, N.,Miyamura, T.,Matsuura, Y.

    Proceedings of the National Academy of Sciences of the United States of America   106 ( 31 )   12986 - 12991   2009年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28 gamma-Dependent Mechanism 査読 重要な業績

    Suzuki, R.,Moriishi, K.,Fukuda, K.,Shirakura, M.,Ishii, K.,Shoji, I.,Wakita, T.,Miyamura, T.,Matsuura, Y.,Suzuki, T.

    Journal of Virology   83 ( 5 )   2389 - 2392   2009年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Human VAP-C Negatively Regulates Hepatitis C Virus Propagation 査読 重要な業績

    Kukihara, H.,Moriishi, K.,Taguwa, S.,Tani, H.,Abe, T.,Mori, Y.,Suzuki, T.,Fukuhara, T.,Taketomi, A.,Maehara, Y.,Matsuura, Y.

    Journal of Virology   83 ( 16 )   7959 - 7969   2009年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • [Processing and pathogenicity of HCV core protein]. 招待 査読

    Moriishi K, Mori Y, Matsuura Y

    Uirusu   58 ( 2 )   183 - 190   2008年12月( ISSN:0042-6857 )

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2222/jsv.58.183

    Scopus

    PubMed

  • HCVの複製に必須な宿主因子の同定と創薬の可能性 (特集 ウイルス感染の仕組みを追う--パンデミックから慢性ウイルス感染まで) 招待 査読

    森 嘉生, 森石 恆司, 松浦 善治

    細胞工学   27 ( 12 )   1226 - 1231   2008年12月( ISSN:0287-3796 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:秀潤社  

    CiNii Books

    その他リンク: http://search.jamas.or.jp/link/ui/2009042020

  • Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation 査読

    Kiyoko Okamoto, Yoshio Mori, Yasumasa Komoda, Toru Okamoto, Masayasu Okochi, Masatoshi Takeda, Tetsuro Suzuki, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   82 ( 17 )   8349 - 8361   2008年9月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) core protein has shown to be localized in the detergent-resistant membrane (DRM), which is distinct from the classical raft fraction including caveolin, although the biological significance of the DRM localization of the core protein has not been determined. The HCV core protein is cleaved off from a precursor polyprotein at the lumen side of Ala(191) by signal peptidase and is then further processed by signal peptide peptidase (SPP) within the transmembrane region. In this study, we examined the role of SPP in the localization of the HCV core protein in the DRM and in viral propagation. The C terminus of the HCV core protein cleaved by SPP in 293T cells was identified as Phe(177) by mass spectrometry. Mutations introduced into two residues (Ile(176) and Phe(177)) upstream of the cleavage site of the core protein abrogated processing by SPP and localization in the DRM fraction. Expression of a dominant-negative SPP or treatment with an SPP inhibitor, L685,458, resulted in reductions in the levels of processed core protein localized in the DRM fraction. The production of HCV RNA in cells persistently infected with strain JFH-1 was impaired by treatment with the SPP inhibitor. Furthermore, mutant JFH-1 viruses bearing SPP-resistant mutations in the core protein failed to propagate in a permissive cell line. These results suggest that intramembrane processing of HCV core protein by SPP is required for the localization of the HCV core protein in the DRM and for viral propagation.

    DOI: 10.1128/JVI.00306-08

    Web of Science

    PubMed

  • A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication 査読

    Toru Okamoto, Hiroko Omori, Yuuki Kaname, Takayuki Abe, Yorihiro Nishimura, Tetsuro Suzuki, Tatsuo Miyamura, Tamotsu Yoshimori, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   82 ( 7 )   3480 - 3489   2008年4月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) regulates viral replication through its interaction with host and other viral proteins. We have previously shown that FK506-binding protein 8 (FKBP8) binds to NS5A and recruits Hsp90 to form a complex that participates in the replication of HCV. In this study, we examined the biochemical characteristics of the interaction and the intracellular localization of NS5A and FKBP8. Surface plasmon resonance analysis revealed that the dissociation constant of the interaction between the purified FKBP8 and NS5A expressed in bacteria was 82 nM. Mutational analyses of NS5A revealed that a single amino acid residue of Val or Ile at position 121, which is well conserved among all genotypes of HCV, is critical for the specific interaction with FKBP8. Substitution of the Val(121) to Ala drastically impaired the replication of HCV replicon cells, and the drug-resistant replicon cells emerging after drug selection were shown to have reverted to the original arrangement by replacing Ala(121) with Val. Examination of individual fields of the replicon cells by both fluorescence microscopy and electron microscopy (the correlative fluorescence microscopy-electron microscopy technique) revealed that FKBP8 is partially colocalized with NS5A in the cytoplasmic structure known as the membranous web. These results suggest that specific interaction of NS5A with FKBP8 in the cytoplasmic compartment plays a crucial role in the replication of HCV.

    DOI: 10.1128/JVI.02253-07

    Web of Science

    PubMed

  • Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 angstrom 査読

    Tetsuo Yamashita, Hideaki Unno, Yoshio Mori, Hideki Tani, Kohji Moriishi, Akihisa Takamizawa, Masanobu Agoh, Tomitake Tsukihara, Yoshiharu Matsuura

    VIROLOGY   373 ( 2 )   426 - 436   2008年4月( ISSN:0042-6822 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    The NS3 protein of Japanese encephalitis virus (JEV) is a large multifunctional protein possessing protease, helicase, and nucleoside 5'-triphosphatase (NTPase) activities, and plays important roles in the processing of a viral polyprotein and replication. To clarify the enzymatic properties of NS3 protein from a structural point of view, an enzymatically active fragment of the JEV NTPase/helicase catalytic domain was expressed in bacteria and the crystal structure was determined at 1.8 angstrom resolution. JEV helicase is composed of three domains, displays an asymmetric distribution of charges on its surface, and contains a tunnel large enough to accommodate single-stranded RNA. Each of the motifs I (Walker A motif), 11 (Walker B motif) and VI was composed of an NTP-binding pocket. Mutation analyses revealed that all of the residues in the Walker A motif (Gly(199) , LYS200 and Thr(201)), in addition to the polar residues within the NTP-binding pocket (Gln(199), Arg(200) and Arg(464)), and also Arg(459) in the outside of the pocket in the motif IV were crucial for ATPase and helicase activities and virus replication. Lys(200) was particularly indispensable, and could not be exchanged for other amino acid residues without sacrificing these activities. The structure of the NTP-binding pocket of JEV is well conserved in dengue virus and yellow fever virus, while different from that of hepatitis C virus. The detailed structural comparison among the viruses of the family Flaviviridae should help in clarifying the molecular mechanism of viral replication and in providing rationale for the development of appropriate therapeutics. (C) 2008 Published by Elsevier Inc.

    DOI: 10.1016/j.virol.2007.12.018

    Web of Science

    PubMed

  • Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication 査読

    Shuhei Taguwa, Toru Okamoto, Takayuki Abe, Yoshio Mori, Tetsuro Suzuki, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   82 ( 6 )   2631 - 2641   2008年3月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is required for the replication of the viral genome and is involved in several host signaling pathways. To gain further insight into the functional role of NS5A in HCV replication, we screened human cDNA libraries by a yeast two-hybrid system using NS5A as the bait and identified human butyrate-induced transcript 1 (hB-ind1) as a novel NS5A-binding protein. Endogenously and exogenously expressed hB-ind1 was coimmunoprecipitated with NS5A of various genotypes through the coiled-coil domain of hB-ind1. The small interfering RNA (siRNA)-mediated knockdown of hB-ind1 in human hepatoma cell lines suppressed the replication of HCV RNA replicons and the production of infectious particles of HCV genotype 2a strain JFH1. Furthermore, these reductions were canceled by the expression of an siRNA-resistant hB-ind1 mutant. Among the NS5A-binding host proteins involved in HCV replication, hB-ind1 exhibited binding with FKBP8, and hB-ind1 interacted with Hsp90 through the FxxW motif in its N-terminal p23 homology domain. The impairment of the replication of HCV RNA replicons and of the production of infectious particles of JFH1 virus in the hB-ind1 knockdown cell lines was not reversed by the expression of an siRNA-resistant hB-ind1 mutant in which the FxxW motif was replaced by AxxA. These results suggest that hB-ind1 plays a crucial role in HCV RNA replication and the propagation of JFH1 virus through interaction with viral and host proteins.

    DOI: 10.1128/JVI.02153-07

    Web of Science

    PubMed

  • Virus-cell interaction of HCV 査読 国際共著

    Hideki Tani, Yasumasa Komoda, Chang-Kwang Limn, Kensuke Suzuki, Kohji Moriishi, Tatsuo Miyamura, Yoshiharu Matsuura

    Structure-Based Study of Viral Replication: (With CD-Rom)   125 - 150   2008年1月

     詳細を見る

    記述言語:英語   掲載種別:論文集(書籍)内論文   出版者・発行元:World Scientific Publishing Co.  

    Hepatitis C virus (HCV) infection is a major health problem worldwide for almost two decades. However, precise mechanisms including an infection of HCV to target cells or a cause of hepatocellular carcinoma are largely unknown. Study of HCV has been hampered by the lack of a robust and reliable cell culture system and a small animal model that supports replication of HCV. Understanding the mechanisms of HCV infection is essential for the development of new effective therapies for chronic hepatitis C. HCV presumably binds to specific receptor(s) and then enters into cells by endocytosis, as do other members of the Flaviviridae family and several host membrane proteins have been identified as receptor candidates for HCV. Recent advances of pseudotype virus systems based on vesicular stomatitis virus or retrovirus have provided further information surrounding the initial steps of HCV infection. In this Chapter, we will present current status of our knowledge on the mechanisms of HCV infection including candidate receptors for HCV. (161 words).

    DOI: 10.1142/9789812790859_0006

    Scopus

  • Baculovirus vector for gene delivery and vaccine development

    Hideki Tani, Takayuki Abe, Tomoko M. Matsunaga, Kohji Moriishi, Yoshiharu Matsuura

    Future Virology   3 ( 1 )   35 - 43   2008年1月( ISSN:1746-0794 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The baculovirus Autographa californica multiple nucleopolyhedrovirus has been widely used not only to acheive a high level of foreign gene expression in insect cells, but also for efficient gene transduction into mammalian cells. Recombinant and pseudotyped baculoviruses possessing chimeric or foreign ligands have been constructed to improve the efficiency of gene transduction and to confer specificity for gene delivery into mammalian cells, respectively. Baculoviral DNA CpG motifs induce proinflammatory cytokines through a Toll-like receptor (TLR9)/ MyD88-dependent signaling pathway. Other baculovirus components produce type I interferons via a TLR-independent pathway-Baculovirus exhibits a strong adjuvant property and recombinant baculoviruses encoding microbial antigens elicit antibodies to the antigens and provide protective immunity in mice. This review deals with recent progress in the application of baculovirus vectors to gene delivery and vaccine development, and discusses the future prospects of baculovirus vectors. © 2008 Future Medicine Ltd.

    DOI: 10.2217/17460794.3.1.35

    Scopus

  • Hepatitis C virus core protein: Its coordinate roles with PA28 gamma in metabolic abnormality and carcinogenicity in the liver 招待 査読

    Yoshio Mori, Kohji Moriishi, Yoshiharu Matsuura

    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY   40 ( 8 )   1437 - 1442   2008年( ISSN:1357-2725 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Hepatitis C virus (HCV) is a major cause of chronic liver diseases, including steatosis, cirrhosis and hepatocellular carcinoma, and epidemiological studies indicate that HCV is also associated with insulin resistance and type 2 diabetes mellitus. The HCV core protein is not only a viral structural component but also a pathogenic factor, since its expression leads to the development of liver steatosis, insulin resistance and hepatocellular carcinoma in mice. The nuclear proteasome activator PA28 gamma/REG gamma, which specifically binds to the core protein, is required for the virulence of the core protein. Elucidation of the mechanisms by which HCV core protein participates in the above conditions may provide clues toward the development of novel therapeutic measures for chronic hepatitis C. (C) 2008 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.biocel.2008.01.027

    Web of Science

    PubMed

  • [Pathogenesis of hepatitis C virus]. 査読

    Moriishi K, Matsuura Y

    Uirusu   57 ( 2 )   141 - 149   2007年12月( ISSN:0042-6857 )

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2222/jsv.57.141

    Scopus

    PubMed

  • Evaluation systems for anti-HCV drugs 招待 査読

    Kohji Moriishi, Yoshiharu Matsuura

    ADVANCED DRUG DELIVERY REVIEWS   59 ( 12 )   1213 - 1221   2007年10月( ISSN:0169-409X )

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Development of therapeutics for chronic hepatitis C has been hampered by the lack of an efficient cell culture system and a small animal model for the hepatitis C virus (HCV). An RNA replicon system, in which the HCV genome replicates autonomously in cells, and replication competent viruses derived from an HCV genotype 2a JFH1 strain efficiently propagating in Huh7 cells have been developed, and these systems have contributed to the evaluation of anti-HCV drugs targeted to viral and host proteins involved in the replication of HCV. Several compounds counteracting the viral enzymes, such as RNA polymerase and proteases, and host proteins involved in the lipid synthesis and protein folding are reported to have anti-HCV activities based on assessments using these in vitro systems. Furthermore, a mouse model transplanted with human liver fragments was shown to be capable of replicating HCV and has been used to evaluate the efficacy of antiviral drugs in vivo. In this review, we summarize information regarding systems for studying the HCV life cycle and potential new targets for therapeutic intervention for chronic hepatitis C.

    DOI: 10.1016/j.addr.2007.04.015

    Web of Science

    PubMed

  • Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines 査読

    Takayuki Abe, Yuuki Kaname, Itsuki Hamamoto, Yoshimi Tsuda, Xiaoyu Wen, Shuhei Taguwa, Kohji Moriishi, Osamu Takeuchi, Taro Kawai, Tatsuya Kanto, Norio Hayashi, Shizuo Akira, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   81 ( 17 )   8953 - 8966   2007年9月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) infection induces a wide range of chronic liver injuries; however, the mechanism through which HCV evades the immune surveillance system remains obscure. Blood dendritic cells (DCs) play a pivotal role in the recognition of viral infection and the induction of innate and adaptive immune responses. Several reports suggest that HCV infection induces the dysfunction of DCs in patients with chronic hepatitis C. Toll-like receptor (TLR) has been shown to play various roles in many viral infections; however, the involvement of HCV proteins in the TLR signaling pathway has not yet been precisely elucidated. In this study, we established mouse macrophage cell lines stably expressing HCV proteins and determined the effect of HCV proteins on the TLR signaling pathways. Immune cells expressing NS3, NS3/4A, NS4B, or NS5A were found to inhibit the activation of the TLR2, TLR4, TLR7, and TLR9 signaling pathways. Various genotypes of NS5A bound to MyD88, a major adaptor molecule in TLR, inhibited the recruitment of interleukin-1 receptor-associated kinase I to MyD88, and impaired cytokine production in response to TLR ligands. Amino acid residues 240 to 280, previously identified as the interferon sensitivity-determining region (ISDR) in NS5A, interacted with the death domain of MyD88, and the expression of a mutant NS5A lacking the ISDR partially restored cytokine production. These results suggest that the expression of HCV proteins modulates the TLR signaling pathway in immune cells.

    DOI: 10.1128/JVI.00649-07

    Web of Science

    PubMed

  • Host factors involved in the replication of hepatitis C virus 招待 査読

    Kohji Moriishi, Yoshiharu Matsuura

    REVIEWS IN MEDICAL VIROLOGY   17 ( 5 )   343 - 354   2007年9月( ISSN:1052-9276 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JOHN WILEY & SONS LTD  

    Hepatitis C virus (HCV) is the major causative agent of blood-borne hepatitis. The majority of HCV-infected individuals develop chronic hepatitis, which eventually progresses to liver cirrhosis, and hepatocellular carcinoma. Although the precise mechanisms of entry, replication, assembly, egress and pathogenesis of HCV are largely unknown, information about viral receptor candidates has accumulated by the development of pseudotype viruses and an in vitro replication system of the HCV JFH1 strain. Furthermore, the autonomous RNA replication system based on the artificial viral genome revealed that HCV replicates in the intracellular replication complex composed of viral and host proteins. Recently, an immunosuppressant, cyclosporin A and inhibitors for sphingolipid synthesis and chaperon were reported to inhibit the replication of HCV by counteracting the interplay between host and viral proteins. This review considers the current knowledge of the host proteins that participate in HCV replication and the possibility of developing novel therapeutics intervention for chronic hepatitis C. Copyright (c) 2007 John Wiley & Sons, Ltd.

    DOI: 10.1002/rmv.542

    Web of Science

    PubMed

  • Processsing of capsid protein by Cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells 査読

    Yoshio Mori, Tetsuo Yamashita, Yoshinori Tanaka, Yoshimi Tsuda, Takayuki Abe, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   81 ( 16 )   8477 - 8487   2007年8月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The flavivirus capsid protein not only is a component of nucleocapsids but also plays a role in viral replication. In this study, we found a small capsid protein in cells infected with Japanese encephalitis virus (JEV) but not in the viral particles. The small capsid protein was shown to be generated by processing with host cysteine protease cathepsin L. An in vitro cleavage assay revealed that cathepsin L cleaves the capsid protein between amino acid residues Lys(18) and Arg(19), which are well conserved among the mosquito-borne flaviviruses. A mutant JEV resistant to the cleavage of the capsid protein by cathepsin L was generated from an infectious cDNA clone of JEV by introducing a substitution in the cleavage site. The mutant JEV exhibited growth kinetics similar to those of the wild-type JEV in monkey (Vero), mosquito (C6/36), and porcine (PK15) cell lines, whereas replication of the mutant JEV in mouse macrophage (RAW264.7) and neuroblastoma (N18) cells was impaired. Furthermore, the neurovirulence and neuroinvasiveness of the mutant JEV to mice were lower than those of the wild-type JEV. These results suggest that the processing of the JEV capsid protein by cathepsin L plays a crucial role in the replication of JEV in neural and macrophage cells, which leads to the pathogenesis of JEV infection.

    DOI: 10.1128/JVI.00477-07

    Web of Science

    PubMed

  • Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins 査読 国際共著

    Hideki Tani, Yasumasa Komoda, Eiko Matsuo, Kensuke Suzuki, Itsuki Hamamoto, Tetsuo Yamashita, Kohji Moriishi, Kazuhito Fujiyama, Tatsuya Kanto, Norio Harashi, Ania Owsianka, Arvind H. Patel, Michael A. Whitt, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   81 ( 16 )   8601 - 8612   2007年8月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Although in vitro replication of the hepatitis C virus (HCV) JFH1 clone of genotype 2a (HCVcc) has been developed, a robust cell culture system for the la and 1b genotypes, which are the most prevalent viruses in the world and resistant to interferon therapy, has not yet been established. As a surrogate virus system, pseudotype viruses transiently bearing HCV envelope proteins based on the vesicular stomatitis virus (VSV) and retrovirus have been developed. Here, we have developed a replication-competent recombinant VSV with a genome encoding unmodified HCV El and E2 proteins in place of the VSV envelope protein (HCVrv) in human cell lines. HCVrv and a pseudotype VSV bearing the unmodified HCV envelope proteins (HCVpv) generated in 293T or Huh7 cells exhibited high infectivity in Huh7 cells. Generation of infectious HCVrv was limited in some cell lines examined. Furthermore, HCVrv but not HCVpv was able to propagate and form foci in Huh7 cells. The infection of Huh7 cells with HCVpv and HCVrv was neutralized by anti-hCD81 and anti-E2 antibodies and by sera from chronic HCV patients. The infectivity of HCVrv was inhibited by an endoplasmic reticulum alpha-glucosidase inhibitor, N-(n-nonyl) deoxynojirimycin (Nn-DNJ), but not by a Golgi mannosidase inhibitor, deoxymannojirimycin. Focus formation of HCVrv in Huh7 cells was impaired by Nn-DNJ treatment. These results indicate that the HCVrv developed in this study can be used to study HCV envelope proteins with respect to not only the biological functions in the entry process but also their maturation step.

    DOI: 10.1128/JVI.00608-07

    Web of Science

    PubMed

  • Evaluation systems for anti-HCV drugs 査読 重要な業績

    Moriishi, K.,Matsuura, Y

    Advanced Drug Delivery Reviews   59 ( 12 )   1213 - 1221   2007年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Host factors involved in the replication of hepatitis C virus 査読 重要な業績

    Moriishi, K.,Matsuura, Y.

    Reviews in Medical Virology   17 ( 5 )   343 - 354   2007年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein 査読

    Masayuki Shirakura, Kyoko Murakami, Tohru Ichimura, Ryosuke Suzuki, Tetsu Shimoji, Kouichirou Fukuda, Katsutoshi Abe, Shigeko Sato, Masayoshi Fukasawa, Yoshio Yamakawa, Masahiro Nishijima, Kohji Moriishi, Yoshiharu Matsuura, Takaji Wakita, Tetsuro Suzuki, Peter M. Howley, Tatsuo Miyamura, Ikuo Shoji

    JOURNAL OF VIROLOGY   81 ( 3 )   1174 - 1185   2007年2月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) core protein is a major component of viral nucleocapsid and a multifunctional Protein involved in viral pathogenesis and hepatocarcinogenesis. We previously showed that the HCV core protein is degraded through the ubiquitin-proteasome pathway. However, the molecular machinery for core ubiquitylation is unknown. Using tandem affinity purification, we identified the ubiquitin ligase E6AP as an HCV core-binding protein. E6AP was found to bind to the core protein in vitro and in vivo and promote its degradation in hepatic and nonhepatic cells. Knockdown of endogenous E6AP by RNA interference increased the HCV core protein level. In vitro and in vivo ubiquitylation assays showed that E6AP promotes ubiquitylation of the core protein. Exogenous expression of E6AP decreased intracellular core protein levels and supernatant HCV infectivity titers in the HCV JFH1-infected Huh-7 cells. Furthermore, knockdown of endogenous E6AP by RNA interference increased intracellular core protein levels and supernatant HCV infectivity titers in the HCV JFH1-infected cells. Taken together, our results provide evidence that E6AP mediates ubiquitylation and degradation of HCV core protein. We propose that the E6AP-mediated ubiquitin-proteasome pathway may affect the production of HCV particles through controlling the amounts of viral nucleocapsid protein.

    DOI: 10.1128/JVI.01684-06

    Web of Science

    PubMed

  • Involvement of the PA28 gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein 査読

    Hironobu Miyamoto, Kohji Moriishi, Kyoji Moriya, Shigeo Murata, Keiji Tanaka, Tetsuro Suzuki, Tatsuo Miyamura, Kazuhiko Koike, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   81 ( 4 )   1727 - 1735   2007年2月( ISSN:0022-538X )

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The hepatitis C virus (HCV) core protein is a component of nucleocapsids and a pathogenic factor for hepatitis C. Several epidemiological and experimental studies have suggested that HCV infection is associated with insulin resistance, leading to type 2 diabetes. We have previously reported that HCV core gene-transgenic (PA28 gamma(+/+)CoreTg) mice develop marked insulin resistance and that the HCV core protein is degraded in the nucleus through a PA28 gamma-dependent pathway. In this study, we examined whether PA28 gamma is required for HCV core-induced insulin resistance in vivo. HCV core gene-transgenic mice lacking the PA28 gamma gene (PA28 gamma(-/-)CoreTg) were prepared by mating of PA28 gamma(+/+)CoreTg with PA28 gamma-knockout mice. Although there was no significant difference in the glucose tolerance test results among the mice, the insulin sensitivity in PA28 gamma(-/-)CoreTg mice was recovered to a normal level in the insulin tolerance test. Tyrosine phosphorylation of insulin receptor substrate 1 (IRS1), production of IRS2, and phosphorylation of Akt were suppressed in the livers of PA28 gamma(+/+)CoreTg mice in response to insulin stimulation, whereas they were restored in the livers of PA28 gamma(+/+)CoreTg mice. Furthermore, activation of the tumor necrosis factor alpha promoter in human liver cell lines or mice by the HCV core protein was suppressed by the knockdown or knockout of the PA28 gamma gene. These results suggest that the HCV core protein suppresses insulin signaling through a PA28 gamma-dependent pathway.

    DOI: 10.1128/JVI.01683-06

    Web of Science

    PubMed

  • Critical role of PA28 gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis 査読 重要な業績

    Moriishi, K.,Mochizuki, R.,Moriya, K.,Miyamoto, H.,Mori, Y.,Abe, T.,Murata, S.,Tanaka, K.,Miyamura, T.,Suzuki, T.,Koiket, K.,Matsuura, Y.

    Proceedings of the National Academy of Sciences of the United States of America   104 ( 5 )   1661 - 1666   2007年1月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語  

  • Critical role of PA28 gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis 査読

    Kohji Moriishi, Rika Mochizuki, Kyoji Moriya, Hironobu Miyamoto, Yoshio Mori, Takayuki Abe, Shigeo Murata, Keiji Tanaka, Tatsuo Miyamura, Tetsuro Suzuki, Kazuhiko Koiket, Yoshiharu Matsuura

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   104 ( 5 )   1661 - 1666   2007年1月( ISSN:0027-8424 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    Hepatitis C virus (HCV) is a major cause of chronic liver disease that frequently leads to steatosis, cirrhosis, and eventually hepatocellular carcinoma (HCC). HCV core protein is not only a component of viral particles but also a multifunctional protein because liver steatosis and HCC are developed in HCV core gene-transgenic (CoreTg) mice. Proteasome activator PA28 gamma/REG gamma regulates host and viral proteins such as nuclear hormone receptors and HCV core protein. Here we show that a knockout of the PA28 gamma gene induces the accumulation of HCV core protein in the nucleus of hepatocytes of CoreTg mice and disrupts development of both hepatic steatosis and HCC. Furthermore, the genes related to fatty acid biosynthesis and srebp-1c promoter activity were up-regulated by HCV core protein in the cell line and the mouse liver in a PA28y-dependent manner. Heterodimer composed of liver X receptor alpha (LXR alpha) and retinoid X receptor alpha (RXR alpha) is known to up-regulate srebp-1c promoter activity. Our data also show that HCV core protein enhances the binding of LXR alpha/RXR alpha to LXR-response element in the presence but not the absence of PA28 gamma. These findings suggest that PA28 gamma plays a crucial role in the development of liver pathology induced by HCV infection.

    DOI: 10.1073/pnas.0607312104

    Web of Science

    PubMed

  • Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein 査読

    Kousuke Nakai, Toru Okamoto, Tomomi Kimura-Someya, Koji Ishii, Chang Kweng Lim, Hideki Tani, Eiko Matsuo, Takayuki Abe, Yoshio Mori, Tetsuro Suzuki, Tatsuo Miyamura, Jack H. Nunberg, Kohji Moriishi, Yoshiharu Matsuura

    JOURNAL OF VIROLOGY   80 ( 22 )   11265 - 11273   2006年11月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) contains two membrane-associated envelope glycoproteins, E1 and E2, which assemble as a heterodimer in the endoplasmic reticulum (ER). In this study, predictive algorithms and genetic analyses of deletion mutants and glycosylation site variants of the E1 glycoprotein were used to suggest that the glycoprotein can adopt two topologies in the ER membrane: the conventional type I membrane topology and a polytopic topology in which the protein spans the ER membrane twice with an intervening cytoplasmic loop (amino acid residues 288 to 360). We also demonstrate that the E1 glycoprotein is able to associate with the HCV core protein, but only upon oligomerization of the core protein in the presence of tRNA to form capsid-like structures. Yeast two-hybrid and immunoprecipitation analyses reveal that oligomerization of the core protein is promoted by amino acid residues 72 to 91 in the core. Furthermore, the association between the E1 glycoprotein and the assembled core can be recapitulated using a fusion protein containing the putative cytoplasmic loop of the E1 glycoprotein. This fusion protein is also able to compete with the intact E1 glycoprotein for binding to the core. Mutagenesis of the cytoplasmic loop of E1 was used to define a region of four amino acids (residues 312 to 315) that is important for interaction with the assembled HCV core. Taken together, our studies suggest that interaction between the self-oligomerized HCV core and the E1 glycoprotein is mediated through the cytoplasmic loop present in a polytopic form of the E1 glycoprotein.

    DOI: 10.1128/JVI.01203-06

    Web of Science

    PubMed

  • Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90 査読 重要な業績

    Okamoto, T.,Nishimura, Y.,Ichimura, T.,Suzuki, K.,Miyamura, T.,Suzuki, T.,Moriishi, K.,Matsuura, Y.

    EMBO Journal   25 ( 20 )   5015 - 5025   2006年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90 査読

    Toru Okamoto, Yorihiro Nishimura, Tohru Ichimura, Kensuke Suzuki, Tatsuo Miyamura, Tetsuro Suzuki, Kohji Moriishi, Yoshiharu Matsuura

    EMBO JOURNAL   25 ( 20 )   5015 - 5025   2006年10月( ISSN:0261-4189 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a component of viral replicase and is well known to modulate the functions of several host proteins. Here, we show that NS5A specifically interacts with FKBP8, a member of the FK506-binding protein family, but not with other homologous immunophilins. Three sets of tetratricopeptide repeats in FKBP8 are responsible for interactions with NS5A. The siRNA-mediated knockdown of FKBP8 in a human hepatoma cell line harboring an HCV RNA replicon suppressed HCV RNA replication, and this reduction was reversed by the expression of an siRNA-resistant FKBP8 mutant. Furthermore, immunoprecipitation analyses revealed that FKBP8 forms a complex with Hsp90 and NS5A. Treatment of HCV replicon cells with geldanamycin, an inhibitor of Hsp90, suppressed RNA replication in a dose-dependent manner. These results suggest that the complex consisting of NS5A, FKBP8, and Hsp90 plays an important role in HCV RNA replication.

    DOI: 10.1038/sj.emboj.7601367

    Web of Science

    PubMed

  • Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus 査読 国際共著

    E Matsuo, H Tani, CK Lim, Y Komoda, T Okamoto, H Miyamoto, K Moriishi, S Yagi, AH Patel, T Miyamura, Y Matsuura

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   340 ( 1 )   200 - 208   2006年2月( ISSN:0006-291X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Although processing of the hepatitis C virus (HCV) polyprotein and characterization of each of its viral proteins have been described in detail, analysis of the structure and assembly of HCV particles has been hampered by the lack of a robust cell culture system to support efficient replication of HCV. In this study, we generated HCV-like particles (HCV-LP) using a recombinant baculovirus encoding structural and a part of non-structural proteins in a human hepatoma cell line. The HCV-LP exhibited a buoyant density of 1.17 g/ml in CsCl equilibrium gradient and particles of 40 to 50 nm in diameter. Binding of the HCV-LP to human hepatoma cells was partially inhibited by the treatment with anti-hCD81 antibody, in contrast to the hCD81-independent binding of HCV-LP produced in insect cells. These results indicate that HCV-LP generated in different types of cells exhibit different cellular tropism for binding to target cells. (c) 2005 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2005.12.001

    Web of Science

    PubMed

  • Nucleolar protein B23 interacts with Japanese encephalitis virus core protein and participates in viral replication 査読

    Y Tsuda, Y Mori, T Abe, T Yamashita, T Okamoto, T Ichimura, K Moriishi, Y Matsuura

    MICROBIOLOGY AND IMMUNOLOGY   50 ( 3 )   225 - 234   2006年( ISSN:0385-5600 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CENTER ACADEMIC PUBL JAPAN  

    Japanese encephalitis virus (JEV) core protein is detected not only in the cytoplasm but also in the nucleoli of infected cells. We previously showed that a mutant JEV lacking the nucleolar localization of the core protein impaired viral replication in mammalian cells. In this study, we identified a nucleolar phosphoprotein B23 as a protein binding with the core protein of JEV but not with that of dengue virus. The region binding with JEV core protein was mapped to amino acid residues 38 to 77 of B23. Upon JEV infection, some fraction of B23 was translocated from the nucleoli to the cytoplasm, and cytoplasmic B23 was colocalized with the core protein of wild-type JEV but not with that of the mutant JEV. Furthermore, overexpression of dominant negatives of B23 reduced JEV replication. These results suggest that B23 plays an important role in the intracellular localization of the core protein and replication of JEV.

    DOI: 10.1111/j.1348-0421.2006.tb03789.x

    Web of Science

    PubMed

  • HCVと発癌 重要な業績

    森石 恆司, 松浦 善治

    臨床とウイルス   33 ( 5 )   330 - 335   2005年12月( ISSN:0303-8092 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    CiNii Books

  • HCVエンベロープ蛋白質を被ったシュードタイプVSVの感染機構 査読

    谷英樹, 菰田泰正, 山下哲生, 鈴木健介, 松尾栄子, 浜本いつき, 津田祥美, 林昌宏, 森石恆司, 考藤達哉, 林紀夫, 宮村達男, 松浦善治

    日本ウイルス学会学術集会プログラム・抄録集   53rd   97   2005年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)  

    J-GLOBAL

  • Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B 査読

    Hamamoto, I, Y Nishimura, T Okamoto, H Aizaki, MY Liu, Y Mori, T Abe, T Suzuki, MMC Lai, T Miyamura, K Moriishi, Y Matsuura

    JOURNAL OF VIROLOGY   79 ( 21 )   13473 - 13482   2005年11月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The hepatitis C virus (HCV) nonstructural protein (NS) 5A is a phosphoprotein that associates with various cellular proteins and participates in the replication of the HCV genome. Human vesicle-associated membrane protein-associated protein (VAP) subtype A (VAP-A) is known to be a host factor essential for HCV replication by binding to both NS5A and NS5B. To obtain more information on the NS5A protein in HCV replication, we screened human brain and liver libraries by a yeast two-hybrid system using NS5A as bait and identified VAP-B as an WA-binding protein. Immunoprecipitation and mutation analyses revealed that VAP-B binds to both NS5A and NS5B in mammalian cells and forms homo- and heterodimers with VAP-A. VAP-A interacts with VAP-B through the transmembrane domain. NS5A interacts with the coiled-coil domain of VAP-B via 70 residues in the N-terminal and 341 to 344 amino acids in the C-terminal polyproline cluster region. NS5A was colocalized with VAP-B in the endoplasmic reticulum and Golgi apparatus. The specific antibody to VAP-B suppressed HCV RNA replication in a cell-free assay. Overexpression of VAP-B, but not of a mutant lacking its transmembrane domain, enhanced the expression of NS5A and NS5B and the replication of HCV RNA in Huh-7 cells harboring a subgenomic replicon. In the HCV replicon cells, the knockdown of endogenous VAP-B by small interfering RNA decreased expression of NS5B, but not of NS5A. These results suggest that VAP-B, in addition to VAP-A, plays an important role in the replication of the HCV genome.

    DOI: 10.1128/JVI.79.21.13473-13482.2005

    Web of Science

    PubMed

  • 【ワクチンの免疫効果の増強法と誘導免疫の特性】 ワクチンベクターとしてのバキュロウイルス 招待 査読

    阿部 隆之, 谷 英樹, 松永 朋子, 林 昌宏, 宮本 大伸, 森 嘉生, 森石 恆司, 松浦 善治

    臨床免疫   43 ( 6 )   652 - 658   2005年6月( ISSN:0386-9695 )

     詳細を見る

    記述言語:日本語   掲載種別:(MISC)総説・解説(学術雑誌)   出版者・発行元:(有)科学評論社  

  • HCV感染と肝発癌 招待 査読

    森石 恆司, 松浦 善治

    臨床と微生物 = Clinical microbiology   32 ( 3 )   233 - 239   2005年5月( ISSN:0910-7029 )

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    CiNii Books

  • Involvement of the toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus 査読

    T Abe, H Hemmi, H Miyamoto, K Moriishi, S Tamura, H Takaku, S Akira, Y Matsuura

    JOURNAL OF VIROLOGY   79 ( 5 )   2847 - 2858   2005年3月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    We have previously shown that mice inoculated intranasally with a wild-type baculovirus (Autographa californica nuclear polyhedrosis virus [AcNPV]) are protected from a lethal challenge by influenza virus. However, the precise mechanism of induction of this protective immune response by the AcNPV treatment remained unclear. Here we show that AcNPV activates immune cells via the Toll-like receptor 9 (TLR9)/MyD88-dependent signaling pathway. The production of inflammatory cytokines was severely reduced in peritoneal macrophages (PECs) and splenic CD11c(+) dendritic cells (DCs) derived from mice deficient in MyD88 or TLR9 after cultivation with AcNPV. In contrast, a significant amount of alpha interferon (IFN-alpha.) was still detectable in the PECs and DCs of these mice after stimulation with AcNPV, suggesting that a TLR9/MyD88-independent signaling pathway might also participate in the production of IFN-alpha by AcNPV. Since previous work showed that TLR9 ligands include bacterial DNA and certain oligonucleotides containing unmethylated CpG dinucleotides, we also examined the effect of baculoviral DNA on the induction of innate immunity. Transfection of the murine macrophage cell line RAW264.7 with baculoviral DNA resulted in the production of the inflammatory cytokine, while the removal of envelope glycoproteins from viral particles, UV irradiation of the virus, and pretreatment with purified baculovirus envelope proteins or endosomal maturation inhibitors diminished the induction of the immune response by AcNPV. Together, these results indicate that the internalization of viral DNA via membrane fusion mediated by the viral envelope glycoprotein, as well as endosomal maturation, which releases the viral genome into TLR9-expressing cellular compartments, is necessary for the induction of the innate immune response by AcNPV.

    DOI: 10.1128/JVI.79.5.2847-2858.2005

    Web of Science

    PubMed

  • Nuclear localization of Japanese encephalitis virus core protein enhances viral replication 査読

    Y Mori, T Okabayashi, T Yamashita, ZJ Zhao, T Wakita, K Yasui, F Hasebe, M Tadano, E Konishi, K Moriishi, Y Matsuura

    JOURNAL OF VIROLOGY   79 ( 6 )   3448 - 3458   2005年3月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Japanese encephalitis virus (JEV) core protein was detected in both the nucleoli and cytoplasm of mammalian and insect cell lines infected with JEV or transfected with the expression plasmid of the core protein. Mutation analysis revealed that Gly(42) and Pro(43) in the core protein are essential for the nuclear and nucleolar localization. A mutant M4243 virus in which both Gly(42) and Pro(43) were replaced by Ala was recovered by plasmid-based reverse genetics. In C6/36 mosquito cells, the M4243 virus exhibited RNA replication and protein synthesis comparable to wild-type JEV, whereas propagation in Vero cells was impaired. The mutant core protein was detected in the cytoplasm but not in the nucleus of either C6/36 or Vero cell lines infected with the M4243 virus. The impaired propagation of M4243 in mammalian cells was recovered by the expression of wild-type core protein in trans but not by that of the mutant core protein. Although M4243 mutant virus exhibited a high level of neurovirulence comparable to wild-type JEV in spite of the approximately 100-fold-lower viral propagation after intracerebral inoculation to 3-week-old mice of strain Jcl:ICR, no virus was recovered from the brain after intraperitoneal inoculation of the mutant. These results indicate that nuclear localization of JEV core protein plays crucial roles not only in the replication in mammalian cells in vitro but also in the pathogenesis of encephalitis induced by JEV in vivo.

    DOI: 10.1128/JVI.79.6.3448-3458.2005

    Web of Science

    PubMed

  • Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses 査読

    Y Kitagawa, H Tani, C Kwang, LTM Matsunaga, K Moriishi, Y Matsuura

    JOURNAL OF VIROLOGY   79 ( 6 )   3639 - 3652   2005年3月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) can infect a variety of mammalian cells, as well as insect cells, facilitating its use as a viral vector for gene delivery into mammalian cells. Glycoprotein gp64, a major component of the budded AcMNPV envelope, is involved in viral entry into cells by receptor-mediated endocytosis and subsequent membrane fusion. We examined the potential production of pseudotype baculovirus particles transiently carrying ligands of interest in place of gp64 as a method of ligand-directed gene delivery into target cells. During amplification of a gp64-null pseudotype baculovirus carrying a green fluorescent protein gene in gp64-expressing insect cells, however, we observed the high-frequency appearance of a replication-competent virus incorporating the gp64 gene into the viral genome. To avoid generation of replication-competent revertants, we prepared pseudotype baculoviruses by transfection with recombinant bacmids without further amplification in the gp64-expressing cells. We constructed gp64-null recombinant bacmids carrying cDNAs encoding either vesicular stomatitis virus G protein (VSVG) or measles virus receptors (CD46 or SLAM). The VSVG pseudotype baculovirus efficiently transduced a reporter gene into a variety of mammalian cell lines, while CD46 and SLAM pseudotype baculoviruses allowed ligand-receptor-directed reporter gene transduction into target cells expressing measles virus envelope glycoproteins. Gene transduction mediated by the pseudotype baculoviruses could be inhibited by pretreatment with specific antibodies. These results indicate the possible application of pseudotype baculoviruses in ligand-directed gene delivery into target cells.

    DOI: 10.1128/JVI.79.6.3639-3652.2005

    Web of Science

    PubMed

  • Molecular determinants for subcellular localization of hepatitis C virus core protein 査読

    R Suzuki, S Sakamoto, T Tsutsumi, A Rikimaru, K Tanaka, T Shimoike, K Moriishi, T Iwasaki, K Mizumoto, Y Matsuura, T Miyamura, T Suzuki

    JOURNAL OF VIROLOGY   79 ( 2 )   1271 - 1281   2005年1月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) core protein is a putative nucleocapsid protein with a number of regulatory functions. In tissue culture cells, HCV core protein is mainly located at the endoplasmic reticulum as well as mitochondria and lipid droplets within the cytoplasm. However, it is also detected in the nucleus in some cells. To elucidate the mechanisms by which cellular trafficking of the protein is controlled, we performed subcellular fractionation experiments and used confocal microscopy to examine the distribution of heterologously expressed fusion proteins involving various deletions and point mutations of the HCV core combined with green fluorescent proteins. We demonstrated that a region spanning amino acids 112 to 152 can mediate association of the core protein not only with the ER but also with the mitochondrial outer membrane. This region contains an 18-amino-acid motif which is predicted to form an amphipathic alpha-helix structure. With regard to the nuclear targeting of the core protein, we identified a novel bipartite nuclear localization signal, which requires two out of three basic-residue clusters for efficient nuclear translocation, possibly by occupying binding sites on importin-a. Differences in the cellular trafficking of HCV core protein, achieved and maintained by multiple targeting functions as mentioned above, may in part regulate the diverse range of biological roles of the core protein.

    DOI: 10.1128/JVI.79.2.1271-1281.2005

    Web of Science

    PubMed

  • ヒト肝癌由来細胞で作製したHCV様粒子の性状 査読

    松尾栄子, 林昌宏, 菰田泰正, 森石恆司, 八木慎太郎, 松浦善治

    日本ウイルス学会学術集会プログラム・抄録集   52nd   206   2004年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(その他学術会議資料等)  

    J-GLOBAL

  • [Candidate molecules for HCV receptor]. 招待 査読

    Moriishi K, Limn CK, Matsuura Y

    Nihon rinsho. Japanese journal of clinical medicine   62 Suppl 7 ( Pt 1 )   191 - 194   2004年7月( ISSN:0047-1852 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Scopus

    PubMed

  • [Development of HCV vaccine]. 招待 査読

    Abe T, Moriishi K, Matsuura Y

    Nihon rinsho. Japanese journal of clinical medicine   62 Suppl 7 ( Pt 1 )   139 - 142   2004年7月( ISSN:0047-1852 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Scopus

    PubMed

  • 【ウイルス性肝炎 基礎・臨床研究の進歩】 C型肝炎ウイルス(HCV) HCVのレセプター候補分子 招待 査読

    森石 恆司, 林 昌宏, 松浦 善治

    日本臨床   62 ( 増刊7 ウイルス性肝炎(上) )   191 - 194   2004年7月( ISSN:0047-1852 )

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:(株)日本臨床社  

  • Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein 査読

    K Okamoto, K Moriishi, T Miyamura, Y Matsuura

    JOURNAL OF VIROLOGY   78 ( 12 )   6370 - 6380   2004年6月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) core protein is suggested to localize to the endoplasmic reticulum (ER) through a C-terminal hydrophobic region that acts as a membrane anchor for core protein and as a signal sequence for El protein. The signal sequence of core protein is further processed by signal peptide peptidase (SPP). We examined the regions of core protein responsible for ER retention and processing by SPP. Analysis of the intracellular localization of deletion mutants of HCV core protein revealed that not only the C-terminal signal-anchor sequence but also an upstream hydrophobic region from amino acid 128 to 151 is required for ER retention of core protein. Precise mutation analyses indicated that replacement of Leu(139), Val(140), and Lett(144) of core protein by Ala inhibited processing by SPP, but cleavage at the core-E1 junction by signal peptidase was maintained. Additionally, the processed El protein was translocated into the ER and glycosylated with high-mannose oligosaccharides. Core protein derived from the mutants was translocated into the nucleus in spite of the presence of the unprocessed C-terminal signal-anchor sequence. Although the direct association of core protein with a wild-type SPP was not observed, expression of a loss-of-function SPP mutant inhibited cleavage of the signal sequence by SPP and coimmunoprecipitation with unprocessed core protein. 139 140 144 These results indicate that Leu(139), Val(140), and Leu(144) in core protein play crucial roles in the ER retention and SPP cleavage of HCV core protein.

    DOI: 10.1128/JVI.78.12.6370-6380.2004

    Web of Science

    PubMed

  • [Baculovirus vector--gene transfer into mammalian cells]. 招待 査読

    Tani H, Abe T, Limn CK, Mochizuki R, Yamagishi J, Kitagawa Y, Watanabe R, Moriishi K, Matsuura Y

    Uirusu   53 ( 2 )   185 - 193   2003年12月( ISSN:0042-6857 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2222/jsv.53.185

    Scopus

    PubMed

  • 【ウイルスベクター 最新の話題】 バキュロウイルスベクター 哺乳動物細胞への遺伝子導入

    谷 英樹, 阿部 隆之, 林 昌宏, 望月 理加, 山岸 潤也, 北川 善紀, 渡辺 理恵, 宮本 大伸, 森石 恆司, 松浦 善治

    ウイルス   53 ( 2 )   185 - 193   2003年12月( ISSN:0042-6857 )

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:日本ウイルス学会  

  • Proteasome activator PA28 gamma-dependent nuclear retention and degradation of hepatitis C virus core protein 査読

    K Moriishi, T Okabayashi, K Nakai, K Moriya, K Koike, S Murata, T Chiba, K Tanaka, R Suzuki, T Suzuki, T Miyamura, Y Matsuura

    JOURNAL OF VIROLOGY   77 ( 19 )   10237 - 10249   2003年10月( ISSN:0022-538X )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Hepatitis C virus (HCV) core protein plays an important role in the formation of the viral nucleocapsid and a regulatory protein involved in hepatocarcinogenesis. In this study, we have identified proteasome activator PA28gamma (1 IS regulator gamma) as an HCV core binding protein by using yeast two-hybrid system. This interaction was demonstrated not only in cell culture but also in the livers of HCV core transgenic mice. These findings are extended to human HCV infection by the observation of this interaction in liver specimens from a patient with chronic HCV infection. Neither the interaction of HCV core protein with other PA28 subtypes nor that of PA28gamma with other Flavivirus core proteins was detected. Deletion of the PA28gamma-binding region from the HCV core protein or knockout of the PA28gamma gene led to the export of the HCV core protein from the nucleus to the cytoplasm. Overexpression of PA28gamma enhanced the proteolysis of the HCV core protein. Thus, the nuclear retention and stability of the HCV core protein is regulated via a PA28gamma-dependent pathway through which HCV pathogenesis may be exerted.

    DOI: 10.1128/JVI.77.19.10237-10249.2003

    Web of Science

    PubMed

  • In vitro and in vivo gene delivery by recombinant baculoviruses 査読 国際共著

    H Tani, CK Limn, CC Yap, M Onishi, M Nozaki, Y Nishimune, N Okahashi, Y Kitagawa, R Watanabe, R Mochizuki, K Moriishi, Y Matsuura

    JOURNAL OF VIROLOGY   77 ( 18 )   9799 - 9808   2003年9月( ISSN:0022-538X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Although recombinant baculovirus vectors can be an efficient tool for gene transfer into mammalian cells in vitro, gene transduction in vivo has been hampered by the inactivation of baculoviruses by serum complement. Recombinant baculoviruses possessing excess envelope protein gp64 or other viral envelope proteins on the virion surface deliver foreign genes into a variety of mammalian cell lines more efficiently than the unmodified baculovirus. In this study, we examined the efficiency of gene transfer both in vitro and in vivo by recombinant baculoviruses possessing envelope proteins derived from either vesicular stomatitis virus (VSVG) or rabies virus. These recombinant viruses efficiently transferred reporter genes into neural cell lines, primary rat neural cells, and primary mouse osteal cells in vitro. The VSVG-modified bacullovirus exhibited greater resistance to inactivation by animal sera than the unmodified baculovirus. A synthetic inhibitor of the complement activation pathway circumvented the serum inactivation of the unmodified baculovirus. Furthermore, the VSVG-modified baculovirus could transduce a reporter gene into the cerebral cortex and testis of mice by direct inoculation in vivo. These results suggest the possible use of the recombinant bacullovirus vectors in combination with the administration of complement inhibitors for in vivo gene therapy.

    DOI: 10.1128/JVI.77.18.9799-9808.2003

    Web of Science

    PubMed

  • 【肝疾患の分子生物学 治療への応用】 C型肝炎 C型肝炎ウイルス感染の分子機構と臨床への応用 招待 査読

    鈴木 健介, 林 昌宏, 菰田 泰正, 森石 恆司, 松浦 善治

    最新医学   58 ( 9 )   2017 - 2022   2003年9月( ISSN:0370-8241 )

     詳細を見る

    記述言語:日本語   掲載種別:(MISC)総説・解説(学術雑誌)   出版者・発行元:(株)最新医学社  

    著者等はHCVの感染機構をin vitroで評価するため,HCVエンベロープタンパク質による細胞融合アッセイ系とエンベロープタンパク質を被ったシュードタイプウイルスを作製した.その結果,HCVの2つのエンベロープタンパク質が細胞表面のタンパク質受容体を認識し,エンドサイトーシスによって細胞内へ侵入することが示唆された.更に,HCVのエンベロープタンパク質のCD81との結合や細胞融合活性を阻害できるヒト型抗HCVエンベロープ抗体を得ることができた

  • Mechanisms of hepatitis C virus infection 査読 重要な業績

    Kohji Moriishi, Yoshiharu Matsuura

    Antiviral Chemistry and Chemotherapy   14 ( 6 )   285 - 297   2003年( ISSN:0956-3202 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Medical Press Ltd  

    Hepatitis C virus (HCV) is the major causative agent of chronic non-A, non-B hepatitis. The life cycle of HCV is largely unknown because a reliable culture system has not yet been established. HCV presumably binds to specific receptor(s) and enters cells through endocytosis, as do other members of Flaviviridae. The viral genome is translated into a precursor polyprotein after uncoating, and viral RNA is synthesized by a virus-encoded polymerase complex. Progeny viral particles are released into the luminal side of the endoplasmic reticulum and secreted from the cell after passage through the Golgi apparatus. Understanding the mechanisms of HCV infection is essential to the development of effective new therapies for chronic HCV infection. Several host membrane proteins have been identified as receptor candidates for HCV. Recent advances using pseudotype virus systems have provided information surrounding the initial steps of HCV infection. An HCV RNA replicon system has been useful for elucidating the replication mechanism of HCV. In this review, we summarize our current understanding of the mechanisms of HCV infection and discuss potential antiviral strategies against HCV infection.

    DOI: 10.1177/095632020301400601

    Scopus

    PubMed

  • Mechanisms of hepatitis C virus infection 査読 重要な業績

    Moriishi, K.,Matsuura, Y.

    Antiviral Chemistry & Chemotherapy   14 ( 6 )   285 - 297   2002年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Induction of Bad-mediated apoptosis by Sindbis virus infection: Involvement of pro-survival members of the Bcl-2 family 査読

    Moriishi, K.,Koura, M.,Matsuura, Y.

    Virology   292 ( 2 )   258 - 271   2002年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Induction of Bad-mediated apoptosis by Sindbis virus infection: Involvement of pro-survival members of the Bcl-2 family 査読

    K Moriishi, M Koura, Y Matsuura

    VIROLOGY   292 ( 2 )   258 - 271   2002年1月( ISSN:0042-6822 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    It is known that infection with Sindbis virus (SNV) induces apoptosis, which is inhibited by two pro-survival members of the Bcl-2 family, Bcl-2 and Bcl-xL. However, the mechanism of involvement of the other members of the Bcl-2 family in SNV-induced apoptosis remains unclear. In this study we report that Bad protein, one of the pro-apoptotic Bcl-2 family members, mediates apoptosis in the mammalian cells infected with SNV Expression of Bad was shown to promote SNV-induced apoptosis in human embryonic kidney 293T and baby hamster kidney cells. SNV infection also induced translocation of endogenous Bad into mitochondria and heterodimerization of Bad with Bcl-xL. On the other hand, the structurally most similar pro-survival members, Bcl-2, Bcl-xL, and Bcl-w, suppressed SNV-induced apoptosis in the absence of Bad, whereas Mcl-1 and A1 did not. Bcl-w could inhibit SNV-induced apoptosis in the presence of Bad, but Bcl-xL could not. Bad could be coimmunoprecipitated with Bcl-xL or Bcl-2, but not with Bcl-w. Two viral Bcl-2 homologs, E1B19K and BHRF1, also suppressed SNV-induced apoptosis irrespective of the presence of Bad and no physical association with Bad was observed. These results suggest that direct interaction of Bad with pro-survival members of the Bcl-2 family contributes to the progress of SNV-induced apoptosis and that nonbinding members restrain SNV-induced apoptosis irrespective of Bad expression. (C) 2002 Elsevier Science.

    DOI: 10.1006/viro.2001.1206

    Web of Science

    PubMed

  • Characterization of pseudotype VSV possessing HCV envelope proteins 査読 国際共著

    Y Matsuura, H Tani, K Suzuki, T Kimura-Someya, R Suzuki, H Aizaki, K Ishii, K Moriishi, CS Robison, MA Whitt, T Miyamura

    VIROLOGY   286 ( 2 )   263 - 275   2001年8月( ISSN:0042-6822 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC  

    The genome of hepatitis C virus (HCV) encodes two envelope glycoproteins (E1 and E2), which are thought to be responsible for receptor binding and membrane fusion resulting in virus penetration. To investigate cell surface determinants important for HCV infection, we used a recombinant vesicular stomatitis virus (VSV) in which the glycoprotein gene was replaced with a reporter gene encoding green fluorescent protein (GFP) and produced HCV-VSV pseudotypes possessing chimeric HCV E1 or E2 glycoproteins, either individually or together. The infectivity of the pseudotypes was determined by quantifying the number of cells expressing the GFP reporter gene. Pseudotypes that contained both of the chimeric E1 and E2 proteins exhibited 10-20 times higher infectivity on HepG2 cells than the viruses possessing either of the glycoproteins individually. These results indicated that both E1 and E2 envelope proteins are required for maximal infection by HCV. The infectivity of the pseudotype virus was not neutralized by anti-VSV polyclonal antibodies, Bovine lactoferrin specifically inhibited the infection of the pseudotype virus. Treatment of HepG2 cells with Pronase, heparinase, and heparitinase but not with phospholipase C and sodium periodate reduced the infectivity. Therefore, cell surface proteins and some glycosaminoglycans play an important role in binding or entry of HCV into susceptible cells, The pseudotype VSV possessing the chimeric HCV glycoproteins might offer an efficient tool for future research on cellular receptors for HCV and for the development of prophylactics and therapeutics for hepatitis C. (C) 2001 Academic Press.

    DOI: 10.1006/viro.2001.0971

    Web of Science

    PubMed

  • Tissue expression and subcellular localization of the pro-survival molecule Bcl-w 査読 国際共著

    LA O'Reilly, C Print, G Hausmann, K Morlishi, S Cory, DCS Huang, A Strasser

    CELL DEATH AND DIFFERENTIATION   8 ( 5 )   486 - 494   2001年5月( ISSN:1350-9047 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Anti-apoptotic members of the Bcl-2 family, such as Bcl-w, maintain cell viability by preventing the activation of the cell death effectors, the caspases, Gene targeting experiments in mice have demonstrated that Bcl-w is required for spermatogenesis and for survival of damaged epithelial cells in the gut. Bcl-w is, however, dispensable for physiological cell death in other tissues. Here we report on the analysis of Bcl-w protein expression using a panel of novel monoclonal antibodies. Bcl-w is found In a diverse range of tissues including colon, brain and testes, A survey of transformed cell lines and purified hematopoietic cells demonstrated that Bcl-w is expressed in cells of myeloid, lymphoid and epithelial origin. Subcellular fractionation and confocal laser scanning microscopy demonstrated that Bcl-w protein is associated with intracellular membranes. The implications of these results are discussed in the context of the phenotype of Bcl-w-null mice and recent data that suggest that Bcl-w may play a role in colon carcinogenesis.

    DOI: 10.1038/sj.cdd.4400835

    Web of Science

    PubMed

  • Inhibition of listeriolysin O-induced hemolysis by bovine lactoferrin 査読

    K Moriishi, S Inoue, M Koura, F Amano

    BIOLOGICAL & PHARMACEUTICAL BULLETIN   22 ( 11 )   1167 - 1172   1999年11月( ISSN:0918-6158 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    Lactoferrin (LFR) plays an important role in the anti-microbial defense through iron binding, lipopolysaccharide binding and immunomodulation. In this study, we demonstrate that bovine LFR specifically inhibits the hemolytic activity of listeriolysin O (LLO) produced by Listeria monocytogenes. The hemolytic activity of LLO was completely inhibited in the presence of bovine LFR that was highly purified on two cation-exchange columns, whereas that of streptolysin O or perfringolysin O was not inhibited at all. A rabbit anti-LFR antibody canceled this inhibitory activity of bovine LFR. Although human transferrin exhibits 62% amino acid identity with bovine LFR, human apo-transferrin could not inhibit LLO-induced hemolysis. An increase in the concentration of FeCl3 or the Fe3+-saturation of bovine LFR, however, slightly reduced its inhibition of the hemolysis. The inhibitory activity of bovine LFR was dependent on pH, since it was observed under neutral and alkali conditions, but not under acidic conditions. These results suggest that the inhibition of LLO-induced hemolysis by bovine LFR is influenced by pH and iron ions, both of which may lead to conformational changes of LFR.

    DOI: 10.1248/bpb.22.1167

    Web of Science

    PubMed

  • Neuronal and glial differentiation of neuroblastoma and glioma cells by Rho inhibitory bacterial exo-enzyme C3 査読

    R Komagome, B Shuto, K Moriishi, K Kimura, M Saito

    NEUROPATHOLOGY   19 ( 3 )   288 - 293   1999年9月( ISSN:0919-6544 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL SCIENCE ASIA  

    Exoenzyme C3 (C3) produced by Clostridium botulinum type C and D strains specifically modifies the small GTP, binding protein Rho. It has been reported that C3 induces neuronal differentiation of the PC12 cell, an adrenergic cell line. In this study, the effects of C3 on a cholinergic cell line (NG108-15) and a glioma (CG) were examined for their differentiation. Treatment of NG108-15 cells and C6 glioma cells with C3 for 3 days induced neurite or process formation. Moreover, treatment by C3 increased the activities of acetylcholine esterase and choline acetyltransferase in NG108-15 cells, and 2',3'-cyclic nucleotide 3'-phosphohydrolase in C6 cells. These results suggest that C3 induces neuronal differentiation of the cholinergic cell as well as the adrenergic cell, and also glial differentiation of the glioma cell.

    DOI: 10.1046/j.1440-1789.1999.00247.x

    Web of Science

  • Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1 査読 国際共著

    K Moriishi, DCS Huang, S Cory, JM Adams

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   96 ( 17 )   9683 - 9688   1999年8月( ISSN:0027-8424 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    The Bcl-2 family of proteins regulates apoptosis, the cell death program triggered by activation of certain proteases (caspases), An attractive model for how Bcl-2 and its closest relatives prevent caspase activation is that they bind to and inactivate an adaptor protein required for procaspase processing. That model has been supported by reports that mammalian prosurvival Bcl-2 relatives bind the adaptor Apaf-1, which activates procaspase-9, However, the itt vivo association studies reported here with both overexpressed and endogenous Apaf-1 challenge this notion. Apaf-1 could be immunoprecipitated together with procaspase-9, and the Apaf-1 caspase-recruitment domain was necessary and sufficient for their interaction, Apaf-1 did not bind, however, to any of the six known mammalian prosurvival family members (Bcl-2, Bcl-x(L), Bcl-w, A1, Mel-1, or Boo), or their viral homologs adenovirus E1B 19K and Epstein-Barr virus BHRF-1. Endogenous Apaf-1 also failed to coimmunoprecipitate with endogenous Bcl-2 or Bcl-xL, or with two proapoptotic relatives (Bax and Bim), Moreover, apoptotic stimuli did not induce Apaf-1 to bind to these family members. Thus, the prosurvival Bcl-2 homologs do not appear to act by sequestering Apaf-1 and probably instead constrain its activity indirectly.

    DOI: 10.1073/pnas.96.17.9683

    Web of Science

    PubMed

  • Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1 査読 重要な業績

    Moriishi, K.,Huang, D. C. S.,Cory, S.,Adams, J. M.

    Proceedings of the National Academy of Sciences of the United States of America   96 ( 17 )   9683 - 9688   1999年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins 査読 国際共著

    JM Adams, DCS Huang, H Puthalakath, P Bouillet, G Vairo, K Moriishi, G Hausmann, L O'Reilly, K Newton, S Ogilvy, ML Bath, CG Print, AW Harris, A Strasser, S Cory

    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY   64   351 - 358   1999年( ISSN:0091-7451 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:COLD SPRING HARBOR LAB PRESS  

    DOI: 10.1101/sqb.1999.64.351

    Web of Science

    PubMed

  • Tyrosine phosphorylation as a convergent pathway of heterotrimeric G protein- and rho protein-mediated Ca2+ sensitization of smooth muscle of rabbit mesenteric artery 査読

    M Sasaki, Y Hattori, F Tomita, K Moriishi, M Kanno, T Kohya, K Oguma, A Kitabatake

    BRITISH JOURNAL OF PHARMACOLOGY   125 ( 8 )   1651 - 1660   1998年12月( ISSN:0007-1188  eISSN:1476-5381 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    1 The aim of this study was to determine whether different signal transduction mechanisms underlie the Ca2+ sensitizing effects of guanosine 5'-O-(3-thiotriphosphate) (GTP(gamma)S) and receptor agonists on beta-escin-skinned smooth muscle of rabbit mesenteric artery.
    2 In the homogenate of the beta-escin-skinned arterial strip, C3 exoenzyme of Clostridium botulinum catalyzed the [P-32]-ADP-ribosylation of only one protein that had the same molecular mass as the protein detected in Western blots with anti-rho p21 antibody. Pretreatment of preparations with C3 resulted in great inhibition of GTP(gamma)S-induced Ca2+ sensitization, although the effect of GTP(gamma)S at higher concentrations (greater than or equal to 30 mu M) was not completely blocked by this treatment. In contrast, the enhancement by phenylephrine and histamine, in the presence of guanosine 5'-triphosphate, of the Ca2+-induced contraction was not affected by C3 pretreatment.
    3 The protein kinase C (PKC) inhibitors calphostin C and staurosporine completely eliminated the enhancement by phorbol ester 12,13-dibutyrate of the Ca2+-induced contraction. However, these PKC inhibitors had no effect on GTP(gamma)S- and receptor agonist-induced Ca2+ sensitization.
    4 The tyrosine kinase inhibitors genistein and tyrphostin 25 caused an irreversible and complete block of the enhancement by GTP(gamma)S of the Ca2+-induced contraction without affecting this Ca2+ contraction. The inactive genistein analogue daidzein did not modify the effect of GTP(gamma)S. The Ca2+ sensitizing effects of phenylephrine and histamine were also blocked by these tyrosine kinase inhibitors.
    5 These results suggest that rho p21 predominantly mediates GTP(gamma)S-induced Ca2+ sensitization of beta-escin-skinned smooth muscle of rabbit mesenteric artery, while the Ca2+ sensitizing actions of heterotrimeric G protein-coupled receptor agonists do not involve this small G protein. However, it seems that tyrosine phosphorylation, but not PKC activation, plays an important role in both of the rho p21 protein- and heterotrimeric G protein-mediated Ca2+ sensitization mechanisms.

    DOI: 10.1038/sj.bjp.0702242

    Web of Science

    PubMed

  • Rapid hybridoma screening method for the identification of monoclonal antibodies to low-abundance cytoplasmic proteins 査読 国際共著

    LA O'Reilly, L Cullen, K Moriishi, L O'Connor, DCS Huang, A Strasser

    BIOTECHNIQUES   25 ( 5 )   824 - +   1998年11月( ISSN:0736-6205 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:EATON PUBLISHING CO  

    Screening assays are the most time-consuming and labor-intensive part of generating monoclonal antibodies (MAbs). Antibodies identified by enzyme-linked immunosorbent assay (ELISA) screening often are not suitable for their intended application such as immunofluorescence staining. We describe here a rapid and efficient flow cytometric screening procedure for the identification of MAbs directed against low-abundance cytoplasmic proteins, in our case, the pro-apoptotic molecule Bim. Cells from all equal mixture of a parental cell line and a subline expressing Bim were fixed, permeabilized and incubated with hybridoma supernatants. The supernatants were derived from a fusion of Sp2/0 plasmacytoma cells and spleen cells from a rat immunized with recombinant glutathione-S-transferase nse (GST)-Bim(L) fusion protein. Secondary staining with fluorochrome-labeled anti-rat Ig antibodies allowed detection of clones expressing Bim-specific antibodies. The screening procedure was rapid and efficient, nod most monoclonal antibodies identified were proven to De useful for immunofluorescence staining and other applications.

    DOI: 10.2144/98255st03

    Web of Science

    PubMed

  • Sequence analysis of the actA gene of Listeria monocytogenes isolated from human 査読

    K Moriishi, M Terao, M Koura, S Inoue

    MICROBIOLOGY AND IMMUNOLOGY   42 ( 2 )   129 - 132   1998年( ISSN:0385-5600 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CENTER ACADEMIC PUBL JAPAN  

    The region encoding proline-rich units of actA genes was amplified from 24 strains of Listeria monocytogenes using polymerase chain reaction (PCR), PCR products of 13 strains showed the expected size of 623 bp, whereas those of 11 strains showed a short size of 518 bp, The shortening of these PCR products resulted from the deletion of one proline-rich unit, These results indicate that ActA proteins are divided into at least two different types which are unrelated to bacterial serotypes.

    DOI: 10.1111/j.1348-0421.1998.tb02261.x

    Web of Science

    PubMed

  • Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies 査読

    T Kubota, T Watanabe, N Yokosawa, K Tsuzuki, T Indoh, K Moriishi, K Sanda, Y Maki, K Inoue, N Fujii

    APPLIED AND ENVIRONMENTAL MICROBIOLOGY   63 ( 4 )   1214 - 1218   1997年4月( ISSN:0099-2240 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Seventeen monoclonal antibodies (MAbs) were previously established against the heavy chain (He) of botulinum type E neurotoxin in BALB/c mice immunized with the type E toroid, Five MAbs (LE15-5, LE34-6, EK19-7, EK21-4, and AE27-9) showed toxin-neutralizing activity in mice, Two of the five MAbs, EK19-7 and EK21-4, recognized the regions located at amino acid positions 731 to 787 and 811 to 897, respectively, One of the remaining three antibodies (LE34-6) reacted with the amino acid sequence VIKAIN, at amino acid positions 663 to 668, closed by the ion channel-forming domain, It is suggested that the ion channel-forming domain may also be associated with the blocking of acetylcholine release, Furthermore, the amino acid sequence YLTHMRD within 30 residues of the C-terminal region of the He component seemed to be recognized by LE15-5, It has been reported that the binding domain of the type E toxin is located on the C-terminal half of the He component, Therefore, the neutralizing activity of LE15-5 antibody may be attributed to its ability to block the binding of neurotoxin to the receptor of target cells.

    Web of Science

    PubMed

  • Expression of listeriolysin O by intracellular Listeria monocytogenes following infection of lipopolysaccharide-treated or untreated J774.1 macrophage-like cells 査読

    K Moriishi, M Koura, F Amano

    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY   16 ( 3-4 )   213 - 222   1996年12月( ISSN:0928-8244 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Listeria monocytogenes replicates in a phagocytic cell following escape into the host cytoplasm. Listeriolysin O, secreted by L. monocytogenes, which belongs to the thiol-activated hemolysin family, is known to play an important role in the escape of the bacterium into the host cytoplasm. In this study, we demonstrated that expression of listeriolysin O by infecting L. monocytogenes was lightly induced in J774.1 macrophage-like cells pretreated with lipopolysaccharide, although the growth of the bacteria was suppressed. The number of viable L. monocytogenes decreased until 4 h post-infection and then increased between 3 and 8 h post-infection in untreated J774.1 host cells, but it decreased until 8 h post-infection in lipopolysaccharide-treated host cells. However, expression of listeriolysin O by L. monocytogenes was not induced in the untreated host cells, while it increased between 0 and 4 h post-infection in the lipopolysaccharide-treated host cells. Expression of listeriolysin O mRNA in the lipopolysaccharide-treated host cells was also induced at 2 h post-infection, suggesting that listeriolysin O was newly synthesized in the macrophage-like cells. These results suggest that macrophage activation induced with lipopolysaccharide could lead to the expression of the listeriolysin O gene and the synthesis of listeriolysin O protein under suppression of the intracellular growth of L. monocytogenes.

    DOI: 10.1016/S0928-8244(96)00085-5

    Web of Science

    PubMed

  • Expression of listeriolysin O by intracellular Listeria monocytogenes following infection of lipopolysaccharide-treated or untreated J774.1 macrophage-like cells 査読

    K Moriishi, M Koura, F Amano

    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY   16 ( 3-4 )   213 - 222   1996年12月( ISSN:0928-8244 )

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Listeria monocytogenes replicates in a phagocytic cell following escape into the host cytoplasm. Listeriolysin O, secreted by L. monocytogenes, which belongs to the thiol-activated hemolysin family, is known to play an important role in the escape of the bacterium into the host cytoplasm. In this study, we demonstrated that expression of listeriolysin O by infecting L. monocytogenes was lightly induced in J774.1 macrophage-like cells pretreated with lipopolysaccharide, although the growth of the bacteria was suppressed. The number of viable L. monocytogenes decreased until 4 h post-infection and then increased between 3 and 8 h post-infection in untreated J774.1 host cells, but it decreased until 8 h post-infection in lipopolysaccharide-treated host cells. However, expression of listeriolysin O by L. monocytogenes was not induced in the untreated host cells, while it increased between 0 and 4 h post-infection in the lipopolysaccharide-treated host cells. Expression of listeriolysin O mRNA in the lipopolysaccharide-treated host cells was also induced at 2 h post-infection, suggesting that listeriolysin O was newly synthesized in the macrophage-like cells. These results suggest that macrophage activation induced with lipopolysaccharide could lead to the expression of the listeriolysin O gene and the synthesis of listeriolysin O protein under suppression of the intracellular growth of L. monocytogenes.

    DOI: 10.1111/j.1574-695X.1996.tb00138.x

    Web of Science

    PubMed

  • Studying on botulinum C2 toxin gene 査読

    T Kubota, K Kimura, Ohishi, I, K Moriishi, E Isogai, H Isogai, N Fujii

    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY   49 ( 5-6 )   267 - 269   1996年10月( ISSN:0021-5112 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:NATL INST INFECTIOUS DISEASES  

    Web of Science

  • Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms 査読 重要な業績

    Moriishi, K.,Koura, M.,Abe, N.,Fujii, N.,Fujinaga, Y.,Inoue, K.,Ogumad, K.

    Biochimica Et Biophysica Acta-Gene Structure and Expression   1307 ( 2 )   123 - 126   1996年6月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms 査読

    K Moriishi, M Koura, N Abe, N Fujii, Y Fujinaga, K Inoue, K Ogumad

    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION   1307 ( 2 )   123 - 126   1996年6月( ISSN:0167-4781 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    We isolated the gene encoding a botulinum neurotoxin (BoNT) of 1285 amino acids with a molecular weight of 147 364 from the toxigenic bacteriophage d-sA of Clostridium botulinum type D strain South African (Dsa). The BoNT of Dsa (BoNT/Dsa) is composed of three regions on the basis of the homology to BoNT types Cl (BoNT/Cl) and D (BoNT/D). The N-terminal (Met-1 to Val-522) and the C-terminal regions (Trp-945 to Glu-1285) have high identity to corresponding regions of BoNT/D (96% identity) and BoNT/Cl (74% identity), respectively. The core region (Pro-523 to Lys-944) is common to three toxins (83% to 92% identity). These results suggest that neurotoxins produced from Clostridium botulinum types C and D an composed in a mosaic-like fashion.

    Web of Science

  • Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. 査読

    Moriishi K, Koura M, Abe N, Fujii N, Fujinaga Y, Inoue K, Ogumad K

    Biochimica et biophysica acta   1307 ( 2 )   123 - 126   1996年6月( ISSN:0006-3002 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/0167-4781(96)00006-1

    PubMed

  • Molecular composition of Clostridium botulinum type A progenitor toxins 査読

    K Inoue, Y Fujinaga, T Watanabe, T Ohyama, K Takeshi, K Moriishi, H Nakajima, K Inoue, K Oguma

    INFECTION AND IMMUNITY   64 ( 5 )   1589 - 1594   1996年5月( ISSN:0019-9567 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The molecular composition of progenitor toxins produced by a Clostridium botulinum type A strain (A-NIH) was analyzed. The strain produced three types of progenitor toxins (19 S, 16 S, and 12 S) as reported previously. Purified 19 S and 16 S toxins demonstrated the same banding profiles on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), indicating that they consist of the same protein components. The nontoxic components of the 19 S and 16 S toxins are a nontoxic non-hemagglutinin (HA) (molecular mass, 120 kDa) and HA. HA could be fractionated into five subcomponents with molecular masses of 52, 35, 20, 19, and 15 kDa in the presence of 2-mercaptoethanol. The molar ratios of neurotoxins, nontoxic non-HAs, and each HA subcomponent of the 19 S and 16 S toxins showed that only HA-35 of the 19 S toxin was approximately twice the size of that of the 16 S toxin, suggesting that the 19 S toxin is a dimer of the 16 S toxin cross-linked by the 35-kDa subcomponent. The nontoxic non-HA of the 12 S toxin, but not those of the 19 S and 16 S toxins, demonstrated two bands with molecular masses of 106 and 13 kDa on SDS-PAGE with or without 2-mercaptoethanol. It was concluded from the N-terminal amino acid sequences that 106- and 13-kDa proteins were generated by a cleavage of whole nontoxic non-HA. This may explain why the 12 S and 16 S (and 19 S) toxins exist in the same culture. We also found that the HA and its 35-kDa subcomponent exist in a free state in the culture fluid along with the three types of progenitor toxins.

    Web of Science

    PubMed

  • Characterization of component-I gene of botulinum C2 toxin and PCR detection of its gene in clostridial species 査読

    N Fujii, T Kubota, S Shirakawa, K Kimura, Ohishi, I, K Moriishi, E Isogai, H Isogai

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   220 ( 2 )   353 - 359   1996年3月( ISSN:0006-291X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS  

    Botulinum C2 toxin is composed of two nonlinked protein components, component-I (light chain) and component-II (heavy chain). It is produced by Clostridium botulinum types C and D, and is thought to play a lethal pathogenic role, These biological activities of C2 toxin may be due to the ADP-ribosylation of non-muscle actin by component-I of the toxin. We were able to isolate two overlapping gene fragments encoding component-I room the chromosomal DNA of Clostridium botulinum type C strain (C)-203U28, and determine the complete nucleotide sequence of component-I gene. The gene for component-I, bc21, consists of one open reading frame (ORF) encoding 431 amino acid residues (1293 nucleotides) without signaling peptide sequence. The molecular mass calculated from the deduced amino acid sequence was 49400.37 Da. Mono-ADP-ribosyltransferase activity was demonstrated in the lysate from E.coli transformed by the recombinant plasmid, pGEM-C2 encompassing whole component-I gene with its own promotor. (C) 1996 Academic Press, Inc.

    DOI: 10.1006/bbrc.1996.0409

    Web of Science

    PubMed

  • Expression of listeriolysin O by intracellular Listeria monocytogenes following infection of lipopolysaccharide-treated or untreated J774.1 macrophage-like cells 査読 重要な業績

    Moriishi, K.,Koura, M.,Amano, F.

    FEMS Immunology and Medical Microbiology   16 ( 3 )   213 - 222   1996年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Molecular cloning of the gene encoding the mosaic neurotoxin: Composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms 査読 重要な業績

    Moriishi, K.,Koura, M.,Fujii, N.,Fujinaga, Y.,Inoue, K.,Syuto, B.,Oguma, K.

    Applied and Environmental Microbiology   62 ( 2 )   662 - 667   1996年2月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • Molecular cloning of the gene encoding the mosaic neurotoxin: Composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms 査読 重要な業績

    K Moriishi, M Koura, N Fujii, Y Fujinaga, K Inoue, B Syuto, K Oguma

    APPLIED AND ENVIRONMENTAL MICROBIOLOGY   62 ( 2 )   662 - 667   1996年2月( ISSN:0099-2240 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    The DNA fragment common to the genes encoding botulinum neurotoxin types C1 (BN/C1) and D (BN/D) was amplified by PCR from the culture supernatant of Clostridium botulinum type C strain 6813 (C6813) that was treated with either DNase I or proteinase K but not from the supernatant that was treated with both DNase I and proteinase K, suggesting the neurotoxin gene is located on a certain bacteriophage DNA. Thus, to isolate the neurotoxin gene, we performed PCR with the culture supernatant of C6813 and seven primer pairs designed from the genes encoding BN/C1 and BN/D. The coding region in the connected sequence encodes a neurotoxin composed of 1,280 amino acids with a molecular weight of 147,817. The neurotoxin from C6813 has 95% amino acid identity to BN/C1, except for its C-terminal one-third, which is quite similar to the C-terminal one-third of BN/D (95% identity). When we performed PCRs with four primer pairs designed from the 5'-terminal two-thirds of the BN/C1 gene and two primers from the 3'-terminal one-third of the BN/D gene, DNA fragments of the expected sizes (0.5 to 1.3 kbp) could be amplified from C. botulinum type C strains 6812 and 6814. These results suggest that some strains of C. botulinum type C contain the gene encoding the mosaic neurotoxin composed of parts of BN/C1 and BN/D.

    Web of Science

    PubMed

  • Molecular composition of progenitor toxins produced by C-botulinum types A and D 査読

    K Inoue, Y Fujinaga, T Watanabe, T Ohyama, K Moriishi, H Sunagawa, K Inoue, K Oguma

    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY   48 ( 5-6 )   263 - 264   1995年10月( ISSN:0021-5112 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(研究会,シンポジウム資料等)   出版者・発行元:NATL INST HEALTH  

    Web of Science

  • TYPE-A AND B NEUROTOXIN GENES IN A CLOSTRIDIUM-BOTULINUM TYPE AB STRAIN 査読

    Y FUJINAGA, K TAKESHI, K INOUE, R FUJITA, T OHYAMA, K MORIISHI, K OGUMA

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   213 ( 3 )   737 - 745   1995年8月( ISSN:0006-291X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS  

    The genetic structure of neurotoxin genes in a Clostridium botulinum strain producing both type A and B neurotoxins (type AB) was investigated. Analyses by polymerase chain reaction (PCR) using type-specific primers corresponding to the coding regions for N-terminals of light-chains and C-terminals of heavy-chains of type A and type B neurotoxins, and Southern hybridization of total DNA showed that the type AB strain I.P.7212 carries at least one copy each of type A and B neurotoxin genes. Partial nucleotide sequences obtained by direct sequencing of the PCR products indicate that the type A and B genes carried by this strain are not classical type A and non-proteolytic type B genes, but are similar to the type A gene present in a strain which had caused infant botulism in Kyoto and the type B gene present in a proteolytic type B strain. (C) 1995 Academic Press, Inc.

    DOI: 10.1006/bbrc.1995.2192

    Web of Science

    PubMed

  • INVOLVEMENT OF RHO IN GTP-GAMMA-S-INDUCED ENHANCEMENT OF PHOSPHORYLATION OF 20 KDA MYOSIN LIGHT-CHAIN IN VASCULAR SMOOTH-MUSCLE CELLS - INHIBITION OF PHOSPHATASE-ACTIVITY 査読

    M NODA, C YASUDAFUKAZAWA, K MORIISHI, T KATO, T OKUDA, K KUROKAWA, Y TAKUWA

    FEBS LETTERS   367 ( 3 )   246 - 250   1995年7月( ISSN:0014-5793 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    In beta-escin-permeabilized cultured pig aortic smooth muscle cells GTP gamma S dose-dependently enhances Ca2+-induced, wortmannin-sensitive phosphorylation of 20 kDa myosin light chain (MLC(20)), GTP gamma S does not potentiate thiophosphorylation of MLC(20), but does inhibit its dephosphorylation, Pretreatment with C, botulinum exotoxin C-3, which specifically ADP-ribosylates and inactivates the rho family of the small molecular weight G proteins, completely abolishes the effects of GTP gamma S, These results indicate that rite is involved in the GTP gamma S-induced enhancement of Ca2+-dependent MLC(20) phosphorylation in aortic smooth muscle cells, and strongly suggest that this effect of rho is due to inhibition of protein phosphatase activity toward MLC(20).

    DOI: 10.1016/0014-5793(95)00573-R

    Web of Science

    PubMed

  • INVOLVEMENT OF RHO IN GTP-GAMMA-S-INDUCED ENHANCEMENT OF PHOSPHORYLATION OF 20 KDA MYOSIN LIGHT-CHAIN IN VASCULAR SMOOTH-MUSCLE CELLS - INHIBITION OF PHOSPHATASE-ACTIVITY 査読

    M NODA, C YASUDAFUKAZAWA, K MORIISHI, T KATO, T OKUDA, K KUROKAWA, Y TAKUWA

    FEBS LETTERS   367 ( 3 )   246 - 250   1995年7月( ISSN:0014-5793 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    In beta-escin-permeabilized cultured pig aortic smooth muscle cells GTP gamma S dose-dependently enhances Ca2+-induced, wortmannin-sensitive phosphorylation of 20 kDa myosin light chain (MLC(20)), GTP gamma S does not potentiate thiophosphorylation of MLC(20), but does inhibit its dephosphorylation, Pretreatment with C, botulinum exotoxin C-3, which specifically ADP-ribosylates and inactivates the rho family of the small molecular weight G proteins, completely abolishes the effects of GTP gamma S, These results indicate that rite is involved in the GTP gamma S-induced enhancement of Ca2+-dependent MLC(20) phosphorylation in aortic smooth muscle cells, and strongly suggest that this effect of rho is due to inhibition of protein phosphatase activity toward MLC(20).

    DOI: 10.1016/0014-5793(95)00573-r

    Web of Science

    PubMed

  • IDENTIFICATION OF GANGLIOSIDES AS INHIBITORS OF ADP-RIBOSYLTRANSFERASES OF PERTUSSIS TOXIN AND EXOENZYME C3 FROM CLOSTRIDIUM-BOTULINUM 査読

    M HARAYOKOYAMA, Y HIRABAYASHI, F IRIE, B SYUTO, K MORIISHI, H SUGIYA, S FURUYAMA

    JOURNAL OF BIOLOGICAL CHEMISTRY   270 ( 14 )   8115 - 8121   1995年4月( ISSN:0021-9258 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    We have previously reported the presence of an endogenous inhibitory activity in bovine brain for the ADP-ribosylation of GTP-binding proteins catalyzed by pertussis toxin (PT) (Hara-Yokoyama, M., and Furuyama, S, (1989) Biochem. Biophys. Res. Commun. 160, 67-71). In the present study, we identified the inhibitor as a ganglioside, The screening of various gangliosides revealed that G(Q1b alpha) most effectively inhibited the ADP-ribosyltransferase activities of both the holoenzyme and the catalytic subunit of PT. G(Q1b alpha) is a ganglioside newly identified as one of the antigens recognized by the cholinergic neuron-specific antibody, anti-Chol-1 alpha (Hirabayashi, Y,, Nakao, T,, Irie, F,, Whittaker, V,P., Ken, R,, and Ando, S. (1992) J. Biol. Chem. 267, 12973-12978), G(Q1b alpha) also inhibited the PT-catalyzed NAD(+) glycohydrolysis. Unlike PT activity, the ADP-ribosylation and the NAD(+) glycohydrolysis catalyzed by the C3 exoenzyme from Clostridium botulinum type C were inhibited by G(T1b) and G(Q1b). The ADP-ribosylation catalyzed by either PT or the C3 exoenzyme was not inhibited by ceramide, galactocerebroside, or sialic acid. In addition to the inhibitory action of gangliosides on ADP-ribosylation, the importance of gangliosides as regulators of NAD(+) metabolism is discussed.

    DOI: 10.1074/jbc.270.14.8115

    Web of Science

    PubMed

  • 2 DIFFERENT TYPES OF ADP-RIBOSYLTRANSFERASE C3 FROM CLOSTRIDIUM-BOTULINUM TYPE D LYSOGENIZED ORGANISMS 査読

    K MORIISHI, B SYUTO, M SAITO, K OGUMA, N FUJII, N ABE, M NAIKI

    INFECTION AND IMMUNITY   61 ( 12 )   5309 - 5314   1993年12月( ISSN:0019-9567 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    We examined production of ADP-ribosyltransferase C3 in 11 strains of Clostridium botulinum type C and D and their nontoxigenic derivatives. Antisera to C3 proteins of type C organisms divided C3 proteins roughly into at least two groups, bearing no relation to their bacterial types. The C3 gene of type D strain South African was isolated from a toxigenic phage library, and the complete sequence of the C3 gene was determined. The C3 protein of type D strain South African had 98% homology to the C3 protein of type C strain 003-9 and 66% homology to that of type D strain 1873. These results indicate that there are two types of C3 protein in type D organisms, as there are in type C organisms.

    Web of Science

    PubMed

  • CONFIRMED NUCLEOTIDE-SEQUENCE OF FANF OF ESCHERICHIA-COLI K99 FIMBRIAE 査読

    N ABE, K MORIISHI, M SAITO, M NAIKI

    JAPANESE JOURNAL OF VETERINARY RESEARCH   41 ( 2-4 )   97 - 99   1993年11月( ISSN:0047-1917 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:HOKKAIDO UNIV  

    Web of Science

    PubMed

  • Two Different Types of Adp-Ribosyltransferase C3 from Clostridium-Botulinum Type D Lysogenized Organisms 査読 重要な業績

    Moriishi, K.,Syuto, B.,Saito, M.,Oguma, K.,Fujii, N.,Abe, N.,Naiki, M.

    Infection and Immunity   61 ( 12 )   5309 - 5314   1993年2月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • INHIBITION OF NOREPINEPHRINE SECRETION FROM DIGITONIN PERMEABILIZED PC12 CELLS BY BOTULINUM TYPE-D TOXIN 査読

    N YOKOSAWA, N FUJII, K TSUZUKI, K KIMURA, B SYUTO, K MORIISHI, K OGUMA

    TOXICON   30 ( 12 )   1555 - 1562   1992年12月( ISSN:0041-0101 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Botulinum type D neurotoxin inhibited Ca2+-evoked norepinephrine secretion in digitonin permeabilized PCl2 cells. Inhibition by the toxin required prior incubation with dithiothreitol (DTT). The inhibition was dependent on both concentration and incubation times of the toxin, and was affected by Ca2+ concentration. With less than 0.7 muM Ca2+ almost complete inhibition was observed; however, above 0.7 muM, Ca2+ stimulated additional norepinephrine release in a dose-dependent manner.

    DOI: 10.1016/0041-0101(92)90027-3

    Web of Science

    PubMed

  • THE STRUCTURE GENES-CODING FOR THE NONTOXIC COMPONENT OF CLOSTRIDIUM-BOTULINUM TYPE-C AND TYPE-E PROGENITOR TOXINS 査読

    K TSUZUKI, N FUJII, K KIMURA, N YOKOSAWA, K MORIISHI, B SYUTO, K OGUMA

    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY   45 ( 5-6 )   292 - 294   1992年10月( ISSN:0021-5112 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:NATL INST HEALTH  

    Web of Science

  • EPIDERMAL-CELL DIFFERENTIATION INHIBITOR ADP-RIBOSYLATES SMALL GTP-BINDING PROTEINS AND INDUCES HYPERPLASIA OF EPIDERMIS 査読

    M SUGAI, K HASHIMOTO, A KIKUCHI, S INOUE, H OKUMURA, K MATSUMOTO, Y GOTO, H OHGAI, K MORIISHI, B SYUTO, K YOSHIKAWA, H SUGINAKA, Y TAKAI

    JOURNAL OF BIOLOGICAL CHEMISTRY   267 ( 4 )   2600 - 2604   1992年2月( ISSN:0021-9258 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Epidermal cell differentiation inhibitor (EDIN) is a recently discovered protein which inhibits terminal differentiation of cultured keratinocytes (Sugai, M., Enomoto, T., Hashimoto, K., Matsumoto, K., Matsuo, Y., Ohgai, H., Hong, Y.-M., Inoue, S., Yoshikawa, K., and Suginaka, H. (1990) Biochem. Biophys. Res. Commun. 173, 92-98). The amino acid sequence deduced from the EDIN gene has revealed that EDIN shares high amino acid sequence homology with the exoenzyme C3 of Clostridium botulinum (Inoue, S., Sugai, M., Murooka, Y., Paik, S.-Y., Hong, Y.-M., Ohgai, H., and Suginaka, H. (1991) Biochem. Biophys. Res. Commun. 174, 459-464), which has been shown to ADP-ribosylate the rho/rac proteins (members of the small GTP-binding protein family). We show here that EDIN ADP-ribosylates rhoB p21 in time- and dose-dependent manners in a cell-free system. Kinetic studies of the ADP-ribosylation and peptide mapping of the reaction products of rhoB p21 by EDIN and C3 suggest that the mode of action of the ADP-ribosylation by EDIN is quite similar to that by C3 and that the ADP-ribosylation site of rhoB p21 by EDIN is presumably the same as that by C3. Proteins in epidermal membranes and keratinocyte homogenate with M(r) values of about 22,000 are ADP-ribosylated by EDIN or C3. Treatment of cultured human keratinocytes by EDIN or C3 results in an inhibition of terminal differentiation and a stimulation of growth of the cells. Moreover, EDIN and C3 injected into adult mouse skin induce hyperplasia of epidermis. These results suggest that EDIN and C3 affect growth and differentiation of keratinocytes by ADP-ribosylation of protein(s) with a M(r) of about 22,000, which may be the rho/rac proteins or related proteins.

    Web of Science

    PubMed

  • CLONING AND WHOLE NUCLEOTIDE-SEQUENCE OF THE GENE FOR THE LIGHT CHAIN COMPONENT OF BOTULINUM TYPE-E TOXIN FROM CLOSTRIDIUM-BUTYRICUM STRAIN-BL6340 AND CLOSTRIDIUM-BOTULINUM TYPE-E STRAIN MASHIKE 査読

    N FUJII, K KIMURA, T YASHIKI, K TSUZUKI, K MORIISHI, N YOKOSAWA, B SYUTO, K OGUMA

    MICROBIOLOGY AND IMMUNOLOGY   36 ( 3 )   213 - 220   1992年( ISSN:0385-5600 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CENTER ACADEMIC PUBL JAPAN  

    Chromosomal DNAs were extracted from Clostridium butyricum strain BL6340 and Clostridium botulinum type E strain Mashike. The 6.0 Kbp fragment coding for the entire light chain (L) component and the N-terminus of heavy chain (H) component of botulinum type E toxin was obtained from each extracted DNAs after digestion with HindIII. The entire nucleotide sequences for the light chain components of these cloned genes were determined, and the derived amino acid sequences were compared to each other, and with those of botulinum type A, Cl, D, and tetanus toxins reported previously. The cleavage site of L and H components of type E toxin was presumed to be Arg-422. In a total of 422 amino acid residues of L component, 17 residues were different between butyricum and type E toxins, and all these differences were found within 200 residues of N-terminus of L component. On the contrary, five regions showing highly homologous sequences were found in L components among these six toxins, and one more region between botulinum type E and tetanus toxins.

    DOI: 10.1111/j.1348-0421.1992.tb01659.x

    Web of Science

    PubMed

  • PURIFICATION AND CHARACTERIZATION OF ADP-RIBOSYLTRANSFERASES (EXOENZYME-C3) OF CLOSTRIDIUM-BOTULINUM TYPE-C AND TYPE-D STRAINS 査読

    K MORIISHI, B SYUTO, N YOKOSAWA, K OGUMA, M SAITO

    JOURNAL OF BACTERIOLOGY   173 ( 19 )   6025 - 6029   1991年10月( ISSN:0021-9193 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    By cation-exchange column chromatography followed by gel filtration or hydroxylapatite column chromatography, ADP-ribosyltransferases (exoenzyme C3) were isolated from culture supernatants of Clostridium botulinum type C strains Stockholm (CST) and 6813 (C6813) and from type D strains South African (DSA) and 1873 (D1873), and their molecular properties were compared. The purified C3 enzymes were homogeneous in polyacrylamide gel electrophoresis. The C3 enzymes existed as single-chain polypeptides with molecular masses of 25.0 to 25.5 kDa and transferred ADP-riboses to the same substrates in rat brain membrane extract. The C3 enzymes could be roughly classified into two groups with respect to amino acid composition, amino-terminal sequence, and antigenicity. One group contains the C3 enzymes of strains C6813 and DSA, and the other contains those of strains CST and D1873. The specific activity of the C3 enzyme of strain C6813 was about 15 times higher than that of the C3 enzyme of strain CST. These results indicate that the classification of the C3 molecules differs from that of the neurotoxin molecules.

    DOI: 10.1128/jb.173.19.6025-6029.1991

    Web of Science

    PubMed

  • Purification and Characterization of Adp-Ribosyltransferases (Exoenzyme-C3) of Clostridium-Botulinum Type-C and Type-D Strains 査読 重要な業績

    Moriishi, K.,Syuto, B.,Yokosawa, N.,Oguma, K.,Saito, M.

    Journal of Bacteriology   173 ( 19 )   6025 - 6029   1991年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)  

  • LOW-MOLECULAR-WEIGHT GTP-BINDING PROTEINS SERVING AS ADP-RIBOSYLATION SUBSTRATE FOR ADP-RIBOSYLTRANSFERASE FROM CLOSTRIDIUM-BOTULINUM AND THEIR RELATION TO PHOSPHOINOSITIDES METABOLISM IN THYMOCYTES 査読

    P WANG, J NISHIHATA, F MAKISHIMA, K MORIISHI, B SYUTO, S TOYOSHIMA, T OSAWA

    JOURNAL OF BIOCHEMISTRY   108 ( 5 )   879 - 885   1990年11月( ISSN:0021-924X )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN BIOCHEMICAL SOC  

    DOI: 10.1093/oxfordjournals.jbchem.a123296

    Web of Science

    PubMed

  • SEPARATION OF TOXIC ACTIVITY AND ADP-RIBOSYLATION ACTIVITY OF BOTULINUM NEUROTOXIN-D 査読

    K MORIISHI, B SYUTO, K OGUMA, M SAITO

    JOURNAL OF BIOLOGICAL CHEMISTRY   265 ( 27 )   16614 - 16616   1990年9月( ISSN:0021-9258 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Web of Science

    PubMed

  • Separation of Toxic Activity and Adp-Ribosylation Activity of Botulinum Neurotoxin-D 査読 重要な業績

    Moriishi, K.,Syuto, B.,Oguma, K.,Saito, M.

    Journal of Biological Chemistry   265 ( 27 )   16614 - 16616   1990年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:研究論文(学術雑誌)  

  • MOLECULAR DIVERSITY OF NEUROTOXINS FROM CLOSTRIDIUM-BOTULINUM TYPE-D STRAINS 査読

    K MORIISHI, B SYUTO, S KUBO, K OGUMA

    INFECTION AND IMMUNITY   57 ( 9 )   2886 - 2891   1989年9月( ISSN:0019-9567 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Web of Science

    PubMed

  • Molecular Diversity of Neurotoxins from Clostridium-Botulinum Type-D Strains 査読 重要な業績

    Moriishi, K.,Syuto, B.,Kubo, S.,Oguma, K.

    Infection and Immunity   57 ( 9 )   2886 - 2891   1989年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

  • ADP-RIBOSYLATION OF 24-26-KDA GTP-BINDING PROTEINS LOCALIZED IN NEURONAL AND NON-NEURONAL CELLS BY BOTULINUM NEUROTOXIN-D 査読

    MATSUOKA, I, H SAKUMA, B SYUTO, K MORIISHI, S KUBO, K KURIHARA

    JOURNAL OF BIOLOGICAL CHEMISTRY   264 ( 2 )   706 - 712   1989年1月( ISSN:0021-9258 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Web of Science

    PubMed

  • Botulinum neurotoxin D: Variations in molecular properties 招待 査読

    K. Moriishi, B. Syuto, S. Kubo, K. Oguma

    Japanese Journal of Medical Science and Biology   42 ( 5-6 )   181 - 182   1989年( ISSN:0021-5112 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)  

    Botulinum neurotoxins are classified into seven types, A to G, based on their antigenicities (1). Among the seven types, C1 and D toxins have complex antigenicities in that they can cross-react with antiserum for the other type (2-4). A partial explanation of the cross reaction is the recent finding that a subtype of C1 neurotoxin has antigenicities of C1 light chain and D heavy chain (2,3,5). On the other hand, specific antibodies against type D toxins from strains South African (D-SA) and 1873 (D-1873) were separated from anti-toxin sera by affinity chromatography (6). These observations suggest that within the same type, C1 and D neurotoxins differ in the molecular structure and antigenicity. In this paper, the antigenic and molecular characteristics of the purified South-African toxin are compared with those of the 1873 toxin. The molecular properties of D-SA toxin were compared to those of neurotoxins from type C strains, Stockholm (C-ST) and 6813 (C-6813), and a type D strain, 1873 (D-1873). D-SA toxin, purified 610-fold from the culture supernatant in an overall yield of 30%, consisted of an intact peptide chain with a molecular weight of 140,000. Limited proteolysis of the toxin by trypsin formed dichain structure consisting of a light chain (Mr 50,000) and a heavy chain (Mr 90,000) linked by disulfide bond(s). Anti D-SA light-chain IgG reacted with D-1873 toxin but not with C1 toxins. On the other hand, anti D-SA heavy chain ross-reacted with C-ST, D-1873 and C-6813 toxins in that order. Amino-acid sequences of the whole molecule, heavy and light chains of D-SA and D-1873 toxins were similar to each other but not identical. These results suggest the molecular diversity in botulinum D toxins.

    Scopus

▼全件表示

書籍等出版物

  • シンプル微生物学

    ( 担当: 分担執筆)

    南江堂  2018年3月   ISBN:978-4-524-25483-5

     詳細を見る

    記述言語:日本語   著書種別:教科書・概説・概論

  • シンプル微生物学

    ( 担当: その他)

    南江堂  2018年3月   ISBN:9784524254835

     詳細を見る

    記述言語:日本語   著書種別:教科書・概説・概論

  • 人獣共通感染症(改訂三版)

    木村哲, 喜田宏( 範囲: -)

    医薬ジャーナル  2016年2月 

     詳細を見る

    担当ページ:141-144   記述言語:日本語  

講演・口頭発表等

  • Identification of rat hepacivirus entry factors for the development of an HCV-surrogate animal model. 招待 国際会議 重要な業績

    Kohji Moriishi

    The 60th Anniversary Ceremony and the 25th International Conference on Emerging Infectious Diseases in the Pacific Rim of the USJCMSP.  2025年3月 

     詳細を見る

    開催年月日: 2025年3月

    記述言語:英語   会議種別:口頭(招待・特別)  

    開催地:東京   国名:日本国  

  • ジスピロ γ-ラクタム構造を持つ新規抗HBV化合物の創製 重要な業績

    山下篤哉、葛西宏威、田中智久、赤池康範、森石恆司

    第71回ウイルス学会総会  2024年11月 

     詳細を見る

    開催年月日: 2024年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:名古屋   国名:日本国  

  • ラットヘパシウイルスの宿主侵入因子の機能解析 重要な業績

    田中智久、赤池康範、葛西宏威、山下篤哉、森石恆司

    第71回ウイルス学会総会  2024年11月 

     詳細を見る

    開催年月日: 2024年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:名古屋   国名:日本国  

  • B型肝炎ウイルスEnhancer I-Xプロモーター活性を抑制する腸内細菌由来代謝物の探索 重要な業績

    福島瞭、葛西宏威、山下篤哉、田中智久、赤池康範、森石恆司

    第71回ウイルス学会総会   2024年11月 

     詳細を見る

    開催年月日: 2024年11月

    記述言語:日本語   会議種別:ポスター発表  

    開催地:名古屋   国名:日本国  

  • HCVコア蛋白質によるポリコム抑制複合体1主要因子RNF2の分解機序 重要な業績

    葛西宏威、山下篤哉、田中智久、赤池康範、森石恆司

    第71回ウイルス学会総会  2024年11月 

     詳細を見る

    開催年月日: 2024年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:名古屋   国名:日本国  

  • Mechanism of HCV infection-dependent degradation of RNF2, a catalytic component of Polycomb repressive complex 1 (PRC1) 国際会議 重要な業績

    Hirotake Kasai and Kohji Moriishi

    ). The 22nd Awaji International Forum on Infection and Immunity.  2024年9月 

     詳細を見る

    開催年月日: 2024年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:京都   国名:日本国  

  • Regulatory mechanism of Polycomb repressive complex 1 by HCV infection 招待 国際会議 重要な業績

    Moriishi, Kohji

    The Joint 24th international conference on emerging infectious diseases in Pacific Rim of the US-Japan cooperative medical sciences program, Hepatitis panel  2024年3月 

     詳細を見る

    開催年月日: 2024年3月

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(指名)  

  • 抗精神病薬AripiprazoleおよびCariprazineの抗HBV活性機序の解析 重要な業績

    山下篤哉、葛西宏威、田中智久、赤池康弘、森石恆司

    第70回日本ウイルス学会総会  2023年9月 

     詳細を見る

    開催年月日: 2023年9月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:仙台   国名:日本国  

  • HBV/HCV共感染による宿主代謝・遺伝子発現への影響 国際会議 重要な業績

    赤池康範、田中智久、山下篤哉、葛西宏威、森石恆司

    第70回日本ウイルス学会総会  2023年9月 

     詳細を見る

    開催年月日: 2023年9月

    記述言語:日本語   会議種別:口頭(一般)  

  • HBV Enhancer I-X promoter活性を標的とする抗ウイルス化合物の構造活性相関の比較 重要な業績

    葛西宏威、山下篤哉、田中智久、赤池康範、森石恆司

    第70回日本ウイルス学会総会  2023年9月 

     詳細を見る

    開催年月日: 2023年9月

    記述言語:日本語   会議種別:ポスター発表  

  • HCV感染の動物モデル開発 招待 重要な業績

    森石恆司

    令和5年年度第一回 宮川庚子記念研究財団研修会  2023年7月 

     詳細を見る

    開催年月日: 2023年7月

    記述言語:日本語   会議種別:公開講演,セミナー,チュートリアル,講習,講義等  

  • 新型コロナウイルスによる血小板血栓形成メカニズムの解明

    佐々木知幸、白井俊光、築地長治、大石沙織、横森良平、髙野勝弘、森石恆司、井上克枝

    第45回日本血栓止血学会学術集会  2023年6月  日本血栓止血学会

     詳細を見る

    開催年月日: 2023年6月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:北九州市   国名:日本国  

  • HBV/HCV共感染の病態悪化に関与する宿主因子の探索

    赤池康範、田中智久、大津直樹、山下篤哉、葛西宏威、森石恆司

    第69回日本ウイルス学会総会  2022年11月  日本ウイルス学会

     詳細を見る

    開催年月日: 2022年11月

    記述言語:日本語   会議種別:ポスター発表  

    開催地:長崎  

  • HBV Enhancer I-X promoterを標的にした抗ウイルス剤の同定とその抑制機序

    山下篤哉、葛西宏威、田中智久、大津直樹、赤池康範、森石恆司

    第69回日本ウイルス学会総会  2022年11月  日本ウイルス学会

     詳細を見る

    開催年月日: 2022年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:長崎  

  • ラットヘパシウイルスのマウス適応化と肝脂肪蓄積への影響

    大津直樹、田中智久、山下篤哉、葛西宏威、赤池康範、森石恆司

    第69回日本ウイルス学会総会  2022年11月  日本ウイルス学会

     詳細を見る

    開催年月日: 2022年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:長崎  

  • ラットヘパシウイルス感染細胞モデルの開発

    田中智久、大津直樹、赤池康範、葛西宏威、山下篤哉、森石恆司

    第69回日本ウイルス学会総会  2022年11月  日本ウイルス学会

     詳細を見る

    開催年月日: 2022年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:長崎  

  • HCV感染によるポリコーム抑制複合体1活性制御に対するアセチル化反応の意義

    葛西宏威、山下篤哉、田中智久、赤池康範、大津直樹、森石恆司

    第69回日本ウイルス学会総会  2022年11月  日本ウイルス学会

     詳細を見る

    開催年月日: 2022年11月

    記述言語:日本語   会議種別:口頭(招待・特別)  

    開催地:長崎  

  • Analysis of the functional interaction between rodent hepacivirus and miR-122 国際会議 重要な業績

    Tomohisa Tanaka, Naoki Ohtsu, Kohji Moriishi

    28th international symposium on Hepatitis C virus, Flaviviruses, and related viruses  2022年7月 

     詳細を見る

    開催年月日: 2022年7月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Ghent, Belgium  

  • HBV・HCV共感染in vitroシステムの構築と感染による宿主遺伝子発現への影響 :新規抗HBV戦略を目指した基盤研究 招待 重要な業績

    森石恆司

    広島肝臓セミナー  2022年4月  ギリアド

     詳細を見る

    開催年月日: 2022年4月

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(公募)  

    開催地:広島  

  • B型およびC型肝炎ウイルスの感染培養細胞系の開発 招待 重要な業績

    森石恆司

    令和3年度「感染・免疫・がん・炎症」全国共同研究拠点シンポジウム  2022年3月  北海道大学遺伝子病制御研究所

     詳細を見る

    開催年月日: 2022年3月

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(公募)  

    開催地:札幌  

  • HCV感染によるポリコーム抑制複合体1活性制御の分子機序

    葛西宏威、山下篤哉、田中智久、赤池康範、大津直樹、森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:神戸市  

  • ラットヘパシウイルスの異種間伝播とマウス適応化

    大津直樹、田中智久、山下篤哉、葛西宏威、赤池康範、森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語   会議種別:口頭(一般)  

  • HBV Enhancer I-X promoterをターゲットとした抗HBV化合物の同定

    山下篤哉、葛西宏威、田中智久、大津直樹、赤池康範、森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語  

    開催地:神戸市  

  • 一過性および安定発現系への適用可能なSARS-CoV-2レプリコンシステムの開発

    田中智久、岡本徹、葛西宏威、山下篤哉、森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:神戸市  

  • HBV Enhancer I-X promoterをターゲットとした抗HBV化合物の同定

    山下篤哉, 葛西宏威, 田中智久, 大津直樹, 赤池康範, 森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    記述言語:日本語  

    開催地:神戸市  

  • 一過性および安定発現系への適用可能なSARS-CoV-2レプリコンシステムの開発

    田中智久, 岡本徹, 葛西宏威, 山下篤哉, 森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:神戸市  

  • ラットヘパシウイルスの異種間伝播とマウス適応化

    大津直樹, 田中智久, 山下篤哉, 葛西宏威, 赤池康範, 森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    記述言語:日本語   会議種別:口頭(一般)  

  • HCV感染によるポリコーム抑制複合体1活性制御の分子機序

    葛西宏威, 山下篤哉, 田中智久, 赤池康範, 大津直樹, 森石恆司

    第68回 日本ウイルス学会総会  2021年11月 

     詳細を見る

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:神戸市  

  • HCV infection impairs monoubiquitination of histone H2A via proteolysis of RNF2 and activates expression of HOX genes 国際会議

    Hirotake Kasai, Kazuki Mochizuki, Tomohisa Tanaka, Atsuya Yamashita, Yoshiharu Matsuura, and Kohji Moriishi

    第19回あわじ感染と免疫国際フォーラム  2021年9月 

     詳細を見る

    開催年月日: 2021年9月

    記述言語:英語   会議種別:ポスター発表  

    開催地:札幌市  

  • HCV infection impairs monoubiquitination of histone H2A via proteolysis of RNF2 and activates expression of HOX genes 国際会議

    Hirotake Kasai, Kazuki Mochizuki, Tomohisa Tanaka, Atsuya Yamashita, Yoshiharu Matsuura, Kohji Moriishi

    第19回あわじ感染と免疫国際フォーラム  2021年9月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:札幌市  

  • Establishment of HepG2-derived cell line that permits HBV and HCV coinfection 国際会議

    Tomohisa Tanaka, Teruhime Otoguro, Takasuke Fukuhara, Moto Fukai, Akinobu Taketomi, Yoshiharu Matsuura, Kohji Moriishi

    27th International meeting on hepatitis C virus and related viruses  2021年7月 

     詳細を見る

    開催年月日: 2021年7月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Toronto, Canada (Hybrid)  

  • Establishment of HepG2-derived cell line that permits HBV and HCV coinfection 国際会議

    Tomohisa Tanaka, Teruhime Otoguro, Takasuke Fukuhara, Moto Fukai, Akinobu Taketomi, Yoshiharu Matsuura, Kohji Moriishi

    27th International meeting on hepatitis C virus and related viruses  2021年7月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Toronto, Canada (Hybrid)  

  • B型およびC型肝炎ウイルス共感染培養細胞系の開発 招待

    森石 恆司

    微研アドバンスド・セミナー  2021年7月 

     詳細を見る

    開催年月日: 2021年7月

    記述言語:日本語   会議種別:公開講演,セミナー,チュートリアル,講習,講義等  

    開催地:大阪府吹田市  

  • B型およびC型肝炎ウイルス共感染培養細胞系の開発 招待

    森石 恆司

    微研アドバンスド・セミナー  2021年7月 

     詳細を見る

    記述言語:日本語   会議種別:公開講演,セミナー,チュートリアル,講習,講義等  

    開催地:大阪府吹田市  

  • B型肝炎ウイルス受容体結合領域に対する感染中和抗体の作製とエピトープ解析

    矢藤慶悟、小野寺大志、松田麻未、藤本陽、渡士幸一、相崎英樹、加藤孝宣、森石恆司、田村浩二、高橋宜聖、脇田隆字、村松正道、鈴木亮介

    第42回 日本分子生物学会総会  2019年12月 

     詳細を見る

    開催年月日: 2019年12月

    記述言語:日本語   会議種別:ポスター発表  

    開催地:福岡  

  • B型肝炎ウイルス受容体結合領域に対する感染中和抗体の作製とエピトープ解析

    矢藤慶悟, 小野寺大志, 松田麻未, 藤本陽, 渡士幸一, 相崎英樹, 加藤孝宣, 森石恆司, 田村浩二, 高橋宜聖, 脇田隆字, 村松正道, 鈴木亮介

    第42回 日本分子生物学会総会  2019年12月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    開催地:福岡  

  • 4,4'-bis(cyclohexylmethyl)biphenyl-2,2',5,5'-tetraol is the novel anti-HBV compound targeting the viral core promoter

    Atsuya Yamashita, Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, and Kohji Moriishi

    第67回日本ウイルス学会学術集会  2019年10月 

     詳細を見る

    開催年月日: 2019年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:東京  

  • Establishment of the cell line permissive for HBV and HCV coinfection

    Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Takasuke Fukuhara, Yoshiharu Matsuura and Kohji Moriishi

    第67回日本ウイルス学会学術集会  2019年10月 

     詳細を見る

    開催年月日: 2019年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:東京  

  • 4,4'-bis(cyclohexylmethyl)biphenyl-2,2',5,5'-tetraol is the novel anti-HBV compound targeting the viral core promoter

    Atsuya Yamashita, Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Kohji Moriishi

    第67回日本ウイルス学会学術集会  2019年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:東京  

  • Establishment of the cell line permissive for HBV and HCV coinfection

    Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Takasuke Fukuhara, Yoshiharu Matsuura, Kohji Moriishi

    第67回日本ウイルス学会学術集会  2019年10月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:東京  

  • Induction of HOX genes by HCV infection via a reduction in histone H2A monoubiquitination 国際会議

    Hirotake Kasai, Kohji Moriishi

    26th International symposium on hepatitis C virus and related viruses  2019年10月 

     詳細を見る

    開催年月日: 2019年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Soul, South Korea  

  • Induction of HOX genes by HCV infection via a reduction in histone H2A monoubiquitination 国際会議

    Hirotake Kasai, Kohji Moriishi

    26th International symposium on hepatitis C virus and related viruses  2019年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Soul, South Korea  

  • Characterization of monoclonal antibodies against hepatitis B virus preS1 region from antigen-specific memory B cells 国際会議

    Keigo Yato1, 2, Taishi Onodera3, Mami Matsuda1, Akira Fujimoto4, Koichi Watashi1, Hideki Aizaki1, Takanobu Kato1, Kohji Moriishi5, Koji Tamura2, Yoshimasa Takahashi3, Takaji Wakita1, Masamichi Muramatsu1, Ryosuke Suzuki1,

    2019 International HBV Meeting  2019年10月 

     詳細を見る

    開催年月日: 2019年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Melbourne, Australia  

  • Involvement of a novel cyclin-dependent kinase in HBV infection 国際会議

    Tomohisa Tanaka, Kohji Moriishi

    2019 International HBV Meeting  2019年10月 

     詳細を見る

    開催年月日: 2019年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Melbourne, Australia  

  • Characterization of monoclonal antibodies against hepatitis B virus preS1 region from antigen-specific memory B cells 国際会議

    Keigo Yato, Taishi Onodera, Mami Matsuda, Akira Fujimoto, Koichi Watashi, Hideki Aizaki, Takanobu Kato, Kohji Moriishi, Koji Tamura, Yoshimasa Takahashi, Takaji Wakita, Masamichi Muramatsu, Ryosuke Suzuki

    2019 International HBV Meeting  2019年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Melbourne, Australia  

  • Involvement of a novel cyclin-dependent kinase in HBV infection 国際会議

    Tomohisa Tanaka, Kohji Moriishi

    2019 International HBV Meeting  2019年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Melbourne, Australia  

  • B型およびC型肝炎ウイルスに近縁なウイルスとその由来 招待

    森石恆司

    日本ウイルス学会 札幌支部会  2019年7月 

     詳細を見る

    開催年月日: 2019年7月

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(指名)  

    開催地:札幌  

  • B型およびC型肝炎ウイルスに近縁なウイルスとその由来 招待

    森石恆司

    日本ウイルス学会 札幌支部会  2019年7月 

     詳細を見る

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(指名)  

    開催地:札幌  

  • Inhibition of signal peptide peptidase restores monoubiquitination of histone H2A and impairs Hox gene expression in HCV-infected cells.

    Hirotake Kasai1, Tomohisa Tanaka1, Atsuya Yamashita1, Teruhime Otoguro1 and Kohji Moriishi1

    第66回日本ウイルス学会学術集会  2018年10月 

     詳細を見る

    開催年月日: 2018年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:京都  

  • Identification of Hepacivirus F subspecies from Japanese rodents

    Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Atsuya Yamashita, Hiroaki Kariwa, and Kohji Moriishi

    第66回日本ウイルス学会学術集会  2018年10月 

     詳細を見る

    開催年月日: 2018年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:京都  

  • Berberine suppresses hepatitis B virus production via impairment of HBV core promoter activity

    Atsuya Yamashita, Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Kohji Moriishi

    第66回日本ウイルス学会学術集会  2018年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

  • Inhibition of signal peptide peptidase restores monoubiquitination of histone H2A and impairs Hox gene expression in HCV-infected cells.

    Hirotake Kasai, Tomohisa Tanaka, Atsuya Yamashita, Teruhime Otoguro, Kohji Moriishi

    第66回日本ウイルス学会学術集会  2018年10月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:京都  

  • Inhibition of signal peptide peptidase restores monoubiquitination of histone H2A and impairs Hox gene expression in HCV-infected cells

    Hirotake Kasai, Tomohisa Tanaka, Teruhime Otoguro, Atsuya Yamashita, Kohji Moriishi

    第66回日本ウイルス学会学術集会  2018年10月 

     詳細を見る

    記述言語:英語  

  • Identification of Hepacivirus F subspecies from Japanese rodents

    Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Atsuya Yamashita, Hiroaki Kariwa, Kohji Moriishi

    第66回日本ウイルス学会学術集会  2018年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

  • Functional Characterization of hepacivirus replication 招待 国際会議

    Kohji Moriishi

    2018 USA-Japan hepatitis panel meeting  2018年10月 

     詳細を見る

    開催年月日: 2018年10月

    記述言語:英語   会議種別:口頭(招待・特別)  

    開催地:京都  

  • Functional Characterization of hepacivirus replication 招待 国際会議

    森石 恆司

    2018 USA-Japan hepatitis panel meeting  2018年10月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

  • Identification of hepacivirus F subspecies in Japan 国際会議

    Tomohisa Tanaka, Hiroaki Kariwa, Kohji Moriishi

    25th International symposium on hepatitis C virus and related viruses  2018年10月 

     詳細を見る

    開催年月日: 2018年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Dublin, Ireland  

  • Identification of hepacivirus F subspecies in Japan 国際会議

    Tomohisa Tanaka, Hiroaki Kariwa, Kohji Moriishi

    25th International symposium on hepatitis C virus and related viruses  2018年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

  • Identification of a cyclin-dependent kinase that facilitates HBV infection 国際会議

    Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    2018 International HBV Meeting  2018年10月 

     詳細を見る

    開催年月日: 2018年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Taormina, Italy  

  • Identification of a cyclin-dependent kinase that facilitates HBV infection 国際会議

    Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    International HBV Meeting  2018年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

  • BerberineのHBV増殖抑制活性とその抑制機序の解明

    山下篤哉、田中智久、葛西宏威、乙黒光姫、梁明秀、 前川伸哉、榎本信幸、森石恆司

    第28回抗ウイルス療法学会  2018年6月 

     詳細を見る

    開催年月日: 2018年6月

    記述言語:日本語   会議種別:口頭(一般)  

  • BerberineのHBV増殖抑制活性とその抑制機序の解明

    山下篤哉, 田中智久, 葛西宏威, 乙黒光姫, 梁明秀, 前川伸哉, 榎本信幸, 森石恆司

    第28回抗ウイルス療法学会  2018年6月 

     詳細を見る

    記述言語:日本語   会議種別:口頭(一般)  

  • BerberineのHBV増殖抑制活性とその抑制機序の解明

    山下篤哉, 田中智久, 葛西宏威, 乙黒光姫, 梁明秀, 前川伸哉, 榎本信幸, 森石恆司

    第28回抗ウイルス療法学会学術集会  2018年6月 

     詳細を見る

    記述言語:日本語  

  • Functional Characterization of Hepacivirus Replication 招待 国際会議 重要な業績

    Kohji Moriishi

    International Symposium. BIOMARKERS FOR PERSONALIZED HEPATOLOGY  2018年5月 

     詳細を見る

    開催年月日: 2018年5月

    記述言語:英語   会議種別:口頭(招待・特別)  

    開催地:ピサ、イタリア  

  • Functional Characterization of Hepacivirus Replication 招待 国際会議

    森石 恆司

    International Symposium. BIOMARKERS FOR PERSONALIZED HEPATOLOGY  2018年5月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

  • 1. The bidirectional interplay of hepatitis B virus and cell-death inducing DFF45-like effectors

    Hirotake Kasai, Jun Yasumoto, Atsuya Yamashita, Tomohisa Tanaka, Koichi Watashi, Takaji Wakita, Teruhime Otoguro, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    開催年月日: 2017年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:大阪  

  • Establishment of hepatitis B and C virus co-infection cell line

    Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    開催年月日: 2017年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:大阪  

  • Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity

    Atsuya Yamashita, Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    開催年月日: 2017年10月

    記述言語:日本語   会議種別:ポスター発表  

    開催地:大阪  

  • 5’-terminal stem-loop of equine hepacivirus RNA permits miR-122-independent replication 重要な業績

    Tomohisa Takana, Teruhime Otoguro, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    開催年月日: 2017年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:大阪  

  • 1. The bidirectional interplay of hepatitis B virus and cell-death inducing DFF45-like effectors

    Hirotake Kasai, Jun Yasumoto, Atsuya Yamashita, Tomohisa Tanaka, Koichi Watashi, Takaji Wakita, Teruhime Otoguro, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:大阪  

  • Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity

    Atsuya Yamashita, Tomohisa Tanaka, Teruhime Otoguro, Hirotake Kasai, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    開催地:大阪  

  • Establishment of hepatitis B and C virus co-infection cell line

    Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:大阪  

  • 5’-terminal stem-loop of equine hepacivirus RNA permits miR-122-independent replication

    Tomohisa Takana, Teruhime Otoguro, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    第65回日本ウイルス学会総会  2017年10月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:大阪  

  • Screening of antiviral compounds using a highly HBV-permissible HpeG2 cell line 国際会議 重要な業績

    Tomohisa Tanaka, Teruhime Otoguro, Wenjia Chen, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    2017 International meeting on Molecular Biology of Hepatitis B virus  2017年9月 

     詳細を見る

    開催年月日: 2017年9月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Washington, D. C., USA  

  • Involvement of cell death inducing DFF45-like effectors in hepatitis B virus replication 国際会議

    Kohji Moriishi, Jun Yasumoto, Hirotake Kasai, Teruhime Otoguro, Atsuya Yamashita, Tomohisa Tanaka

    2017 International meeting on Molecular Biology of Hepatitis B virus  2017年9月 

     詳細を見る

    開催年月日: 2017年9月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Washington DC, USA  

  • Involvement of cell death inducing DFF45-like effectors in hepatitis B virus replication 国際会議

    Kohji Moriishi, Jun Yasumoto, Hirotake Kasai, Teruhime Otoguro, Atsuya Yamashita, Tomohisa Tanaka

    2017 International meeting on Molecular Biology of Hepatitis B virus  2017年9月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Washington DC, USA  

  • Screening of antiviral compounds using a highly HBV-permissible HpeG2 cell line 国際会議

    Tomohisa Tanaka, Teruhime Otoguro, Wenjia Chen, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi

    2017 International meeting on Molecular Biology of Hepatitis B virus  2017年9月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Washington, D. C., USA  

  • CDK9 inhibitor FIT-039 suppresses HBV propagation.

    Moriishi K, Tanaka T, Okuyama-Dobashi K, Chen W, Okamoto T, Ueda K, Hosaya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    開催年月日: 2016年10月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:札幌  

  • Anti-HBV activity of Coptidis rhizome alkaloids via targeting the viral core promoter.

    Yamashita A, Tanaka T, Okuyama-Dobashi K, Kasai H, Moriishi K

    第64回日本ウイルス学会総会  2016年10月  日本ウイルス学会

     詳細を見る

    開催年月日: 2016年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:札幌  

  • Establishment of highly HBV-permissible HepG2 cell line to facilitate screening of antiviral compounds

    Otoguro T, Tanaka T, Chen W, Kasai H, Yamashita A, Okuyama-Dobashi K, Moriishi K,

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    開催年月日: 2016年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:札幌  

  • Cross-species compatibility of hepacivirus 5’ untranslated region 国際会議

    Tanaka T, Otoguro T, Kasai H, Yamashita A, Okuyama-Dobashi K, Moriishi K

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    開催年月日: 2016年10月

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(指名)  

    開催地:札幌  

  • Hepatitis C virus infection impairs mono-ubiquitination of histone H2A and activates expression of homeobox genes.

    Kasai H, Tanaka T, Yamashita A, Dobashi-Okuyama K, Moriishi K.

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    開催年月日: 2016年10月

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(指名)  

  • Anti-HBV activity of Coptidis rhizome alkaloids via targeting the viral core promoter.

    Yamashita A, Tanaka T, Okuyama-Dobashi K, Kasai H, Moriishi K

    第64回日本ウイルス学会総会  2016年10月  日本ウイルス学会

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:札幌  

  • Hepatitis C virus infection impairs mono-ubiquitination of histone H2A and activates expression of homeobox genes.

    Kasai H, Tanaka T, Yamashita A, Dobashi-Okuyama K, Moriishi K

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(指名)  

  • Establishment of highly HBV-permissible HepG2 cell line to facilitate screening of antiviral compounds

    Otoguro T, Tanaka T, Chen W, Kasai H, Yamashita A, Okuyama-Dobashi K, Moriishi K

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    記述言語:英語   会議種別:口頭(一般)  

    開催地:札幌  

  • Cross-species compatibility of hepacivirus 5’ untranslated region 国際会議

    Tanaka T, Otoguro T, Kasai H, Yamashita A, Okuyama-Dobashi K, Moriishi K

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(指名)  

    開催地:札幌  

  • CDK9 inhibitor FIT-039 suppresses HBV propagation.

    Moriishi K, Tanaka T, Okuyama-Dobashi K, Chen W, Okamoto T, Ueda K, Hosaya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M

    第64回日本ウイルス学会総会  2016年10月 

     詳細を見る

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:札幌  

  • Functional homology of hepacivirus 5’ UTRs in IRES activity and replication. 国際会議

    Tanaka T, Otoguro T, Kasai H, Yamashita A, Okuyama-Dobashi K, Moriishi K

    23rd International symposium on hepatitis C virus and related viruses  2016年10月 

     詳細を見る

    開催年月日: 2016年10月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Kyoto, Japan  

  • Functional homology of hepacivirus 5’ UTRs in IRES activity and replication. 国際会議

    Tanaka T, Otoguro T, Kasai H, Yamashita A, Okuyama-Dobashi K, Moriishi K

    23rd International symposium on hepatitis C virus and related viruses  2016年10月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Kyoto, Japan  

  • Inhibition of HBV propagation by treatment with CDK9 inhibitor FIT-039 国際会議

    Tanaka T, Okuyama-Dobashi K, Chen W, Okamoto T, Ueda K, Hosaya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M and Kohji Moriishi

    2016 Internationa HBV meeting  2016年9月 

     詳細を見る

    開催年月日: 2016年9月

    記述言語:英語   会議種別:ポスター発表  

    開催地:Yosei, Korea  

  • Inhibition of HBV propagation by treatment with CDK9 inhibitor FIT-039 国際会議

    Tanaka T, Okuyama-Dobashi K, Chen W, Okamoto T, Ueda K, Hosaya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M, Kohji Moriishi

    2016 Internationa HBV meeting  2016年9月 

     詳細を見る

    記述言語:英語   会議種別:ポスター発表  

    開催地:Yosei, Korea  

  • プレセニリン阻害剤のC型肝炎ウイルス増殖抑制効果の検討 重要な業績

    乙黒光姫,田中智久,葛西宏威,山下篤哉,森石恆司

    第63回日本ウイルス学会学術集会  2015年11月 

     詳細を見る

    開催年月日: 2015年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:福岡  

  • Metachromin A, sesquiterpene from marine sponge Dactylospongia metachromia, exerts anti-HBV activity via inhibition of HBV core promoter. 重要な業績

    Atsuya Yamashita1,Tomohisa Tanaka,Kaori Okuyama-Dobashi , Kohji Moriishi

    第63回日本ウイルス学会学術集会  2015年11月 

     詳細を見る

    開催年月日: 2015年11月

    記述言語:英語   会議種別:口頭(一般)  

  • Hepatitis B virus infection impairs lipid droplet growth via host regulatory proteins 重要な業績

    The 2015 Italy-Japan Liver Workshop: Steato-Hepatitis and Hepatocellular Carcinoma  2015年10月 

     詳細を見る

    開催年月日: 2015年10月

    記述言語:英語   会議種別:口頭(招待・特別)  

    開催地:ナポリ、イタリア  

  • Establishment of a novel cell line with high susceptibility to NTCP-dependent HBV infection 重要な業績

    Moriishi K

    The 2nd Japan-Italy Liver Workshop:“Hepatitis, Steatosis and Hepatocellular Carcinoma: Molecular Basis and Clinical Links  2014年11月 

     詳細を見る

    開催年月日: 2014年11月

    記述言語:英語   会議種別:口頭(招待・特別)  

    開催地:広島  

  • トリプシン・EDTAによるNTCP依存HBV感染の増強

    圡橋香織,葛西宏威,田中智久,森石恆司,他

    第62回日本ウイルス学会学術集会  2014年11月 

     詳細を見る

    開催年月日: 2014年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:横浜  

  • 海洋生物抽出物ライブラリーソースからのB型肝炎ウイルス転写活性抑制化合物の探索

    山下篤哉,藤本雄介,田中智久,葛西宏威,森石恆司,他

    第62回日本ウイルス学会学術集会  2014年11月 

     詳細を見る

    開催年月日: 2014年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:横浜  

  • EFdA,a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium 重要な業績

    Takamitsu Matsuzawa,Tatsuyoshi Kawamura,Youichi Ogawa,K Maeda,H Nakata,Kohji MORIISHI,Y Koyamagi,H Gatanaga

    DC 2014 13th international symposium  2014年9月 

     詳細を見る

    開催年月日: 2014年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Tours,France  

  • Infection of equine hepacivirus in a closed colony of Japanese native horse

    Tanaka T, Kasai H, Yamashita A, and Moriishi K

    The 21st International meeting on Hepatitis C virus and related viruses  2014年9月 

     詳細を見る

    開催年月日: 2014年9月

    記述言語:英語   会議種別:その他  

    開催地:Banff, Canada.  

  • Establishment of a novel cell line with high susceptibility to NTCP-dependent HBV infection.

    Dobashi K, Kasai H, Tanaka T, and Moriishi K

    2014 International Meeting on Molecular Biology of Hepatitis B viruses  2014年9月 

     詳細を見る

    開催年月日: 2014年9月

    記述言語:英語   会議種別:その他  

    開催地:Los Angels, USA  

  • CCR5阻害薬Maraviroc内服による表皮内ランゲルハンス細胞のHIV-1感染性への影響 重要な業績

    川村 龍吉,松澤 高光,小川 陽一,青木 類,森石 恆司,小柳 義夫,潟永 博之,島田 眞路

    第24回抗ウイルス療法研究会  2014年5月 

     詳細を見る

    開催年月日: 2014年5月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:富士吉田  

  • EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium 重要な業績

    Takamitsu Matsuzawa,Tatsuyoshi Kawamura,Youichi Ogawa,Kohji MORIISHI,Yoshio Koyanagi,Hiroyuki Gatanaga,Shinji Shimada,Hiroaki Mitsuya

    LC2013 13th International Workshop on Langerhans Cells  2013年10月 

     詳細を見る

    開催年月日: 2013年10月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Amsterdam, The Netherlands  

  • Caffeic acid phenethyl esterとその類縁化合物によるHCVゲノム複製阻害効果の検討 

    山下篤哉,沈暉,葛西宏威,藤本雄介,森石恆司

    第60回日本ウイルス学会学術集会  2012年11月 

     詳細を見る

    開催年月日: 2012年11月

    記述言語:日本語   会議種別:その他  

  • 新規宿主因子FKBP6によるHCV複製制御機構の解析 重要な業績

    葛西宏威,河上國洋,平田有佳理,山下篤哉,池田正徳,加藤宣之,岡本徹,松浦善治,楠木正己,森石恆司 

    第60回日本ウイルス学会学術集会  2012年11月 

     詳細を見る

    開催年月日: 2012年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:大阪  

  • 海綿動物Amphimedon sp. 抽出画分によるHCVNS3プロテアーゼ・ヘリカーゼ活性阻害の解析 重要な業績

    藤本雄介,山下篤哉,池田正徳,加藤宣之,森石恆司

    第60回日本ウイルス学会学術集会  2012年11月 

     詳細を見る

    開催年月日: 2012年11月

    記述言語:日本語   会議種別:その他  

  • FKBP6 plays an important role in HCV replication through binding to HCV NS5A. 重要な業績

    Kasai H.,Kawakami K.,Yamashita A. ,Ikeda M.,Kato N. ,Matsuura Y. ,Kusunoki M.,Moriishi K.

    19th International Symposium on Hepatitis C virus and related viruses.  2012年10月 

     詳細を見る

    開催年月日: 2012年10月

    記述言語:英語   会議種別:その他  

    開催地:Venezia, Italia  

  • IL-28B(IFNλ-3)and IFN-αsynergistically inhibit HCV replication 重要な業績

    Hiroko SHINDOH,Shinya MAEKAWA,Nobutoshi KOMATSU,Kazuki KOMASE,Mika MIURA,Makoto KADOKURA,Ryota SUEKI,Fumitake Amemiya,Yasuhiro NAKAYAMA,Taisuke INOUE,Minoru SAKAMOTO,Atsuya YAMASHITA,Kohji MORIISHI,Nobuyuki ENOMOTO

    第3回国際交流フォーラム  2012年4月 

     詳細を見る

    開催年月日: 2012年4月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:東京  

  • Regulation of HCV replication by FKBP8-dependent or -independent Hsp90 activity 重要な業績

    Kunihiro KAWAKAMI,Hirotake KASAI,Atsuya YAMASHITA,Yoshiharu MATSUURA,Masami KUSUNOKI,Kohji MORIISHI

    第34回日本分子生物学会  2011年12月 

     詳細を見る

    開催年月日: 2011年12月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:横浜  

  • Baculovirus GP64-mediated entry into mamalian cells 重要な業績

    Chikako KATAOKA,Hideki TANI,Yuuki KANAME,Shuhei TAGUWA,Hiroyuki ABE,Takasuke FUKUHARA,Kohji MORIISHI,Yoshiharu MATSUURA

    第34回日本分子生物学会  2011年12月 

     詳細を見る

    開催年月日: 2011年12月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:横浜  

  • ウイルス感染による細胞内SUMO化修飾の動態解析 重要な業績

    芦沢 暁,森石 恆司,藤室 雅弘

    第34回日本分子生物学会  2011年12月 

     詳細を見る

    開催年月日: 2011年12月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:横浜  

  • Involvement of cyclophilin B in the replication of Japanese encephalitis virus 重要な業績

    Hiroto KAMBARA,Hideki TANI,Yoshio MORI,Takayuki ABE,Hiroshi KATOH,Takasuke FUKUHARA,Shuhei TAGUWA,Kohji MORIISHI,Yoshiharu MATSUURA

    International Union of Microbiological Societies 2011 Congress  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Spporo  

  • Marine natural products as a source of the novel antiviral agent targeting to HCV NS3 helicase 重要な業績

    Atsuya YAMASHITA,Yuusuke FUJIMOTO,Kohji MORIISHI

    International Union of Microbiological Societies 2011 Congress  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Sapporo  

  • Inhibitory effect of marine natural products on the replication of hepatitis C virus 重要な業績

    Yuusuke FUJIMOTO,Atsuya YAMASHITA,Kohji MORIISHI

    International Union of Microbiological Societies 2011 Congress  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Sapporo  

  • Regulation of HCV replication by FKBP8-dependent or -independent Hsp90 activity 重要な業績

    Kunihiro KAWAKAMI,Hirotake KASAI,Atsuya YAMASHITA,Nobuyuki ENOMOTO,Yoshiharu MATSUURA,Masami KUSUNOKI,Kohji MORIISHI

    18th International Symposium on Hepatitis C Virus and Related Viruses  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Seattle  

  • 海洋生物抽出物より取得したcholestrol slfateによるC型肝炎ウイルスNS3 helicase阻害作用 重要な業績

    古田 篤史,Kazi Abdus SALAM,長浜 夏樹,秋光 信佳,田中 淳一,谷 英典,山下 篤哉,森石 恆司,常田 聡,関口 勇地,野田 尚宏

    第63回日本生物工学会大会  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:東京  

  • Inhibitors against NS3 helicase of hepatitis C virus from coral reef invertebrates 重要な業績

    Junichi TANAKA,Natsuki NAGAHAMA,Atsushi FURUTA,Kazi Abdus SALAM,Nobuyoshi AKIMITSU,Hidenori TANI,Atsuya YAMASHITA,Kohji MORIISHI,Satoshi TSUNEDA,Yuji Sekiguchi,Naohiro NODA

    52nd Annual American Society of Pharmacognosy meeting  2011年8月 

     詳細を見る

    開催年月日: 2011年8月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:San Diego  

  • Identification and biochemical characterization of novel hepatitis C virus NS3 inhibitors, Manoalide and Psammaplin A 重要な業績

    Kazi Abdus SALAM,Atsushi FURUTA,Natsuki NAGAHAMA,Junichi TANAKA,Atsuya YAMASHITA,Hidenori TANI,Yuji SEKIGUCHI,Satoshi TSUNEDA,Kohji MORIISHI,Kenichi IJIRI,Naohiro NODA,Nobuyoshi AKIMITSU

    16th Annual Meeting of the RNA Society  2011年6月 

     詳細を見る

    開催年月日: 2011年6月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Kyoto  

  • In silico分子設計手法によるHCV NS3 protease活性阻害化合物の創製 重要な業績

    山下 篤哉,松本 武久,高谷 大輔,上條 加寿恵,前川 伸哉,坂本 直哉,池田 正徳,加藤 宣之,梅山 秀明,横山 茂之,榎本 信幸,森石 恆司

    第21回抗ウイルス療法研究会  2011年5月 

     詳細を見る

    開催年月日: 2011年5月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:金沢  

  • 海洋生物をライブラリーソースとしたHCV NS3 Helicase活性阻害化合物の検索 重要な業績

    山下 篤哉,古田 篤史,田中 淳一,長浜 夏樹,秋光 信佳,Kazi Abdus SALAM,谷 英典,松田 泰嘉,藤田 統,藤本 雄介,池田 正徳,加藤 宣之,前川 伸哉,榎本 信幸,常田 聡,関口 勇地,野田 尚宏,森石 恆司

    第21回抗ウイルス療法研究会  2011年5月 

     詳細を見る

    開催年月日: 2011年5月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:金沢  

  • C型肝炎ウイルス感染細胞特異的なウイルス排除システムの構築 重要な業績

    温 暁玉,阿部 隆之,久木原 博,田鍬 修平,森 嘉生,谷 英樹,加藤 宣之,鈴木 哲朗,巽 正志,森石 恆司,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • HCVによる脂質代謝障害の分子機序 重要な業績

    森石 恆司,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • バキュロウイルスベクターの遺伝子導入に伴う宿主自然免疫応答の解析 重要な業績

    二宮 彰紀,温 暁玉,要 祐喜,谷 英樹,森石 恆司,阿部 隆之,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • C型肝炎ウイルスの細胞侵入におけるフォスフォリパーゼCおよびプロテインキナーゼC依存的なシグナル伝達経路の関与 重要な業績

    谷 英樹,阿部 隆之,森石 恆司,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • C型肝炎ウイルスはオートファジーを誘導して持続感染を成立させる 重要な業績

    寒原 裕登,田鍬 修平,藤田 尚信,野田 健司,森石 恆司,吉森 保,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • 核小体蛋白質B23はC型肝炎ウイルスの複製を抑制する 重要な業績

    加藤 大志,森 嘉生,寒原 裕登,要 祐喜,谷 英樹,阿部 隆之,神谷 亘,森石 恆司,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • 不死化ヒト肝細胞株であるHc細胞に対する患者血清由来HCVの持続感染システム 重要な業績

    塩川 舞,福原 崇介,後藤 志典,二宮 彰紀,谷 英樹,阿部 隆之,森石 恆司,松浦 喜治

    第58回日本ウイルス学会学術集会  2010年11月 

     詳細を見る

    開催年月日: 2010年11月

    記述言語:日本語   会議種別:口頭(一般)  

    開催地:徳島  

  • A splice variant of CD44 participates in the IP-10 production in cells infected with HCV 重要な業績

    Takayuki ABE,Kohji MORIISHI,Yoshiharu MATSUURA

    17th International Meeting on Hepatitis C Virus and Related Viruses  2010年9月 

     詳細を見る

    開催年月日: 2010年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Yokohama  

  • Inhibition of autophagy induces lysosomal vacuolation in cells replicating HCV 重要な業績

    Hiroto KAMBARA,Shuhei TAGUWA,Naonobu FUJITA,Takeshi NODA,Tamotsu YOSHIMORI,Kohji MORIISHI,Yoshiharu MATSUURA

    17th International Meeting on Hepatitis C Virus and Related Viruses  2010年9月 

     詳細を見る

    開催年月日: 2010年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Yokohama  

  • HCV replication enhances secretion of an immature cathepsin B through induction of an incomplete autophagy 重要な業績

    Shuhei TAGUWA,Hiroto KAMBARA,Naonobu FUJITA,Takeshi NODA,Tamotsu YOSHIMORI,Kohji MORIISHI,Yoshiharu MATSUURA

    17th International Meeting on Hepatitis C Virus and Related Viruses  2010年9月 

     詳細を見る

    開催年月日: 2010年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Yokohama  

  • Involvement of PA28gamma in the propagation of HCV 重要な業績

    Kohji MORIISHI,Ikuo SHOJI,Yoshio MORI,Ryosuke SUZUKI,Tetsuro SUZUKI,Chikako KATAOKA,Yoshiharu MATSUURA

    17th International Meeting on Hepatitis C Virus and Related Viruses  2010年9月 

     詳細を見る

    開催年月日: 2010年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Yokohama  

  • Involvement of phospholipatse C and protein kinase C-dependent signaling pathways in the entry of HCV 重要な業績

    Hideki TANI,Takayuki ABE,Kohji MORIISHI,Yoshiharu MATSUURA

    17th international Meeting on Hepatitis C Virus and Related Viruses  2010年9月 

     詳細を見る

    開催年月日: 2010年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Yokohama  

  • Intracellular delivery of serum-derived HCV 重要な業績

    Takasuke FUKUHARA,Hideki TANI,Mai SHIOKAWA,Takayuki ABE,Kohji MORIISHI,Akinobu TAKETOMI,Yoshihiko MAEHARA,Yoshiharu MATSUURA

    17th Intrnational Meeting on Hepatitis C Virus and Related Viruses  2010年9月 

     詳細を見る

    開催年月日: 2010年9月

    記述言語:英語   会議種別:口頭(一般)  

    開催地:Yokohama  

▼全件表示

産業財産権

  • 細胞株及びその作製方法

    森石恆司、田中智久

     詳細を見る

    出願番号:特願2022-077289  出願日:2022年5月

  • 細胞株及びその作製方法

    森石恆司、田中智久

     詳細を見る

    出願番号:特願2021-084127  出願日:2021年5月

  • 細胞株及びその作製方法

    田中智久, 森石恆司

     詳細を見る

    出願人:国立大学法人山梨大学

    出願番号:特願2021-084127  出願日:2021年5月

担当授業科目(学内)

  • 人体の生命科学

    2024年度  科目区分:共通教育(学部)

  • 生命科学特論II(病態制御学) 重要な業績

    2024年度

  • 感染免疫学総論

    2024年度

  • 肝病態医学特論 重要な業績

    2024年度

  • 微生物学 重要な業績

    2024年度

  • 病態・生理論

    2024年度

  • 人体の生命科学

    2024年度

  • 微生物学 重要な業績

    2023年度

  • 肝病態医学特論 重要な業績

    2023年度

  • 生命科学特論II(病態制御学) 重要な業績

    2023年度

  • 統合臨床医学コース5

    2023年度

  • 統合臨床医学コース4

    2023年度

  • 統合臨床医学コース2

    2023年度

  • 統合臨床医学コース1

    2023年度

  • 感染制御学

    2021年度  科目区分:専門教育(学部)

  • 新総合医学概論

    2017年度

  • チュートリアルコース3

    2017年度  科目区分:専門教育(学部)

  • チュートリアルコース2

    2017年度

  • チュートリアルコース8

    2017年度  科目区分:専門教育(学部)

  • 環境健康科学

    2017年度  科目区分:その他(学部)

  • 微生物学(二年) 重要な業績

    2017年度  科目区分:専門教育(学部)

  • 生命科学特論II(病態制御学)

    2017年度  科目区分:修士(大学院)

  • チュートリアルコース7

    2017年度  科目区分:専門教育(学部)

  • チュートリアルコース5

    2017年度  科目区分:専門教育(学部)

  • 微生物学(三年) 重要な業績

    2017年度  科目区分:専門教育(学部)

    微生物学総論、細菌学、ウイルス学、真菌学

▼全件表示

担当経験のある科目(授業)

  • 大阪大学

    機関名:ウイルス学

  • 微生物学

    機関名:浜松医科大

  • 環境健康科学

    機関名:山梨大学 生命環境学部

  • 微生物学

    機関名:山梨大学 医学部

  • 大阪大学

    機関名:ウイルス学

  • ウイルス学

    機関名:大阪大学

▼全件表示

指導実績

  • 2022年度

    種別:学部(専攻科Aコース)卒業論文指導  期間:12ヶ月  年間指導時間:200時間

    指導人数 :1人 

    担当教員数:2人

     詳細を見る

    卒論研究、生命環境学部学生

  • 2018年度

    種別:博士学位論文指導  期間:48ヶ月  年間指導時間:200時間

    指導人数 :2人  (内 留学生):0人

    卒業/修了/学位取得人数 :1人  (内 留学生):0人

    担当教員数:2人

     詳細を見る

    論文作成と発表を指導

  • 2017年度

    種別:博士学位論文指導

    指導人数 :2人 

  • 2016年度

    種別:修士(専攻科Bコース)学位論文指導  期間:24ヶ月  年間指導時間:200時間

    指導人数 :1人 

    卒業/修了/学位取得人数 :1人 

    担当教員数:2人

     詳細を見る

    研究および論文作成指導

その他の学部学生指導

  • 2021年度

    卒論研究指導、生命環境学部

    卒論、生命環境学部学生1名

教科書・教材

  • シンプル微生物学 第六版

    出版社:南江堂  2018年02月27日

修士・博士論文審査

  • 2024年度

    主査副査分類:主査

    課程博士 :1人  (内 留学生):1人

    論文博士 :1人  (内 留学生):1人

  • 2022年度

    主査副査分類:主査

    修士 :0人  (内 留学生):0人

    課程博士 :1人  (内 留学生):0人

    論文博士 :0人  (内 留学生):0人

  • 2019年度

    主査副査分類:主査

    課程博士 :1人  (内 留学生):0人

  • 2018年度

    主査副査分類:主査

    修士 :1人 

    課程博士 :1人 

    論文博士 :0人  (内 留学生):0人

  • 2017年度

    主査副査分類:主査

    課程博士 :1人 

外部発表指導の実績

  • 2023年度

    日本語論文発表指導・口頭発表 (指導人数):5人  (指導時間):10時間

    英語 論文発表指導・学術論文 (指導人数):5人  (指導時間):10時間

  • 2018年度

    日本語論文発表指導・口頭発表 (指導人数):3人  (指導時間):12時間

    日本語論文発表指導・学術論文 (指導人数):0人  (指導時間):0時間

    英語 論文発表指導・口頭発表 (指導人数):2人  (指導時間):48時間

    英語 論文発表指導・学術論文 (指導人数):1人  (指導時間):100時間

社会貢献活動

  • 今だから知りたい感染症のこと

    役割:講師

    山梨県  2021年4月 - 2021年5月

     詳細を見る

    対象: 社会人・一般

    種別:講演会

  • 今だから知りたい感染症のこと

    役割:講師

    山梨県  2021年4月 - 2021年5月

     詳細を見る

    対象: 社会人・一般

    種別:講演会

  • 動物生理

    役割:講師

    2017年7月 - 現在

     詳細を見る

    対象: 大学生

    種別:出前授業

  • スーパーサイエンスハイスクール指導員

    役割:助言・指導

    韮崎高校  韮崎高校  2017年4月 - 2023年3月

     詳細を見る

    対象: 高校生

    種別:研究指導

  • スーパーサイエンスハイスクール指導員

    役割:助言・指導

    韮崎高校  韮崎高校  2017年4月 - 2022年3月

     詳細を見る

    対象: 高校生

    種別:研究指導

  • スーパーサイエンス指定校の評価委員

    役割:助言・指導

    韮崎高校  韮崎高校  韮崎高校  2016年4月 - 2017年3月

     詳細を見る

    対象: 高校生

    種別:研究指導

▼全件表示

所属学協会

  • 日本ウイルス学会

  • 日本分子生物学会

  • 日本分子生物学会

  • 日本ウイルス学会

委員歴

  • 日本ウイルス学会   常任理事  

    2023年1月 - 2025年12月   

      詳細を見る

    団体区分:学協会

  • 韮崎高校 スパーサイエンスハイスクール 評価委員会   外部評価委員  

    2020年4月 - 現在   

  • 韮崎高校 スパーサイエンスハイスクール 評価委員会   外部評価委員  

    2020年4月 - 2021年3月   

  • 日本ウイルス学会    評議員  

    2019年4月 - 2025年3月   

  • 日本ウイルス学会   理事  

    2019年4月 - 2020年3月   

  • 日本ウイルス学会   理事  

    2019年4月 - 2020年3月   

  • 日本ウイルス学会   評議員  

    2019年4月 - 2020年3月   

  • 日本ウイルス学会    評議員  

    2017年4月 - 2019年3月   

  • 日本ウイルス学会   理事  

    2017年4月 - 2019年3月   

  • 日本ウイルス学会   理事  

    2017年4月 - 2019年3月   

  • 日本ウイルス学会   評議員  

    2017年4月 - 2019年3月   

  • 日本ウイルス学会   評議委員  

    2016年4月 - 現在   

  • 日本ウイルス学会   理事  

    2016年4月 - 2019年3月   

  • 日本ウイルス学会   理事  

    2016年4月 - 2017年3月   

  • 日本ウイルス学会   評議委員  

    2016年4月 - 2017年3月   

▼全件表示